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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

The Urology Papers
On several occasions, the Canadian
Academy of Urological Surgeons dis
cussed the scarcity of urological arti
cles published in the Canadian Journal
of Surgery. The academy recognized
that urological investigators had a
natural tendency to publish their work
in journals that were more likely to be
read by their peers in the specialty,
but it also believed that its responsibil
ity towards the only national surgical
journal was not being discharged.
Probably other surgical bodies have
addressed themselves to the same issue.
In the present era of specialization
there is a risk that specialists will be
come increasingly less aware of progress
made in other disciplines. Although it
is impossible to keep abreast of all the
new discoveries in all the disciplines,
specialists would be deficient if they did
not attempt to be apprised of pertinent
developments, particularly by their col
leagues. Several institutions have jour

nals that tie their members together and
allow communication and exchanges
between the members, and “Canadian
surgery” as an institution is no excep
tion. Obviously some discretion should
be applied by individuals submitting
articles in selecting appropriate topics
that are of wide interest, in order to
have a larger number of readers and
to give credence to their work.
Because of the concerns expressed
above, it was suggested that the initial
step could be more readily accom
plished if it was undertaken collective
ly. This notion met with success and
most urologists who were approached
showed an immediate willingness to
contribute. The articles submitted were
too numerous to be included in one is
sue and the coeditors have decided to
split them between the current issue
and the November issue.
Although the collective spirit of this
project generated enthusiasm, the suc

cess of the Canadian Journal of Sur
gery will depend on the initiative of
individual investigators
and
their
continuing support.
Besides being a vehicle for the pub
lication of scientific articles, the Cana
dian Journal of Surgery is a forum for
discussion of subjects of mutual inter
est to many Canadian surgeons— un
dergraduate and postgraduate teaching,
continuing education and research, for
example. It would be a sad reflection
on “Canadian surgery” if this journal
was not adequately supported and we,
the urologists of Canada, show our
support through the publication of
the articles that appear in this issue
and in the November issue.
S aid A. A w a d , m b , b ch frcs [c ]

Department of urology,
Queen’s University,
Kingston, Ont.

Prognostication or Biology: Acquired Abnormalities
of Host Defence Mechanism in Surgical Patients
When discussing the role of acquired
defects in host defence in the devel
opment or prediction of clinical out
come one must question which came
first, the septic process or the defect
in the immune system. It is increasing
ly apparent that sepsis can be both
the cause and the result of acquired
defects in host defence.1'3 The value of
any measurement which predicts pa
tient outcome is twofold. First, partic
ular measures can be taken to improve
results in an individual patient. Second,
certain patients known to be at risk
VOLUME 22, NO. 5, SEPTEMBER 1979 /

can be assessed to determine the
biologic processes that contribute to
their poor outcome. It is only by
defining specific defects that an ap
proach to management can be devel
oped which will contribute to im
proved survival.
In this issue (page 447), McCredie
and colleagues have described some
immunologic abnormalities in patients
with sepsis who subsequently died.
Their results demonstrate that the ac
tivity of K cells (nonimmune lympho
cytes) as measured by an antibody

dependent cellular cytotoxicity (ADCC)
test is reduced, as is the total number
of lymphomononuclear cells, and that
adherence of polymorphonuclear leu
kocytes is decreased in all patients
with sepsis, particularly in those who
died. It appears therefore that patients
with these markers should be watched
particularly closely and treated urgent
ly for all correctable causes of possible
morbidity. These are interesting results
and may help to clarify why some
patients do poorly. The balance of
McCredie’s study indicates a number
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of negative findings, not all of which
are in agreement with data in the
literature.
The design of the study has some
worrisome aspects. The study popula
tion, consisting of 34 patients all of
whom are stated to have had sepsis, is
not well defined. A description of the
nature and type of their infections
and the microbiologic causes would
have been interesting. Ten of these 34
patients were not receiving antibiotics
although that may have been the case
only at the time the investigation was
carried out. In the study of patients
with sepsis, it is critical that strict
criteria (e.g., a positive blood culture,
a confirmed abscess or other totally
objective assessment) be utilized so
that data from one series can be
compared with those from another.
The definition of the numbers of
B and T cells is occasionally confus
ing. With lymphocytopenia the num
bers of B and T cells circulating are
reduced. The ADCC test is a com
plicated test to do and to interpret. It
depends upon the recognition of an Fc
fragment by an Fc receptor on the
specific K cell. Cells that contain these
Fc receptors include neutrophils, mo
nocytes, B and T lymphocytes, baso
phils and possibly eosinophils. There
fore, unless the cell populations are
highly purified and defined, the num
ber of lytic units demonstrated by
ADCC testing may not reflect lympho
cyte function but rather the function
of an altered Fc receptor or any num
ber of leukocytes. This would suggest
that a circulating factor was affecting
this receptor, a finding which would
be consistent with immunosuppressive
factors reported by others.3"5
The data on neutrophil adherence
are at variance with those of Mac
Gregor’s group6 and of our own.7
There does not seem to be an ex
planation for this and it may depend
entirely upon the definition of the
patient population. The neutrophil bac
tericidal studies against Pseudomonas
aeruginosa may be statistically differ
ent but it is hard to be convinced that
they differ biologically. The percent
ages of colony forming units at 120
minutes were 97.7% versus 99.3%.
This difference of approximately 1.6%
or 32 000 colony forming units is not
large when the original population was
2 million bacteria. Most laboratories
performing bactericidal assays require
a difference in killing of at least
half a log to ascribe any statistical
significance to it.8 In the chemotactic
studies' a relatively nondiscriminating
end point (i.e., the number of cells
on the far side of the filter) was used,
which may account for the differing
results obtained by McCredie and as
404

sociates from those of other laborato
ries.9"11
The ADCC test appears to be the
most discriminating. The mechanism
for reduction is not clear since drugs
may also affect Fc receptor func
tion. The question arises: Were pa
tients in McCredie’s study treated
differently (i.e., 10 patients did not
receive antibiotics, 7 patients received
steroids and 9 patients had total paren
teral nutrition)? The use of the term
predictive in this setting without graph
ic presentation of the actual data is
difficult as the sensitivity of the test
cannot be evaluated. To be effectively
predictive, a test must be sensitive as
well as discriminating. Regardless of
their prognostic value, the ADCC ab
normalities provide data that are useful
in defining acquired host defects in sur
gical patients. The results of the test
suggest that there is a factor either
circulating or upon the cell membrane
which affects the Fc receptor.
It is unfortunate that skin testing
with a variety of recall antigens was
not performed. This approach to the
identification of the patient with al
tered host defences and as a predictor
of outcome is becoming well estab
lished. '■’•1*,,s The specific value of skin
testing is twofold. First, it is prognostic,
it identifies the patient at risk of sepsis
and death. Second, and perhaps more
important, when the population at risk
has been identified, the biology of the
increased frequency of sepsis and mor
tality in this group can be intensively
studied to define the acquired defects
and to develop therapeutic approaches.
The causative factors contributing to
anergy include sepsis, hemorrhage,
trauma, surgery, malnutrition, cancer
and a variety of other factors.2,4 The
relating of clinical events with biologic
processes in anergic patients has
facilitated the development of thera
peutic strategy. Malnutrition clearly
plays a role but is not the only factor.
Drainage of sepsis, biliary tract sur
gery, resection of colonic cancer, re
storation of blood volume with control
of hemorrhage are all associated with
rapid restoration of skin test responses
and improvement of neutrophil chemotaxis.2 Levamisole, effective in vitro
against circulating inhibitors of neutro
phil chemotaxis,14 can in vivo reduce
morbidity from sepsis but could not be
shown statistically to have an effect
upon mortality, anergy or neutrophil
chemotaxis.2
It is only by defining immunologic
processes, as McCredie and his group
have done, that ultimately the biology
of altered host resistance to infection
can be adequately described and treat
ment delineated. There are a number
of areas to which much research must
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be directed. These include: circulating
factors; the speed with which these
defects can appear following sepsis or
trauma, or both; whether or not plas
mapheresis or the administration of
anti-inhibitors may play a role; phar
macologic manipulation with drugs such
as levamisole, aspirin and other pres
ently unidentified drugs; and a preop
erative method to assess accurately the
risk and to pinpoint its correction.
Prognostication is important for the
individual patient. However, it is only
by description and definition of the
altered biology of patients with ac
quired defects in host resistance to
infection that therapeutic strategies
can be developed to improve the
prognosis.
J.L. M eakins , m d , frcs [c]
Department of surgery
Royal Victoria Hospital,
Montreal, PQ
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Early Surgical Management of Acute Cholecystitis
The object of therapy in acute chole
cystitis is definitive treatment with mi
nimal mortality and morbidity. Over
the years, considerable literature has
accumulated concerning both merits
and disadvantages of early versus de
layed cholecystectomy for acute chole
cystitis.
According to Hinchey, Elias and
Hampson,1 a survey of American sur
geons showed that 70% favoured early
operations for acute cholecystitis.
In this issue of the Journal (page
464) Archibald, Colapinto and Frost
confirm that early cholecystectomy in
acute cholecystitis can be done safely
with low morbidity and mortality. Un
fortunately, because it is not a prospec
tive randomized study, this paper does
not analyse many aspects of the pre
operative, intraoperative and postop
erative complications (e.g., jaundice,
liver profiles, cultures of bile and gall
bladder wall, frequency of explorations
of the common bile duct that yield no
abnormality or of retained stones in
the common bile duct). The clear ad
vantage shown by this study is the
economic one: the patient’s stay in the
hospital is shorter with early operative
intervention.
The authors are to be congratulated
on the low mortality and complication
rate they achieved for the entire
group, particularly since approximately
40% of the patients belonged to groups
2 or 3, in which the operation was
performed 72 hours after admission,
regardless of when the symptoms
began.
Some workers2"7 have reported an in
creased frequency of major intra-ab
dominal complications (bacteremia,
wound infection or dehiscence, or both)
when cholecystectomy is delayed or
when bile or gallbladder-wall cultures
have given positive results. Interest
ingly, this correlation was not found
in Archibald’s paper, and the obvious
and important message is the insignifi
cant increase of major complications
in patients who underwent cholecys
tectomy up to 7 days after admission.
Cholecystostomy has been advo
cated for patients deemed to be too
ill for cholecystectomy, usually the
elderly with decompensated heart dis
ease, poorly controlled diabetes, pulVOLUME 22, NO. 5, SEPTEMBER 1979

monary or renal insufficiency, or evi
dence of cerebrovascular disease in as
sociation with acute gangrenous or per
forated gallbladder. The authors have
reaffirmed that the mortality associated
with cholecystostomy is 5 to 10 times
higher than that for cholecystectomy.
A cholecystectomy can be completed
safely on most occasions.
It is important to emphasize the fre
quency of false-negative results of intra
venous cholangiography in the presence
of acute cholecystitis. Although 3.6% of
Archibald’s patients had false-negative
results of cholangiography, the diag
nosis of acute cholecystitis was con
firmed at operation. In one study,8 80
of 152 patients with no opacification
of the gallbladder on two consecutive
oral cholecystograms, and evidence of
disease at operation, also underwent
intravenous cholangiography. In 14
(approximately 17%) the gallbladder
filled and was interpreted as normal,
an obviously erroneous diagnosis in
view of the subsequent findings of
cholelithiasis in 12 patients, chronic
cholecystitis in 1 and acute chole
cystitis in 1.
Previously we7 reported a 6% fre
quency of normal oral cholecystograms
in patients with acute cholecystitis,
confirmed by pathological examination
of the resected gallbladder. This and
other studies8,9 demonstrated that a sub
stantial number of patients with cholelithasis or acute cholecystitis, or both,
show no abnormality on cholecysto
graphy. In order to avoid an erroneous
diagnosis, the suggested alternative
method at present is ultrasonography10
or technetium scanning9 of the gall
bladder, which has a diagnostic ac
curacy of 95% to 98%.
Treatment of patients with acute
cholecystitis should include administra
tion of fluids intravenously and routine
use of broad spectrum antibiotics,
urinary monitoring by means of a
Foley catheter if necessary, recording
of central venous pressure and an
intensive effort to evaluate and treat
associated diseases. The operation
should be considered urgent but
seldom an emergency measure. The
degree of risk associated with chole
cystectomy is small and it is the
procedure of choice in the absence of
/

signs or symptoms of common duct
stones or cholangitis, both of which
require, in addition, common bile duct
exploration or decompression.
Should the patient’s clinical condi
tion deteriorate, cholecystostomy can
be a safe operation if the following
precautions are taken: there can be
no free perforation of the gallbladder;
clear bile must be seen returning
through the cystic duct and if not, the
common bile duct must be decom
pressed; the common bile duct must
also be decompressed in all patients
with jaundice, chills and fever, and
those in whom common bile duct
stones are demonstrated.11
N enad M. G agic ,

m d , f r c s [c ]

Department of surgery,
McMaster University,
Hamilton, Ont.
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Symposium on Vascular Surgery
The vascular surgical service of the
department of surgery, and extended
programs in medical education of the
University of California School of
Medicine, San Francisco, will present
a conference on vascular surgery from
Feb. 7-9, 1980. This course has been
designed to focus on and elucidate
areas of current controversy in the
field of vascular surgery. There will be
discussions on surgical shunting in
portal hypertension, the surgical ap
proach to vascular disorders of the
abdominal aorta and its branches,
femoropopliteal occlusive disease and
the surgical management of cerebro
vascular insufficiency. The guest
faculty includes Dr. Allan Callow,
chief, general and vascular surgical
services, Tufts New England Medical
Center, Boston; Mr. H.H.G. Eastcott,
consultant surgeon, St. Mary’s Hos
pital, London, England; Dr. Jesse E.
Thompson, surgeon, private practice,
Dallas; and Dr. Robert Zeppa, profes
sor and chairman, department of
surgery, University of Miami. Registra
tion will take place on Thursday
morning, Feb. 7, 1980, from 700 to
800 hours in the Emerald Ballroom,
Golden Gateway Holiday Inn, 1500
Van Ness Ave., San Francisco. The fee
is $185 for physicians and $95 for
non-UCSF interns, residents and
fellows with letter of verification. It is
recommended that registration be made
in advance. For more information ad
dress inquiries to: Extended Programs
in Medical Education, University of
California, 1308 Third Avenue, San
Francisco, CA 94143.
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The 5th International Symposium
on Atherosclerosis
This conference will be held in
Houston, Texas, from Nov. 6-9, 1979.
Registration takes place on Monday,
Nov. 5, 1979 from 1200 to 2100 hours
at the Shamrock Hilton Hotel. The
registration fee is $100 for active par
ticipants, $25 for students and $10 for
accompanying guests. For more in
formation on topics for plenary ses
sions, workshops and oral presenta
tions, address correspondence to: Dr.
A.M. Grotto, The 5th International
Symposium on Atherosclerosis, De
partment of medicine, Baylor College
of Medicine, The Methodist Hospital,
6516 Bertner Ave., Mail Station A 601,
Houston, TX 77030.

CANADA LIMITED

P 0 BOX 1005. POINTE-CLAIRE.
DORVAL H 9R4P8
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UROLOGY PAPERS

Results of Radical Nephrectomy in 178 Cases
of Renal Cell Adenocarcinoma
J.A. O liver, md , frcs[c], M.P.

O n e hund red and s e v e n ty -e ig h t p a tie n ts
w ith re na l c e ll a d e n o c a rc in o m a w e re
c la s s ifie d by s ta g e an d tre a te d by
ra d ic a l n e p h re cto m y . A tra n sa b d o m in a l
ap p ro ach w a s u se d in 92% o f c a s e s
and ly m p h a d e n e c to m y w a s n o t per
fo rm e d u n le s s ip s ila te ra l h ila r nodes
w e re in v o lv e d . S u rv iv a l ra te s are
p re se n te d in the fo rm o f life -ta b le
c u rv e s. T h e se c u rv e s in d ic a te that
s u rv iv a l d e p e n d s on th e s ta g e of the
d is e a s e a t the tim e o f in itia l tre atm e n t;
ab o u t 80% o f p a tie n ts w ith sta g e 1
le s io n s (tu m o u r c o n fin e d to th e kidney)
su rv iv e d fo r 10 y e a rs c o m p a re d w ith
o n ly 30% to 35% o f s ta g e 2 (in v o lv e 
m e n t o f p e rin e p h ric fa t) and s ta g e 3
(in v o lv e m e n t o f re n a l v e in o r re g ion al
lym p h n o d e s) p a tie n ts and le s s than
10% o f s ta g e 4 ( m e ta s ta tic sp re ad )
p a tie n ts . R a d ica l n e p h re c to m y ap p e ars
to be th e b e s t m e th o d o f tre a tm e n t
fo r p a tie n ts w ith s ta g e 1, 2 o r 3 le sio n s .
S im p le p a llia tiv e n e p h re c to m y m ay
be in d ic a te d in s e le c te d p a tie n ts w ith
sta g e 4 le s io n s .
C e n t so ix a n te -d ix-h u it p a tie n ts
so u ffra n t d ’un a d e n o c a rc in o m e d e s
c e llu le s re n a le s o n t e te c la s s if ie s
p a s s ta d e c lin iq u e e t t r a it e s par
n e p h re c to m ie ra d ic a le . U n a b o rd tra n s
a b d o m in al a e te u t ilis e c h e z 92%
d e s c a s e t une ly m p h a d e n e c to m ie
n'a pas e te p ra tiq u e e a m o in s qu’il
n ’y a it une a tte in te ip s ila t e r a le des
g a n g lio n s h ila ire s . L e s ta u x d e su rv ie
so n t p re s e n te s s o u s fo rm e de
c o u rb e s a c tu a rie lle s . C e s c o u rb e s

From the departments of urology,
Royal Victoria Hospital and Montreal
General Hospital, McGill University,
Montreal, PQ
Reprint requests to: Dr. J.A. Oliver,
Department of urology, Royal Victoria
Hospital, 687 Pine Ave. W, Montreal,
PQ H3A 1A1

L aplante , md , frcs [c ],

E.C.

R eid, md , frcs [c ] and

in d iq u e n t que la s u rv ie depend du
s ta d e de la m a la d ie au m o m e n t du
tra ite m e n t in itia l; e n v iro n 8 0 % d e s
p a tie n ts ay a n t une le s io n d e s ta d e
1 (tu m e u r lim ite e au rein) o n t
s u rv e c u 10 an s, c o m p a ra tiv e m e n t a
s e u le m e n t 30 % e t 35% pour le s
p a tie n ts de sta d e 2 (a ttein te d u t is s u
a d ip e u x p e rin e p h riq u e ) e t de s ta d e 3
(a tte in te de la v e in e re n a le e t d e s
g a n g lio n s ly m p h a tiq u e s re g io n a u x),
e t m o in s de 10% p o u r les p a tie n ts
de sta d e 4 (e n v a h is s e m e n t m e ta s ta tiq u e ).
La n e p h re c to m ie ra d ic a le s e m b le e tre
la m e ille u re m e th o d e de t r a it e 
m e n t p o u r le s p a tie n ts ayant d e s
le s io n s d e s s ta d e s 1 , 2 ou 3. U n e
n e p h re c to m ie p a llia tiv e sim p le p e u t
e tre in d iq u e e c h e z d e s p a tie n ts c h o is is
ay a n t d e s le s io n s de s ta d e 4.

R.S.

Schual , md

the stage of the disease using life-table
survival curves.
Patient Data and Methods
Staging of the disease was by the
Robson modification1 of Flocks and
Kadesky’s classification as follows:
stage 1—tumour confined to the kid
ney, stage 2—perinephric fat involved
but tumour confined to Gerota’s fascia,
stage 3— involvement by tumour of
renal vein or regional lymph nodes
80

60

40

Between Jan. 1, 1965 and Dec. 31,
1977, 178 patients with renal cell
adenocarcinoma were treated by radical
nephrectomy at two McGill Univer
STAGE
sity teaching hospitals. This paper
presents the clinical aspects and re
lates the results of radical surgery to FIG. 1—Distribution of patients by stage.
20

T

1

2

3

FIG. 2—Age and sex distribution. Male:female ratio was 1.4:1.
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with or without involvement of vena
cava and stage 4—metastatic spread
distantly or to adjacent visceral struc
tures. Fig. 1 illustrates the percentage
distribution by stage of the 178 pa
tients and is in keeping with that re
ported in other large series.1-3 There
were 82 patients with stage 1 lesions,
22 with stage 2, 45 with stage 3 and
29 with stage 4 disease.
The age and sex distributions are
shown in Fig. 2; they correspond to
those reported in other series.
Table I lists the major presenting
signs and symptoms. Renal cell adeno
carcinoma may present in a variety of
ways, and while the members of the
“clinical triad” (hematuria, pain and
palpable mass) were often noted, 24%
of patients presented with nonspecific
systemic symptoms such as fever,
weight loss, anorexia and severe ma
laise. In 17% of the patients there
were no presenting symptoms or signs
and the tumour was discovered dur

ing other surgical procedures or as an
mcidental finding on intravenous pye
lography done for other reasons.
The abnormal laboratory findings
at the time of presentation are shown
in Table II. Although these findings
may alert the clinician to the possibil
ity of a serious pathologic condition,
no relationship has been reported be
tween abnormal laboratory findings
and survival rate3'4 and this was sup
ported in our series.

Sign or symptom

In radical nephrectomy a “pedicle
liist approach is used in which the
renal vein is mobilized and the under
lying renal artery is ligated primarily,
followed by ligature of the vein. The
kidney, and sometimes the adrenal
gland, is removed leaving overlying
peritoneum and Gerota’s fascia intact.
Hilar nodes are dissected, but if spread
to these nodes is not evident, complete

Table IV— Cause of Death by Stage
Stage, no. (% * )
Cause of
death

1

2

3

4

Total

Operation
Cancer
O ther

1 (1)
9 (1 1 )
6 (7)

0
7 (3 2 )
2 (9)

2 (4)
20 (44)
3 (7)

4 (1 4 )
23 (80)
0

7 (4)
59 (33)
11 (6)

66 (81.8)

13 (59)

20 (44)

2 (6)

101 (57)

A live
Table 1— Presenting Signs and Symptoms

Surgical Treatment

♦Crude percentages, not based on life-table curves.

C as es,%

Hem aturia
53
Pain
24
Mass
19
None, but incidental finding of mass
on intravenous pyelography
17
Systemic
24

Table I I — Percentage of Patients with
Abnormal Laboratory Findings
Laboratory finding
Hemoglobin, > 16 g/dl
< 1 0 g/dl
Lactic dehydrogenase (elevated
above upper lim it of norm al)
A lkaline phosphatase (elevated
above upper lim it of norm al)
Proteins, increase in a 2 glo
bulin
Calcium, > 1 1 g /d l (2.74 fj.mol/1)
or < 9 g /d l (2.25 ^ m o l/l)
Serum glutam ic oxaloacetic
transam inase (elevated above
upper lim it of normal)

Patients, %
8
12

FIG. 3— Sites of late metastases developing in each stage expressed as percentage
of cases in each stage.

18
16
41
26
1

Table I I I — Sites of Metastases in the 29
Patients w ith Stage 4 Lesions at the Tim e of
Nephrectomy
Site
Lung
Bone
Liver
Brain
Other

Patients, %
48
31
14
3
7

FIG. 4— Life-table survival curve for all stages (SE = standard error).
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para-aortic or paracaval node dissec
tion is not routinely done. In our hos
pitals, a transabdominal incision is gen
erally used with full kocherization for
right-sided tumours and preaortic dis
section for left-sided lesions as de
scribed by Scott and Selzman.5 When
necessary, the inferior mesenteric vein
is divided together with the ligament
of Treitz. This approach provides good
exposure for most tumours although for
large upper pole lesions, the thoraco
abdominal technique is used.6'7 In our
series the transabdominal approach
was used for 165 patients and the
thoracoabdominal for the remaining
13.
R esults

FIG. 5__Comparison of survival curves of stages 1, 2 and 3 patients with that
of entire series (49 and 52 = number of patients at risk at 6 years).

The sites of metastases in the 29
stage 4 patients are shown in Table
III; late metastases developing in each
stage are shown in Fig. 3 and are ex
pressed as a percentage of all cases in
each stage. As expected, lesions classi
fied clinically as stage 1 rarely metas
tasized, and these rare instances of
metastasis were attributable to staging
errors. Stage 2 and stage 3 lesions
showed little difference in their meta
static activity either in site or in fre
quency.
The causes of death by stage are
shown in Table IV. Operative death
refers to that which occurred while
the patient was still in hospital follow
ing nephrectomy, regardless of length
of stay and cause of death. The over
all operative mortality was 3.9% but,
when the stage 4 patients were ex
cluded, it was 2.2%.
S u rviva l Figures

FIG. 6— Life-table survival curves plotted separately for each stage. Numbers
at risk at 6 years are shown by figures above curves themselves.

FIG. 7— Comparison of survival curves for stages 3A, 3B and 3C.
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The survival figures were evaluated
from the life-table curves. The survival
curve for all stages (Fig. 4) shows a
flattening at 4 years with a slight falloff between 6 and 7 and 11 and 12
years. Fig. 5 compares the survival of
patients with stages 1, 2 and 3 (po
tentially “curable”) lesions with that
of the entire series. Given the poor
prognosis of stage 4 patients, the im
provement in the mortality when these
patients are excluded is expected.
The survival curves for each stage
are shown in Fig. 6. The curve for
stage 1 patients indicates an extremely
good prognosis. The fall-off at 11 years
represents death from causes other
than cancer. There was no statistically
significant difference in the survival
of stage 2 and stage 3 patients in this
series. The curve for stage 4 patients
was predictable.
Stage 3 patients were subdivided for
analysis as follows: stage 3A—disease
involving the renal vein with or with
out vena caval extension (30 patients),
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stage 3B—disease involving the lymph
nodes (8 patients), and stage 3C— dis
ease involving both the renal vein and
the lymph nodes (7 patients).
The survival rate of these patients
is shown in Fig. 7. There was no sig
nificant difference between these curves.
It is worth noting, however, that
whereas the overall survival of pa
tients in stages 2 and 3 was not sig
nificantly different, the curve for stage
3C does suggest a significant differ
ence in prognosis between those having
involvement of both the vein and re
gional lymphatics (3C) and stage 2
patients. Certainly invasion of the renal
vein by tumour leads to a significant
reduction in estimated survival com
pared with stage 1 patients; this is
the finding of most series though it is
contrary to that of Skinner, Vermillion
and Colvin.3
Discussion

The prognosis in this series of pa
tients conforms fairly closely to that
of other comparable series. Survival
depends on the stage of the disease
at the time of primary management.

Patients whose tumours are diag
nosed and treated in stage 1 do
well and have an estimated 10year survival rate of approximately
80%. Barely 35% of patients with
stage 2 and stage 3 tumours survive
10 years and, for the stage 4 patients,
less than 10% survive that long.
The average duration of symptoms
for patients with stage 1, stage 2 and
stage 3 lesions was almost identical
which is discouraging in terms of im
proving overall survival rates, particu
larly since, given the great difference
in survival between stage 1 patients
and those in more advanced stages,
improved techniques for early diag
nosis are of greatest importance.
As far as operation is concerned,
radical nephrectomy results in higher
survival rates in stages 1, 2 and 3
than any other method. Radical
nephrectomy is not indicated in
stage 4 and simple palliative nephrec
tomy in selected cases is the most that
should be done. The surgical approach,
either transabdominal or thoracoabdo
minal, depends on the size and loca
tion of the tumour. The transabdomi
nal approach gives excellent results in

most cases. Node dissection in the ab
sence of positive hilar nodes does not
improve survival rates. Despite the low
mortality associated with the proce
dure, it is not a necessary part of
radical nephrectomy.
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Renal Cell Carcinoma in Children
S. H e r s c h o r n ,

b s c , m d , c m , f r c s [ c ],

B.M. C h u r c h il l ,

The authors reviewed the records of
eight children with renal cell carcinoma
and correlated the clinical presentation,
pathological and radiologic findings,
stage and treatment of the disease with
patient survival. Angiography revealed
tumours of sparse neovascularity,
associated with varied histologic
patterns. Patient survival was dependent
on the stage of the disease at the time
of treatment; treatment of localized
disease was effective but of metastatic
disease was generally poor. Tumour
staging appeared to be the only reliable
indicator of prognosis. Children with
renal cell carcinoma differ from adults
in that a palpable mass in a child does
not necessarily indicate that there
is metastatic disease.
From the department of surgery, division
of urology, The Hospital for Sick
Children, Toronto, Ont.
Reprint requests to: Dr, B.E. Hardy,
Division of urology, The Hospital for
Sick Children, 555 University Ave.,
Toronto, Ont. M5G 1X8
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B.E. H ardy ,

m b , c h b , fra cs and

m d , f r c s [c ]

Les auteurs ont etudie les dossiers
de huit enfants ayant un carcinome
des cellules renales et ont etabli une
correlation entre le tableau clinique,
les observations pathologiques et
radiologiques, le stade et le traitement
de la maladie d'une part, et la survie
du patient d'autre part. L’angiographie
a revele des tumeurs ayant une
neovascularite rare, associees a des
morphologies histologiques variees.
La survie du patient a ete dependante
du stade de la maladie au moment
du traitement; le traitement d’une
tumeur localisee a ete efficace mais
celui d’une atteinte metastatique a
generalement ete pauvre. L'etablissement
du stade de la tumeur a semble etre
le seul indicateur fiable du pronostic.
Les enfants ayant un carcinome des
cellules renales different des adultes en
ce que la presence d'une masse
palpable chez I'enfant n’est pas
necessairement I'indice d’une maladie
metastatique.
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Renal cell carcinoma in children is rare.
In the review by Riches, Griffiths and
Thackray1 of 1500 cases of kidney tu
mour, only 0.5% of the patients were
children; others have reported an in
cidence of 2.3% to 6.6%.2 We can
trace fewer than 100 well-documented
cases reported since 1934 in which the
follow-up was longer than 5 years.
In reviewing the records at the Hos
pital for Sick Children in Toronto, we
found eight patients in whom renal cell
carcinoma had been diagnosed. This
report correlates survival of these chil
dren with their clinical presentation,
tumour stage and treatment, and de
scribes similarities to and differences
from renal cell carcinoma in adults.
Patients and Methods

Eight patients (five boys and
girls) with renal cell carcinoma
treated at the Hospital for Sick
dren or at the Princess Margaret
pital, Toronto, between January

three
were
Chil
Hos
1961
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and December 1977. Age at presenta
tion ranged from 5 to 15 years (mean
9.75 years). The tumours were left
sided in six of the children; no patient
had bilateral tumours. All underwent
routine investigations for metastases.
Intravenous pyelography (IVP) was
performed in all patients, arteriography
in five, radionuclide renal scanning in
three, inferior vena cavography, cysto
scopy and retrograde pyelography in
two each, and computerized axial tomo
graphy in one.
Primary treatment was radical ne
phrectomy in seven cases and simple
nephrectomy in one, with ipsilateral
lymph-node dissection in three. Five
children received radiation therapy
(3500 to 4500 rads) to the abdomen
and affected kidney bed postoperatively. Chemotherapy was not used
routinely, although one child, thought
initially to have a Wilms’ tumour, was
given actinomycin D, 300 /zg/ d for 5
days, starting 1 day before operation.
In two other patients who had metas
tatic disease, chemotherapy was started
shortly before they died.
All surviving patients are being fol
lowed up.
Findings
Clinical
The presenting symptoms and signs,
and their relation to survival, are shown
in Table I. Two patients (nos. 1 and 5)
had sustained trauma to the flank, re
sulting in retroperitoneal rupture of the
tumour. Of the two patients with fever,
one (no. 2) had a localized tumour and
one (no. 1) had metastatic disease. Two
of the three patients who had a pal
pable mass on presentation have sur
vived for more than 5 years (nos. 2 and
3).

Retrograde pyelography, performed in
two cases, confirmed the IVP findings.
Radionuclide renal scanning showed
filling defects in all three cases in
which it was done, including the patient
(no. 8) whose IVP demonstrated de
creased function. Computerized axial
tomography was also performed in
this patient and showed enlargement of
the affected kidney.
Arteriography demonstrated sparse
neovascularity in three patients and
none in two. Inferior vena cavography
showed compression by the tumour in
one of two patients.

stage I disease on presentation. All
survivors had better differentiated tu
mours with clear cell elements as well
as pseudocapsules; however, these char
acteristics were also seen in nonsur
vivors.
Treatment
Three survivors had disease confined
to the kidney and one had positive hilar
lymph nodes. Each had a radical ne
phrectomy; two (nos. 4 and 6) under
went lymph-node dissection, and two
(nos. 3 and 6) had radiation therapy.

Laboratory
Two patients were anemic due to
blood loss after trauma (nos. 1 and 5)
and in one child (no. 8) with metas
tases, the erythrocyte sedimentation
rate was 69 mm/h. Results of all other
hematologic, renal and liver function
tests were normal.
Pathological
The staging system used is shown
in Table III and its relation to pathol
ogical findings and survival in Table
IV.
Tumour size did not correlate with
survival: two survivors had large tu
mours (diameter, 10 cm in patient 2
and 8 cm in patient 3) and both had

Radiologic (Table II)
Intravenous pyelography demon
strated a mass in seven children and
decreased renal function in one; calci
fication was seen in only one patient.

Table III—Tumour Staging* and 5-Year
Survival in 30 Children
Survival
at 5 yr,
%

Stage

79

1 - Intrarenal tumour
I I - Extrarenal tumour with local
extension
a - direct extension
b - vascular extension
c - local lymphatic
(lymph-node) extension
I I I - Extrarenal tumour with
distant metastases

80
30
75
10

*From Castellanos, Aron and Evans.2

Table II— Roentgenographic Findings
Case
no.

No. of
patients

Investigation

8

Intravenous pyelography

2

Retrograde pyelography

3
5

Radionuclide renal scanning
Arteriography

2

Inferior vena cavography

1

Computerized axial tomography

1 -7
8
2
8
4,6,8
5- 7
4 ,8
6
8
8

Findings
Mass
Decreased renal function
Mass
Thin calyces, upper pole
Filling defect
Hypovascular tumour
Avascular tumour
Normal
Compressed by tumour
Enlarged affected kidney

Table I— Relation between Clinical Presentation and Survival
Symptoms and signs
Patient
no.

Age, yr

Sex

1

13

M

2
3
4
5
6
7
8

6
5
6
9
11
13
15

F
F
F
M
M
M
M

Pain

Mass

Hematuria

+

+
+
—
—
+
+
—
+

Fever

+
+

+

Duration
of symptoms

Trauma,
weight loss

Acute, 3 mo

Dead

3 mo

Pain for 1 yr
Acute
2 mo
Acute
3 wk
Acute
2 mo

Alive
Alive
Alive
Dead
Alive
Alive
Dead

14 yr
11 yr
7 yr
4 yr
5 yr
3 yr
2 mo

+

+

+
+
+
+

_
_
_
_
—

Duration of
follow-up

Other
features

Trauma
Weight loss

Outcome

+ = present, — = absent.

VOLUME 22, NO. 5, SEPTEMBER 1979 /

THE CANADIAN JOURNAL OF SURGERY

4 13

Table IV— Relation of Pathological Findings to Stage, Treatment and Outcome
Patient
Tumour
Degree of
no.
pseudocapsule differentiation
i
2

No
Yes

Moderately
Well

3
4
5

Yes
Yes
Yes

6
7

Yes,
partial
' No

Moderately

8

No

Poorly

Pattern and
granularity

Stage

Extent of
disease

lib
1

Renal vein
No metastases

Moderately
Well
Well

Papillary, G
Alveolar, C
and G
Papillary, C
Papillary, C
Alveolar, C

1
1
lla

No metastases
No metastases
Capsular
lymphatics

Well

Papillary, C

lie

Hilar nodes

Papillary
ill
and tubular,
c
Pleomorphic
III

Operation

Radiotherapy

N
RN

Chemotherapy

Outcome

Yes
No

No
No

Died, 3 mo
NED, 14 yr

RN
RN and LND
RN and LND

Yes
No
Yes

Yes
No
Yes

RN and LND

Yes

No

NED, 11 yr
NED, 7 y r
Died with liver
metastases after
4 yr
NED, 5 yr

Distant peri
aortic nodes

RN

Yes

No

Alive with
metastases, 3 yr

Diffuse disease

RN

No

Yes

Died, 2 mo

C - clear cell, G - granular, N = simple nephrectomy, RN = radical nephrectomy, LND = lymph-node dissection and NED = no evidence of disease.

The patient with hilar node involve
ment (no. 6) had both node dissection
and radiation therapy.
Discussion
Clinical Findings
The mean age of the children at the
time of presentation in our series (9.75
years) is similar to that in a previous
review.2
Renal cell carcinoma in children
shows no bias for either sex,2 unlike
its 3:1 male predominance in adults.3
M ore right-sided tumours were re
corded in a 1974 review,2 but a later
report gave contrary findings4 and the
tumour was left sided in six of our eight
patients. Bilateral tumours have been
reported5 but, as in adults, it is not
known whether these are coexisting pri
maries or represent metastatic di
sease.6
No correlation has been demon
strated with developmental defects, al
though some patients have had uro
genital anomalies such as imperforate
anus with rectourethral fistula,6 ectopic
ureter7 or horseshoe kidney.8 Some pa
tients have been reported to have other
primary tumours, such as retroperi
toneal teratoma, ependymoma2 and
neuroblastoma;4 von Hippel-Lindau di
sease has been reported in some adults3
but not in children.
One third of adult patients present
with systemic symptoms such as weight
loss and weakness with or without ane
mia and two thirds have one or more
features of the classic triad of hema
turia, pain and a mass. Most adults who
have a palpable mass on presentation
already have metastases.3 Many chil
dren with renal cell carcinoma also
have systemic initial symptoms (two
of our patients presented with weight
loss and two others with fever). The
414

commonest urologic signs are a pal
pable mass and hematuria.2 The major
difference from adult cases is that a
palpable mass is not necessarily as
sociated with metastatic disease9 (which
may reflect the ease with which a mass
in a child’s abdomen and flanks can be
detected by palpation10); indeed, two of
our three patients with stage I disease
had a palpable mass.
Trauma may call attention to the
tumour.2 One survivor had sustained
tumour rupture secondary to trauma,11
but in that report the follow-up was less
than 5 years. Neither of our patients in
whom trauma was a major feature of
their presenting history survived; pa
tient 1 died 3 months after treatment
and patient 5 died with liver metastases
4 years after apparent cure.12
Duration of symptoms is not neces
sarily related to survival.9 Patient 2 had
had pain for 1 year, but had no
evidence of disease 12 years after
primary treatment. Others2,4 have re
ported survival of patients who had had
symptoms for 1 to 2 years before
treatment.
Hypertension has been noted in 6%
of cases2 but was not found in our
series. No endocrine effects have been
recorded, but liver dysfunction has
been described.13
Six per cent of pediatric patients2 and
a similar percentage of adults3 present
with symptoms of metastases.2 None of
our patients gave evidence of me
tastases initially.
Radiologic Findings
The accuracy of roentgenography in
the diagnosis of renal cell carcinoma
in adults is almost 95%.3 Renal masses
in children can be demonstrated by
IVP and retrograde pyelography in
97% of cases,2 but until now, diagnosis
has been made at the time of operation.
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In adults, arteriography is an excel
lent diagnostic tool. The typical appear
ance is of multiple tumour vessels, ar
teriovenous shunts and microaneu
rysms.14 Hypovascular or avascular
masses, which have been reported in
5% to 22% 14,15 of adult cases, reflect
poor blood supply or necrosis. Until
recently, tumours with poor blood sup
ply were thought to be papillary in
type,14 but other histologic patterns have
been described with this angiographic
appearance;16,17 moreover, not all papil
lary tumours are hypovascular.16
Arteriography has been little used in
the diagnosis of renal cell carcinoma
in children. Love and associates18 used
arteriography to diagnose renal cell car
cinomas in three of five children with
renal masses, and Shanberg, Srouji and
Leberman19 reported one case in
which it was used. Others2,4,20 have
mentioned using arteriographic find
ings. Fisher and associates8 described
two patients who had renal angiography.
Five of our patients had arteriography.
Table V8,18,19,21 (igSCribgS
angio
graphic and pathological appearances
in all 12 traceable patients. In only 2
patients did the tumours have the char
acteristic appearance seen in adults;
the other 10 patients had hypovascular
or avascular tumours of varied histology.
Inferior vena cavography has not
previously been reported in the diag
nosis of this tumour. No inferior vena
caval invasion was demonstrated in
our two patients who had this study,
but extrinsic compression by tumour
was apparent in one.
Pathological Findings
Dehner, Leestma and Price9 showed
a correlation between histology and
survival. Of their few patients whose
tumours were of mixed trabecular and
tubular pattern with clear cells, 80%

THE CANADIAN JOURNAL OF SURGERY

survived. In their series the prognosis
was better with clear cell tumours than
with granular tumours, and a tumour
pseudocapsule was a favourable sign.
In our series more survivors had
clear cell tumours (Table IV) than had
granular ones, but this histologic pat
tern did not guarantee survival. Fur
thermore, although all four survivors
had tumour pseudocapsules, so did one
nonsurvivor. Histologic grading cor
related to some degree with survival:
seven of the eight tumours were well or
moderately well differentiated and four
of the seven patients survived more
than 5 years; the only patient with a
poorly differentiated tumour died 2
months after admission. Thus we agree
that pathological criteria are not con
sistent indicators of prognosis.2 This
finding is similar to that in renal cell
carcinoma in adults:22 cellular granular
ity and patterns of organization are not
generally considered useful indicators
of prognosis.3
Staging, Treatment and Survival

Tumour staging based on surgical
and pathological criteria is at present
the best method for predicting and
comparing survival rates.3 Castellanos,
Aron and Evans2 were the first to use
staging to analyse reported cases. A
summary of their findings in 30 pa
tients followed up for more than 5

years (Table III) shows a good 5-year
survival rate for patients with tumours
localized to the kidney, with locally
invasive tumours or with spread of the
disease to the regional nodes only, and
a poor survival rate for those with vas
cular permeation and distant metastases. In adults, renal vein extension is
associated with a better prognosis than
nodal metastases23 and large tumours
commonly are associated with a higher
stage;3 the latter does not hold for
children.10 In both age groups, stage III
disease has a poor prognosis.
Additional reports of children fol
lowed up for more than 5 years are
summarized in Table VI.4'8'21,23,24 Good
survival is noted for stages I and lie,
and poor survival for stages lib and
III, as in adult series.25
Our results in relation to stage and
treatment (Table IV) show that survival
usually was related to stage. The stage
lie survivor (patient 6) underwent
lymph-node dissection and received
radiation therapy in addition to radical
nephrectomy.
Cassady and associates4 in a series of
eight cases, achieved better results than
those previously reported.2 Their sur
vivors (the exact duration of follow-up
was not specified) included some who
had had vascular invasion. They
treated every patient by nephrectomy,
radiation
therapy
and long-term

Table V—Angiographic and Pathological Appearances Reported in 12
Children with Renal Cell Carcinoma

Angiographic appearance

No. of patients

Neovascular with arteriovenous shunts
Hvpovascular

218-19
8818.21

Avascular

2

Pathological
findings (when stated)
Papillary, glandular19
Papillary with necrosis8
Necrosis18
Alveolar (patient 5)
Papillary (patients 6 and 7)
Pleomorphic (patient 8)
Papillary (patient 4)

Table V I—Staging, Treatment and Survival in 12 Reported Cases of Renal Cell
Carcinoma in Children in Addition to Those Reviewed by Castellanos, Aron and Evans2

chemotherapy; their impressive results
may be related to the intensive and
prolonged use of chemotherapy.
Late recurrence after apparent cure,
which is well described for adults, has
been reported in some cases of renal
cell carcinoma in children.26 Also, cases
of prolonged survival with disease have
been reported.16 The erratic behaviour
of this tumour is therefore the same in
adults and children.
Conclusions

The clinical presentation of renal
cell carcinoma in children may dif
fer from that in adults: fewer chil
dren have advanced disease when they
have a palpable mass, and symptoms
may be present for some time with
out the development of metastases.
Traumatic rupture of the tumour be
fore treatment carries a poor prognosis.
Arteriographic findings have dif
fered in the two age groups in that
neovascularity is usually sparse in chil
dren. This angiographic picture is seen
with different histologic patterns.
The significance of pathological find
ings in regard to prognosis in both age
groups is confusing. However, longer
survival has been recorded with better
differentiated, clear cell tumours.
Tumour staging is most reliable in
predicting prognosis. Patients with intrarenal disease, minimal local exten
sion and regional nodal disease at the
time of presentation had good survival
rates. Vascular extension in children,
in contrast to its occurrence in adults,
was an ominous finding.
Aggressive surgery has yielded good
results in patients with local and re
gional nodal disease. The reports on
chemotherapy and radiation therapy
have not been detailed enough to allow
comparison of their efficacy in treating
distant disease.
Although it may differ in clinical
presentation, renal cell carcinoma in
adults and in children is similar in
pathological appearance and in be
haviour. In both age groups metastatic
disease responds unpredictably
to
various treatment modalities.
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Because Marcaine lets y o u r patient come around
long before the pain.
W inthrop Laboratories

That’s tw o to three times longer than lidocaine.P) Division o f Sterling Drug Ltd., Aurora, Ontario L4G 3H6.

Delay the pain, delay the need for narcotics.

References:

1. Humphreys C.F and Kay H.,The Control of Postoperative Wound Pain with
the Use of Bupivacaine Injections. J. Urologyil6j618-619,1976.
2. Moore D.C. et al, Bupivacaine for Peripheral Nerve Block: A Comparison
with Mepivacaine, Lidocaine, and Tetracaine Anesth. 32;460-463, May 1970.

Prescribing Information.

MARCAINE*

Brand of bupivacaine hydrochloride

Indications
Peripheral nerve block, infiltration, sympathetic blockade, caudal,
epidural, paracervical and pudendal block.
Contraindications
Marcaine is contraindicated in persons with known sensitivity to
local anaesthetics of the amide type.
When used with epinephrine the usual caution in respect of any
vasopressor drug applies.
The use of Marcaine is contraindicated in the presence of sepsis
near the site of proposed injection, in severe shock and in heart block.
Precautions
The lowest dosage that gives effective anaesthesia should be used,
to avoid high plasma levels and serious systemic side effects.
Injection of repeated doses of Marcaine may cause a significant increase
in blood levels due to accumulation of the drug or its metabolites.
Tolerance varies with the status of the patient. Debilitated,
elderly and acutely ill patients may require reduced doses
commensurate with age and physical condition.
Safe use in pregnant women, other than in labour, has not
been established.
Foetal bradycardia may follow paracervical block with local
anaesthetics of the amide type and may be associated with foetal
acidosis. Foetal heart rate should always be monitored during
paracervical anaesthesia. Added risk appears to be present in pre
maturity, toxaemia of pregnancy and foetal distress. The physician
should weigh the possible advantages against dangers when
considering paracervical block in these conditions. When the
recommended dose is exceeded, the incidence of foetal bradycardia
increases. The incidence of foetal bradycardia, observed in clinical
trials with Marcaine in which paracervical block was used, varied
between zero and 35%.
Obstetricians are reminded that severe persistent hypertension
may occur if oxytocic drugs are administered to patients who have
already received a vasopressor.
Solutions containing a vasopressor agent, should be used with
caution, if at all, in patients who are receiving monoamine oxidase
inhibitors or tricyclic antidepressants because severe prolonged
hypertension may result. Dose related cardiac arrhythmias may occur
if preparations containing epinephrine are employed in patients
during or immediately following the administration of chloroform,
halothane, cyclopropane, trichloroethylene or other related agents.
The decision to use a local anaesthetic containing a vasocon
strictor in areas with a limited blood supply or in patients with
peripheral vascular disease, will depend on the physician’s appraisal
of the relative advantages and risks.
Administration of Marcaine in children under 12 years is not
recommended.
Caution is advised in administration of repeat doses of Marcaine
to patients with severe liver disease.
Adverse reactions
Reactions to Marcaine are characteristic of those associated with
amide-type local anaesthetics. A major cause of adverse reactions to
this group of drugs is excessive plasma levels, which may be due to
overdosage, inadvertent intravascular injection, or slow metabolic
degradation. Other causes of reactions to these local anaesthetics
may be hypersensitivity, idiosyncrasy, or diminished tolerance.
Excessive plasma levels cause systemic reactions involving the
central nervous system and cardiovascular system. The central
nervous system effects are characterized by excitation or depression.
VOLUME 22, NO. 5, SEPTEMBER 1979

/

The first manifestation may be nervousness, dizziness, blurred
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Management of Disseminated Testicular Cancer
E.W. R am sey ,

Thirteen patients with disseminated
nonseminomatous germ cell tumours
of the testis were treated with a
three-drug combination (vinblastine,
bleomycin and cis-diamminedichloroplatinum). Of 12 patients with meas
urable disease, 8 had complete and
3 partial remission. One patient
with a solitary metastasis failed to
respond but is disease free following
surgical excision. Toxicity was moderate
but no drug-related deaths occurred
and there were no apparent lasting
side-effects. No patients with
complete remission have relapsed. Ten
of the 13 patients are without evidence
of disease from 9 to 36 months after
treatment, 6 of these for 2 years or
more. One patient died after a partial
remission of 16 months. One is
undergoing further treatment for relapse
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with liver metastases and one remains
in partial remission at 30 months. These
results demonstrate the efficacy of
this drug combination in testicular
cancer.
Treize patients souffrant de tumeurs
testiculaires germinales non seminomateuses ont ete traites avec une
association de trois medicaments
(vinblastine, bleomycine et cis-diamminedichloroplatine). Chez les 12
patients ayant une atteinte mesurable,
8 ont eu une remission complete
et 3, une remission partielle. Un
patient porteur d'une metastase
solitaire ne repondit pas mais il est
maintenant exempt de lesion suite
a une excision chirurgicale. La
toxicite a ete moderee mais aucun
deces attribuable aux medicaments
n’est survenu et il n'y a eu aucune
reaction indesirable persistante.
Aucun patient ayant beneficie d'une
remission complete n'a rechute. Dix
des 13 patients n'ont aucun signe
de maladie apres 9 a 36 mois, dont
6 apres plus de 2 annees. Un
patient est decede apres une remission
partielle de 16 mois. Un patient repoit
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plus de traitement pour une rechute
avec metastases du foie et un autre
patient est en remission partielle apres
30 mois. Ces resultats demontrent
I’efficacite de cette association
medicamenteuse dans le cancer
testiculaire.

Testicular cancer is the most common
malignant condition occurring in men
from 20 to 35 years of age.1 It is there
fore an important disease although ac
counting for only 1% of all cancer in
males. Seminoma, which accounts for
about 40% of testicular cancer, is
highly radiosensitive. Cure rates ap
proach 100% in stage I disease (con
fined to the testis) and are 70% to
80% in stage II (regional nodes in
volved).2 Nonseminomatous germ cell
tumours are less radiosensitive and the
relative roles played by surgery and
radiation therapy are controversial.
The 3-year survival rate for patients
treated by retroperitoneal lymphadenectomy or by irradiation is 80% to 90%
for stage I and 40% to 80% for stage
II tumours.3-5
Although a 5-year survival rate of
55% has been achieved for metastatic
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had embryonal carcinoma, six had em
bryonal carcinoma and teratoma and
one had embryonal carcinoma and
choriocarcinoma.
Cis-platinum was given at a dosage
of 20 m g/m 2 body surface daily for
5 days, repeated at 3-week intervals for
three courses. One patient received a
fourth course. Patients were hydrated
before infusion and mannitol (20 g) was
given with the cis-platinum. Vinblastine
(0.2 mg/kg body weight daily) was
given on days 1 and 2, for a total of
five courses every 3 weeks. More re
cently, the dose of vinblastine has been
reduced to 0.15 mg/kg. Bleomycin
(30 units intravenously) was given
weekly for 12 weeks. During cis-plati
num therapy bleomycin was given on
day 2, 6 hours after vinblastine. Patients
obtaining complete remission continued
to receive vinblastine 0.3 mg/kg body
weight every 4 weeks. Bacille Calmet
Guerin immunotherapy, as initially de
scribed by Einhorn, Furnas and
Powell,7 was not used.

seminoma treated by radiation therapy,6
the majority of patients with dissemin
ated testicular cancer require chemo
therapy. Progress in the treatment of
this disease has included the develop
ment of new active drugs and their use
in combination. In 1976, Einhorn,
Furnas and Powell7 presented their in
itial results using vinblastine, bleomycin
and cis-diamminedichloroplatinum (cisplatinum). In this paper we report our
experience with a similar drug regimen
in patients with nonseminomatous germ
cell tumours of the testis.
Patients and Methods

We studied 13 patients with disse
minated nonseminomatous germ cell
tumours. Seven had disseminated di
sease at the time of initial presentation
and in five metastases developed within
4 months of completing treatment to
the regional nodes. One patient had had
a relapse following previous complete
response to chemotherapy. Six patients

Results

Twelve patients had measurable di
sease and of these 8 obtained com
plete remission and 3 partial remission.
None of those in complete remission
have relapsed and they have remained
free of disease for 9, 11, 16, 23, 25, 31,
35 and 36 months. Of the three patients
in partial remission, two presented with
extensive intra-abdominal and pul
monary disease and one with extensive
pulmonary disease (Fig. 1). One died
at 16 months from progressive intra
abdominal disease. One had complete
remission of multiple lung lesions but
had persistent minimal intra-abdominal
disease for which he received radiation
therapy. Liver metastases developed
while he was completing this treatment
and he is at present receiving further
chemotherapy. The patient whose chest
film is shown in Fig. 1 had a partial
remission. He remains asymptomatic
30 months later and although he has
received no therapy for 18 months his
disease has not progressed.
One patient with a solitary lung me
tastasis failed to respond to treatment
so this lesion was excised. His original
testicular tumour was mainly embry
onal with teratomatous elements. Only
teratomatous elements were found in
the metastatic lesion, this being mainly
cartilage. He remains free of disease
15 months after excision of the metas
tatic tumour. One patient did not have
measurable disease but was treated
because of incomplete resection of in
tra-abdominal lesions. This patient with
teratocarcinoma at initial presentation
had a large solid mass in the pelvis,
extensively involved retroperitoneal
nodes and a peritoneal cavity filled with

Fig. lb
FIG. 1— (a) Chest film before treatment
showing extensive pulmonary metastases
and (b) 30 months later, showing partial
remission of disease.
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teratomatous cysts. These were all re
sected but fragm ents of tumour re
mained adherent to pelvis and bowel.
He is without evidence of disease 34
months later.
Ten (77%) o f the 13 patients have
no evidence o f disease at 9 to 36
months, 6 of these 2 years or more
after treatment. One patient died after
a partial remission of 16 months, one
remains in partial remission at 30
months and o n e is being treated for
relapse.
Eight patients had an elevated con
centration of the serum a-fetoprotein,
or elevated tite r of the beta subunit of
human urinary chorionic gonadotropin,
or both. In all cases of complete remis
sion these values returned to normal and
have remained normal. In all three
patients achieving partial remission,
these values w ere grossly elevated in
itially, but returned to normal despite
evidence of persisting disease. They
have remained normal in the patient in
partial remission but became elevated
in the two patients who relapsed.
All patients had nausea, vomiting and
alopecia during the period of induction
therapy. Severe leukopenia occurred in
all patients. Although three patients
required hospitalization for granulocy
topenia and fever, none had proven
sepsis. No patients have demonstrated
impairment of renal function after re
ceiving cis-platinum or of pulmonary
function after receiving bleomycin.
Myalgia occurred frequently as a result
of giving vinblastine and this was most
severe during the maintenance phase.
Discussion

From January 1972 until May 1976,
16 patients with disseminated non
seminomatous germ cell tumours were
treated at our institution with a variety
of chemotherapeutic agents. Three had
a complete remission and two partial
remission. These results are similar to
those of other reports published before
1976 (Table I8'13). In 1976 Cvitkovic,
Hayes and Golbey14 reported a com
plete remission rate of 69% using a
five-drug combination of vinblastine,
bleomycin, cyclophosphamide, dactinomycin and cis-platinum. Einhorn,
Furnas and Powell7 using a three-drug
combination of vinblastine, bleomycin
and cis-platinum reported a complete
remission rate of 75%. Our present
results using vinblastine, bleomycin and
cis-platinum are similar and represent
a notable improvement over our pre
vious experience. None of the eight
patients in complete remission have re
lapsed to date and five of these have
been in remission for 2 years or more.
Previous experience with testicular
cancer indicates that most relapses
occur within 2 years15,16 so it is likely
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surgery or radiation therapy, or both,
some may be converted to complete
remission. Relapses to date have been
few in those with a complete remission
and eventual cure appears a strong
possibility. Moderate toxicity is as
sociated with this regimen but it was
generally well tolerated and no drugrelated deaths occurred. N o permanent
toxic effects have been noted. This
combination chemotherapy represents
a notable advance in the management
of patients with testicular cancer.

Table I— Results of Treatm ent of Nonseminomatous Germ Cell Tumours before 1976

Year

Author

Treatm ent

1960 Li and associates'*
1966
1967
1970
1970
1975

Dactinomycin, methotrexate,
chlorambucil
M ackenzie9
Dactinomycin ± chlorambucil
± m ethotrexate
W yatt and McAninch10
Methotrexate
Mendelson and Serpick11
Cyclophosphamide, vincristine,
m ethotrexate, fluorouracil
K ennedy12
Mithram ycin
Samuels, Johnson and Holoye19 Vinblastine, bleomycin

No. of
Complete
patients remissions,%
23

30

154

16

10
17

40
29

23
23

22
39

References
that many of these patients will be
cured.
While partial remissions resulting
from chemotherapy are generally of
short duration it is of interest that one
patient has been in partial remission for
30 months. It seems likely that these
persisting lesions have undergone m a
turation to a more benign form as has
been previously documented.17,18 In pa
tients obtaining partial response an
attempt should be made to eradicate
residual disease by surgery supple
mented as necessary by radiation therapy.
One unanswered question is, Should
retroperitoneal lymphadenectomy be
performed in patients who appear to
be in complete remission? Two such
patients in this series did not receive
either surgery or irradiation to regional
nodes. In the series reported by Einhorn
and D onohue19 lymphadenectomy was
reserved for those with residual di
sease. Results to date suggest that fur
ther therapy, either surgery or irradia
tion, may be necessary only when re
sidual disease is suspected or perhaps
when bulky retroperitoneal disease is
present initially.
Initial results with the Einhorn re
gimen suggested a lower response rate
for teratocarcinoma compared with em
bryonal carcinoma.19 Further experience
has shown similar response rates.20 The
one patient who failed to respond in
the present series had a primary terato
carcinom a with predominantly em
bryonal elements. The persisting metas
tatic lesion was teratomatous with
no embryonal component. The one
patient who died in this series had
some elements of choriocarcinoma. Al
though choriocarcinoma in combina
tion does not appear to worsen prog
nosis, results obtained in patients with
pure choriocarcinoma are less good.20
The present series did not include cases
of pure seminoma. Einhorn20 has re
ported complete remission in 9 of 13
patients with pure seminoma. Although
irradiation remains the primary mode
of therapy for such patients, these re
sults indicate that chemotherapy for dis
42 0

seminated seminoma should be consi
dered before extensive radiation ther
apy to bone marrow or to lungs makes
it difficult to use these chemotherapeu
tic agents.
Impairment of pulmonary function by
bleomycin or of renal function by cisplatinum was not encountered in our
series. Attention to hydration and the
use of mannitol helped to prevent the
latter. The most serious side effect was
neutropenia which occurred in all pa
tients. Our policy was to admit and
isolate only those patients who were
febrile and thought to have sepsis.
Aminoglycosides should not be adminis
tered in these patients as there is a risk
of irreversible renal failure when used
in patients receiving cis-platinum.21
The availability of effective chemo
therapy for disseminated testicular can
cer raises the question of its use as
adjuvant therapy for patients with non
seminomatous germ cell tumour. The
risk of recurrence must be weighed
against the toxicity of adjuvant chemo
therapy and the fact that over 60% of
those developing metastases may be
cured of their disease by subsequent
chemotherapy. With possible cure rates
of over 80% there is little indication
for adjuvant therapy of patients with
stage I disease. Recurrence is much
more likely to occur in those with stage
II disease. If 40% of patients with stage
II disease relapse and if 60% of these
can be cured by subsequent chemo
therapy then an overall survival of
85% would be expected. This would
prevent 60% of stage II patients from
receiving unnecessary chemotherapy.
To determine if adjuvant therapy can
improve upon these results will require
a large randomized trial.
Conclusion
Combination therapy with vin
blastine, bleomycin and cis-platinum
gives a complete remission rate of ap
proximately 70% in patients with dis
seminated testicular cancer. Almost
all the remaining patients will obtain
partial remission and with adjunctive
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Surgical Treatment of Carcinoma of the Prostate
C.J. R obson,

que demontre par diverses epreuves
comme la mesure de la phosphatase
acide, la scintigraphie au technetium
et le titrage radio-immunologique,
est confinee a la prostate. Idealement,
les ganglions lymphatiques le long
des vaisseaux iliaques et obturateurs
devraient etre enleves et mis en
section rapidement. Si des cellules
malignes sont retrouvees dans les
ganglions lymphatiques, la maladie est
consideree chirurgicalement incurable
et I'intervention devrait etre
abandonnee. Si, toutefois, les ganglions
sont sains une prostatovesiculectomie
totale devrait etre pratiquee.
L’auteur discute egalement du role
de la chirurgie palliative, telle que
la resection transuretrale dans le
traitement du cancer de la prostate.

Prostatic cancer kills more men than
any other malignant condition except
that arising from the lung. “Cancer
Therapy: Prognostic Factors and
Criteria of Response” predicted
that there would be approximately
17 500 deaths due to this disease in
the United States in 1978.
Surgery is only applicable in stages
A and B, when the tumour, as shown
by various tests, such as measurement
of the acid phosphatase value, technetium
scanning and radioimmunoassay, is
confined to the prostate. Ideally, the
lymph glands along the iliac and
obturator vessels should first be
removed and quick-sectioned. If malignant
cells are found in the lymph glands,
the disease is considered surgically
incurable and the procedure should be
abandoned. If, however, the glands are
disease free, a total prostatovesiculectomy should be carried out.
The author also discusses the place
of palliative surgery, such as
transurethral resection, in the treatment
of cancer of the prostate.

More men die of prostatic cancer than
of any other malignant disease with
the exception of that arising in the
lung. In those over 75 years of age
prostatic cancer is the prime killer.
The statistics in “Cancer Therapy:
Prognostic Factors and Criteria of Res
ponse”1 indicated that there would be
approximately 17 500 deaths due to
cancer of prostate in 1978.
From a different viewpoint it is
estimated that 11 % of all carcinomas
in the male are prostatic in origin, and
routine autopsies have shown that the
frequency of prostatic cancer ranges
from 14% to 46% even up to 90%,
depending on the criteria for diagnosis
as well as the thoroughness of the
examination.
Regarding the management of this
disease, there is no dogmatic statement
which cannot be refuted by reference
to the literature.

Le cancer de la prostate tue plus
d’hommes que toute autre maladie
maligne, sauf cedes du poumon.
“ Cancer Therapy: Prognostic Factors
and Criteria of Response” predisait
qu'il y aurait approximativement
17 500 deces attribuables a cette
maladie aux Etats-Unis, en 1978.
La chirurgie n'est applicable qu'aux
stades A et B, quand la tumeur, tel
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topsies performed on patients who
had had carcinoma of the prostate,
stated that 99% Of the growths oc
curred peripherally and at least one
third of thes^ were multifocal. Fie al
so pointed out that the grade of lesion
varied in the same specimen, one area
showing well-defined adenocarcinoma
grade I and another less well-defined
tumour, grades III or IV, according
to Broders’ classification.4 The growth
remains localized for a time, then
spreads through the capsule and hence
to the lumbar spine and pelvis, usually
via Batson's plexus of veins. Initial
spread is by way of the pelvic and
para-aortic lymph nodes and also by
the blood stream to other bony sites.
Indeed, the lung and brain may be
involved in a carcinomatosis type of
spread.
Diagnosis

Only 5% to 10% of cancers of the
prostate are diagnosed when they are
amenable to surgical cure or treat
ment. They are usually discovered by
the physician who finds a nodule or
induration on routine rectal examina
tion. The remaining 90% to 95% are
found because the patient has symp
toms of bladder neck obstruction,
which is almost always due to a stage
C or D lesion (one which has penetrat
ed the prostatic capsule), or because
of symptoms due to metastases (e.g.,
bone pain).
In recent years we have added to
our diagnostic armamentarium three
aids to staging: (a) the isolation of the
prostatic fraction of the serum acid
phosphatase, which is almost always
diagnostic when the value is elevated;
(b) the estimation of the bone marrow
acid phosphatase value as advocated
by Veenema and associates,5’® who
showed that elevation of the bone mar
row acid value indicates extracapsular
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spread of the growth some time be
fore the serum acid phosphatase con
centration becomes elevated; and (c)
the radioimmunoassay for prostatic acid
phosphatase as developed by Fenimore Cooper.712 This assay gives po
sitive results in 30% of cases in which
the bone marrow and serum acid phos
phatase values are normal as estimated
by other methods. So far, this is the
most sensitive test we have to detect
extraprostatic spread of disease.
Normally pedal lymphangiography
does not show the obturator or in
ternal iliac nodes which are the first
to be involved by cancer of the pros
tate. If these nodes are demonstrated,
it is almost certainly by retrograde
filling of these lymphatics due to ob
struction of the lymph channels in the
common iliac chain or possibly the
para-aortic chain.
Prognosis

The prognosis depends on two fac
tors, stage and grade, in addition to
the immune response of the host to
tumour.
Stage
There are four stages of carcinoma
of the prostate which may be num
bered 1 to 4 or, as in this paper,
lettered A to D. In stage A the diag
nosis is made by microscopic exam
ination alone. The serum acid phos
phatase values are normal. The lesion
cannot be detected clinically. In stage
B l, the lesion is less than 2 cm in
diameter. The serum phosphatase val
ues are normal. In stage B2 lesions
the growth is confined within the cap
sule of the prostate and, on clinical
examination, does not involve the base
of the bladder or seminal vesicles. In
stage C the growth has penetrated the
capsule and invaded the base of the
bladder or the seminal vesicles, or
both. In this stage pelvic lymph nodes
are involved in 50% to 85% of cases
but the tumour is limited to the pelvis.
In stage D there are metastases.
Grade
Grading of prostatic carcinoma is
extremely difficult because of the wide
variation within the same specimen.13
It is therefore impossible to grade a
prostatic carcinoma accurately from
two or three small needle biopsy speci
mens. This has been a serious problem
in assessing the importance of grading
in various series. Unquestionably, grad
ing of a tumour should be on the
basis of the highest grade within the
specimen and this can only be assessed
accurately from the whole specimen.
422

Treatment

Carcinoma of the prostate may be
divided into two main clinical groups.
The first comprises stages A and B,
the second, stages C and D. Tumours
in stages A and B are potentially cur
able by total prostatovesiculectomy,
with or without lymph-node dissection.
As a result of this procedure, 95%
or more of patients may become im
potent and 10% to 20% will have
some degree of urinary incompetence.
Stages A and B
Stage A .— The management of pa
tients with stage A lesions is contro
versial. Many urologists believe that
the large majority of patients with a
tumour of this stage will not die of
their disease and that their life expec
tancy is equal to a similar age group
without the disease. We do not sub
scribe to this belief. We believe that
stage A tumours should be treated
like any other operable cancer. Some
urologists actually base their treatment
on the percentage of tissue with malig
nant change and are of the opinion that
if it is less than 30% , the patient should
be treated expectantly. Recently,
the grade of the lesion has been shown
to have a very important effect on the
prognosis.1316 If the tumour is a welldifferentiated adenocarcinoma and re
peat biopsy specimens of the prostatic
capsule after 1 month and a transrectal
needle biopsy specimen of the posterior
lobe fail to show any remaining disease,
then these patients should not be sub
jected to total prostatectomy. On the
other hand, if the lesion is of high grade
(and 20% to 50% of them are), we
agree with Bauer, McGavran and Car
lin16 that the prognosis even with endo
crine therapy is poor and that these pa
tients should be treated by total pros
tatovesiculectomy if they have no se
rious concomitant disease and have a
life expectancy of 10 years or more.
Stage B l .—In a patient with this
stage of tumour who is younger than
70 years and who is otherwise in good
health, the optimum cure rate will be
achieved by total prostatovesiculecto
my if the lymph nodes taken from
the internal iliac and obturator areas
show no tumour.
Stage B2.—Autopsy series show
that 6% of patients with these tumours
have positive nodes (stage C lesions).
Because of the complications of im
potence and incontinence, there are
two groups of urologic surgeons who
advocate widely divergent treatment.
One group advocates expectant treat
ment, in stages A and B lesions, with
the exception, perhaps, of introducing
iodine-125 needles directly into the
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gland or of external irradiation in
cases of high-grade tumour.17 For tu
mours of lower grade, therapy is
withheld until symptoms develop on the
premise that many carcinomas of the
prostate are extremely slow growing.18
Unfortunately, at present, we cannot
predict the behaviour of such tumours.
Grading may be a guide but, as al
ready noted, is not dependable in bi
opsy specimens. This is the approach
now recommended by Whitmore,18
but considerable time is neces
sary before a thorough assessment of
this approach can be completed. On
the other hand, Jewett19 and workers
from the Mayo Clinic,20,21 amongst
others,22 believe that the disease merits
a radical operation and that the 10- to
15-year survival justifies this despite
the complications. It is generally agreed
that radical or total prostatectomy
should be reserved for patients who
normally have at least a 10-year life
expectancy from the time of operation.
It is of interest that supplying estro
gens after total prostatectomy does not
improve the prognosis.23
Stages C and D .—The second clin
ical group of cases, stages C and
D, may require palliative surgery, such
as a procedure to relieve bladder neck
obstruction (usually with some degree
of benign prostatic hypertrophy) which
has not been relieved by estrogen
therapy. In some relatively healthy pa
tients with stage C tumour, the dis
ease may have extended to the base
of the bladder and involved the lower
ends of the ureters producing hydro
ureter and hydronephrosis and life
threatening renal failure. In such cases,
bilateral reimplantation of the ureters
to a higher site in the bladder may be
of value.
Surgical Approach

The ideal surgical approach to the
malignant prostate should: (a) allow
sampling of the internal iliac and ob
turator lymph nodes, because if these
nodes contain malignant cells the dis
ease is surgically incurable and the
operation should not be continued; (b)
allow easy access to the gland itself
even after a complete transurethral re
section (i.e., in stage A disease); (c)
permit accurate and easy anastomosis
of the bladder to the urethra; (d) keep
incontinence and impotence to a mini
mum; and (e) result in minimal mor
bidity, mortality and hospital stay.
Perineal Exposure
Unless this is done in two steps or
by two teams, examination of the pel
vic lymph nodes is not possible. It is
a most difficult operation if there has
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been a previous transurethral resection
or enucleation. In our hands the fre
quency of impotence has been almost
100% and some degree of inconti
nence has occurred in about 50% of
patients.
Retropubic Approach

This can be most difficult technical
ly, particularly with respect to urethral
anastomosis and after a previous pros
tatic operation. The anastomosis can
be so difficult that some advocate leav
ing a small portion of prostate behind
to facilitate it. Byar and Mostofi23 have
deplored this action because they
found cancer at the prostatic apex in
75% of 208 prostates removed for
?arly carcinoma. The incidence of im
potence and incontinence is approxi
mately the same as for perineal prosta
tectomy.

clinically stage A and three stage B.
Two of these tumours were highly dif
ferentiated adenocarcinomas, two mod
erately well differentiated and two
were anaplastic. There were therefore
36 patients who underwent radical
transpubic prostatovesiculectomy. It is
interesting that about 60% of these
tumours were understaged, although
pathologically the lines of resection in
all cases were clear.
Results

Follow-up on these patients is too
short to be evaluated statistically, but
some interesting facts have emerged:
(a) after the operation 35 of the 36
patients walked without difficulty.
Leaving a bridge of symphysis may
have helped; (b) 3 of the 36 patients
have persistent stress incontinence re
quiring a clamp or collecting appa
ratus. Anastomosis using a bladder
tube, as described by Flocks and Culp,
should eliminate this problem; and (c)
3 of the 36 patients were potent.

Total Trans-sacral Prostatectomy

This operation was originally pro
posed for patients who could not be
put into the exaggerated lithotomy po
sition. It allows easy access to the
prostate, and visualization of the anas
tomosis is superior to that obtained
with the retropubic approach but, like
the perineal approach, it does not allow
examination of the lymph nodes.

Conclusions and Summary

Carcinoma of the prostate is fatal
for about 17 500 Americans each year,
and with increasing longevity this in
cidence will increase. In men who
have a life expectancy of 10 years
from the time of presentation and
who have a lesion which is clin
ically stage A, B1 or B2, the treatment
of choice is surgical. In the case of
a stage A tumour, if the repeat trans
urethral and needle biopsy specimens
after 1 month fail to show any
tumour and the tumour was of low
grade, then watchful waiting is prob
ably permissible. On the other hand,
no matter what size the tumour
may be, if it is of high grade or if
repeat biopsy specimens show that the
tumour is still within the capsule, then
serious consideration should be given
to performing a total prostatectomy.
We believe that surgical extirpation is
the treatment of choice in patients with
stage B lesions, either B1 or B2.
The transpubic approach for prosta
tovesiculectomy is the best one with
minimal morbidity and complications.
At present we are understaging
about 60% of our cases of carcinoma
of the prostate.

Transpubic Approach

Within the last 4 years this ap
proach has been used almost exclusive
ly by the staff of the Toronto General
Hospital. It allows the extraperitoneal
removal of the iliac and obturator
nodes for quick section before mani
pulation of the prostate. It allows ex
cellent exposure of the prostate for its
removal and for anastomosis of the
bladder to the urethra under direct
vision. The procedure can be carried
out by one team. It is the exposure
of choice, particularly when a prosta
tic procedure has been done previous
ly. There is some morbidity due to
pain in the adductor regions on walk
ing, but this has seldom persisted more
than a few weeks; by leaving a small
bridge of symphysis, this pain can be
almost eliminated. Stress incontinence
has been a problem but has been
solved by fashioning a bladder tube
to anastomose to the urethra after the
method of Flocks and Culp.24
From Aug. 1, 1974, to Dec. 31,
1978, 42 patients with carcinoma of
the prostate considered to be either
stage A or B were operated on at
the Toronto General Hospital. S'ix of
the patients had malignant cells in
the nodes on quick section and the
procedure was terminated; three were
VOLUME 22, NO. 5, SEPTEMBER 1979
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Radiation Therapy for Adenocarcinoma of the Prostate
A.W . B ruce , mb, ch b, frcs ( edin ), facs, frcs[c ],* D.E. M ahan, ph d * and S. L ott , md, dmrt , FRCP[c]f

Forty-eight patients with different
stages of adenocarcinoma of the
prostate w ere treated by external beam
therapy. Biopsy results are correlated
w ith stage of disease, original grade
of tumour and with the findings on
examination. The authors discuss the
significance of histologic progression of
the disease particularly in relation
to prognosis. They review the place
of staging lymphadenectomy before
radiotherapy and the overall morbidity
associated with treatment.
Quarante-huit patients souffrant
d'adenocarcinomes prostatiques a
differents stades ont ete traites par
faisceau de rayonnement externe.
On a fait la correlation entre les
resultats de biopsie et le stade de la
maladie, le grade initial de la tumeur
et les constatations de I'examen rectal.
Les auteurs discutent de la significativite de 1'evolution histologique
de la maladie en relation, particulierement, avec le pronostic. Ils revoient
le role du classement du stade
clinique de la maladie par lymphadenectomie avant la radiotherapie, et
la morbidite globale associee au
traitem ent.

Surgical extirpation of early intracapsular adenocarcinoma of the prostate
is associated with unavoidable morbid
ity.1,2 Furthermore, all forms of hor
monal therapy provide control rather
than cure of this malignant condition.
Over the past 15 to 20 years there has
been increasing interest in the role of
radiation therapy in the treatment of
patients with potentially curable pro
static cancer and as a form of pallia
tion for patients with bone metastases
associated with localized pain. Adeno
carcinoma of the prostate is a radio
sensitive tumour and the introduction
of external beam therapy and intersti
tial irradiation allow the delivery of a
tumoricidal dose of radiation to the
prostate without damage to the skin
and other normal tissue. Acceptable
long-term survival statistics are becom
ing available from centres using ex
ternal beam therapy.3 In addition, en
couraging results of treatment with in

terstitial irradiation have been re
ported.4
The method of assessing local re
sponse of tumour to radiotherapy is
still controversial and requires clearer
definition. The inadequacy of rectal
examination in the follow-up of pa
tients with adenocarcinoma of the
prostate is not well recognized. Despite
the drawbacks of biopsy this form of
assessment provides more objective
evidence of tumour response to radia
tion therapy. We present biopsy data
in a selected series of patients with
carefully staged adenocarcinoma of the
prostate treated by external beam
therapy, to review early clinical re
sults, particularly in relation to biop
sy findings, and to report on the
morbidity associated with this particu
lar form of radiation therapy.
Methods

A modification of the American
Urological System of staging5 was used
(Table I) to record the extent of the
disease. Staging procedures included
rectal examination, prostatic biopsy,
technetium-99 bone scanning, radio
immunoassay to measure serum and
bone-marrow acid phosphatase values6
and pelvic lymphadenectomy. Patients
have to be carefully selected for stag
ing lymphadenectomy, which was em
ployed in 63% of the patients studied
(Table II). Routinely, four biopsy
specimens (two from each lobe) were
obtained from the prostate before and
after treatment. Pathological grading
of the tissue was carried out using a
modification of the method recom
mended by the Veterans Administra
Table 1—American Urological System for Sta
ging Adenocarcinoma of the Prostate
Tumour
stage
A
A,
A2
B
B,

Bo
C

c,

From the departments of *urology
and Eradiation oncology, Queen’s
University, Kingston, Ont.
Reprint requests to: Dr. A.W. Bruce,
Queen's University, Victory 4, Kingston
General Hospital, Kingston, Ont. K7L 2V7
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C2
D
D,

Do

Description
Incidental finding
Focal
Diffuse
Confined to prostate
Small, discrete nodule
Large or multiple nodules
Localized to periprostatic area
No involvement of seminal
vesicles
Involvement of seminal vesicles
Metastatic disease
Pelvic lymph-node metastases
Bone or distant lymph-node or
soft tissue metastases
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tion Cooperative Urological Research
Group.7 The grading was performed
under low magnification (40 to 100X)
and a histologic description was given
of the primary and secondary his
tologic patterns, the primary pattern
occupying more than 50% of the
malignant area. Each specimen was
assigned two numbers, ranging from 1
to 4 representing the primary and
secondary histologic fields. These two
numbers were then combined to give
an overall pattern score. When the
pattern score was less than 4, the
tumour was described as being well
differentiated, when 5 or 6 moderate
ly differentiated and when 7 or 8 as
being anaplastic.
External beam therapy (with cobalt60) was used to treat all patients. In
those without evidence of lymphatic
spread the prostate and periprostatic
area were irradiated with up to 6000
rads. In patients with positive lymph
nodes (Di), the whole pelvis was irradi
ated to a dose of 4000 rads, and the
prostate and periprostatic area were
given a further 2000 rads. Both forms
of treatment were delivered over a 6week period.
Patients

Forty-eight patients were treated as
described above. Their average age at
time of treatment was 65.8 years
(range 49 to 79 years). These patients
did not receive adjuvant therapy and
additional treatment was withheld until
clinical progression was evident.
Following irradiation, biopsies were
done annually; 105 specimens were
available for study in addition to the
original 48 (average 2.2 post-treatment
biopsies per patient). The mean follow
up was 40 months (range 14 to 81
months). The distribution of patients
Table II—Data on 48 Patients with Cancer of
the Prostate Treated by External Beam
Therapy

Stage
A2
Bi
b2
C

No. of
patients

No. of
laparatomies

Average
pattern
score

8
13
12
15

2
10
9(3*)
6(3*)

4.9
3.9
4.9
5.3

♦Patients with lymph-node
average pattern score 5.5.

metastases,
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by stage is shown in Table II.
ing lymphadenectomy, six
were restaged Di, three from
three from C categories. The
pattern score for each stage
given in Table II.

Follow
patients
B2 and
average
is also

Results

As of Dec. 31, 1978, eight patients
have died, four from progression of
their prostatic cancer and four of un
related causes (two of coronary throm
bosis, one of atherosclerosis and one
of lung cancer). One patient was lost
to follow-up after 46 months. In addi
tion to the four patients who died of
adenocarcinoma of the prostate, five
patients have shown either extension
of local disease or the development of
metastases, or both. Table III lists in
detail the clinical status of these nine
patients. Seven of the nine patients did
not have the benefit of a staging
lymphadenectomy and this may be of
significance in three of the patients
who later had metastatic disease and
in two of the four patients who died.
In three of these four patients, biopsy
specimens obtained prior to death
showed anaplastic carcinoma and the
fourth patient probably had metastases
at the time of treatment (common iliac
lymph nodes showed metastatic dis
ease). Two of the eight patients with
A2 disease had metastases. Of the 12
patients with B2 disease, 2 had exten
sion of disease, and 5 of 15 patients
with stage C disease (2 with lymphnode metastases) also failed to respond
to radiation therapy. No patient in
stage Bi had progression of disease.
A comparison was made between
rectal examination and follow-up biop
sy findings. There was an overall dis
agreement between rectal examination
and histologic information in 38%
of the biopsy specimens studied. There
was a false-positive rate of 47% (nor
mal biopsy result associated with
clinically positive rectal examinations)
and a false-negative rate of 33%
(biopsy specimens showing tumour as
sociated with clinically normal rectal
examinations).
The initial stage of the disease was
compared with the post-treatment
biopsy findings at 1-year, 2-year and
3-year intervals (Table IV). The six pa
tients with lymph nodes containing
malignant cells were included and re
ported under their initial clinical stage.
At 1-year follow-up, 43% (17 of 40) of
the biopsy specimens failed to show
any malignant lesion but after 2 years,
only 33% (11 of 33) of biopsy speci
mens were cancer free and after 3
years, only 28% (5 of 18). Although the
numbers are small, patients with A2 and
B disease appeared to respond more
VOLUME 22, NO. 5, SEPTEMBER 1979 /

effectively to radiation therapy than
those with stage C disease.
The original histologic grade of the
tumour was also compared with the
post-treatment biopsy findings (Table
V). Patients with well-differentiated
neoplasms appear to have a better
prognosis than those with either a
moderately well differentiated or an

anaplastic lesion. The 13 patients with
Bi disease had a pattern score under
4 indicating a well-differentiated tu
mour and, as previously noted, in no
patient has the disease progressed.
The clinical response of the patient
in relation to change in biopsy findings
was also studied. The grading method
used allowed a quantitative evaluation

Table I I I — Clinical Status of Patients Who Had Extension of Prostatic Cancer or Died of the Disease

Original
clinical
stage

Control
of primary
Laparotomy tumour

A,
A2
b2
b2

No
No
No
No
No
No
No
Yes*
Yes*

c
c
c
c
c

Death due
to prostatic
Metastases carcinoma

No
Yes
Yes
No
No
No
No
Yes
No

Yes
Yes
Yes
No
No
Yes
Yes
Yes
Yes

Biopsy
pattern score
Remission
tim e, mo

O riginal Follow -up

31
24
54
23
16
24
21
28
24

—

Yes
—
—

No
—

Yes
Yes
Yes

5
4
4
7
4
8
7
4
4

7
8
Neg
6
5
7
8
Neg
8

*Lymphnodes positive.

Table IV— Comparison of In itia l Stage of Disease and Postoperative
Biopsy Findings at 1, 2 and 3 Years after Treatm ent
Follow-up, yr; no. tu m o u r-fre e biopsy specimens /to ta l no.(and

a2

B
C

% )

1

2

3

4 /6 (67)
9/21 (43)
4/13 (31)

5 /6 (83)
5/19 (26)
1/8 (12)

2 /4 (50)
3/11 (27)
0/3 ( 0 )

17/40 (43)

11/33 (33)

5/18 (28)

In itia l stage

Table V— Comparison of O riginal Histologic Grade and Biopsy Findings at
1, 2 and 3 Years a fte r Treatm ent
Follow-up, yr; no. tum o ur-free biopsy
specim ens/total no. (and % )
O riginal grade
Well differentiated
M oderately well differentiated
Anaplastic

No. of
patients

1

2

3

26
12
10

12/21 (57)
3/10 (30)
2/9 (22)

7/16 (44)
1/8 (12)
3 /9 (33)

3 /8 (37)
1/7 (14)
1 /3 (33)

48

17/40 (43)

11/33 (33)

5/18 (28)

Table V I— Clinical Response in Relation to Biopsy Findings
C linical follow -up

Summary of
fo llo w -up
biopsy

Well

Progression

Well differentiated

Im provem ent
No change
D eterioration

6
13
2

2
0
3

Moderately w ell differentiated

Im provem ent
No change
D eterioration

6
5
0

0
0
1

Anaplastic

Im provem ent
No change

6
1

1
2

O riginal biopsy
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of biopsy material (Table VI). Three
categories were arbitrarily chosen to
summarize and compare post-treatment
biopsy findings with the original his
tologic descriptions: (a) “improvement”
represents elimination of tumour or
consistent reduction in pattern score
by two or more units, (b) “no change”
indicates no net increase or decrease
in pattern score and (c) “deterioration”
means a consistent increase in pat
tern score of two or more units.
Of the 26 patients with well-differen
tiated lesions (pattern scores of 4
or less) 21 are clinically well without
evidence of metastases and without
evidence of local progression. Improve
ment was demonstrated histologically
in two patients following radiation
therapy yet metastases developed in
one 54 months after completion of
therapy. This patient did not have a
staging lymphadenectomy. The other
patient had metastases at the time of
therapy and would now, under our
present protocol, be treated by hor
mones. Five patients showed increas
ingly anaplastic biopsy specimens
after treatment. Two have died of
cancer, one has had a transurethral
resection of the prostate and two re
main well.
Of the 12 patients with moderately
well-differentiated
adenocarcinomas
(pattern score of 5 to 6), 11 are clinic
ally well and have shown improve
ment or no change in their pattern
score. One patient had deterioration,
demonstrated histologically, with con
current progression of disease both
locally and distally. This patient did
not have a staging lymphadenectomy.
Finally, of the 10 patients with
anaplastic histology (pattern scores of
7 and 8), 7 are clinically well and 3
have shown progression of disease.
Two of the three have had persistently
anaplastic biopsy specimens but one
has shown local improvement. With an
average follow-up of 40 months, 35 of
44 are clinically well.
Complications

We were impressed by the frequency
of serious side effects. Irritable blad
der and bowel symptoms following
radiotherapy occurred in the majority
of the patients, but these were gen
erally easily controlled by simple medi
cations and subsided after completion
of therapy. We found persistent symp
toms beyond the 3-month period in only
five patients (10%). These were in the
form of irritable bladder or bowel
symptoms or some form of scrotal,
penile or thigh edema. We found it
hard to assess impotence but most of
the younger patients were potent fol
lowing therapy. However, in patients
426

with decreasing libido prior to therapy,
impotence generally followed. Our
overall figure for impotence in pa
tients who were potent before treat
ment was begun was 54%. We found
no increase in complication rates for
those who underwent pelvic lymphade
nectomy prior to therapy. Lymphoceles
occurred in two of the patients sub
jected to lymphadenectomy and drains
were left in situ following the proce
dure until drainage had completely
ceased. There were no cases of bowel
obstruction. Similar findings have been
reported by others.4,8,9
Discussion

Rectal examination is an inaccurate
method of assessing the response erf
the prostate to radiotherapy. Kurth and
associates10 and Carlton and associates4
have reported a 41% frequency of
normal findings on rectal examination
associated with positive biopsy results.
A similar figure, 33%, was found in
our series. On the other hand, biopsy
results were negative in 47% of our
patients with abnormal rectal findings.
Although a proportion of this discre
pancy undoubtedly results from the
inaccuracy inherent in biopsy methods
(15%),u these results demonstrate that
it is most difficult to distinguish the
presence of tumour from the effects
of radiotherapy by rectal examination
alone. In the follow-up of these pa
tients it would appear that the only
value of rectal examination is in de
tecting obvious clinical progression of
disease.
There have been a number of re
ports related to biopsy findings follow
ing radiotherapy for localized adeno
carcinoma of the prostate. As shown in
Table VII4,10,12-15 there are considerable
differences in tumour-free biopsy rates
— from 81% to 35%. Such a large dif
ference is difficult to explain on the
basis of either biopsy or radiotherapy
techniques. Furthermore, Cox and
Stoffel12 reported an increasing num
ber of negative biopsy results—from
34% to 81% over a 30-month period,
whereas Nachtsheim and associates14
found the opposite response (71% to
41% over a 36-month period). Our
data also showed a decrease in the

number of negative biopsy results with
time.
When the initial grade of the tumour
was compared with subsequent his
tologic patterns, we found that the
well-differentiated tumour had a much
greater chance of being eliminated by
radiotherapy (Table IV). Furthermore,
although a high percentage (70%) of
our patients with anaplastic tumours
showed improvement in grade, total
elimination of tumour cells was not
achieved. This result varies, however.
Kurth and associates10 reported no rela
tionship in response to radiotherapy
with different grades of tumour where
as McLoughlin and associates16 found
that the results with anaplastic lesions
were better.
There has been much discussion on
the prognostic importance of biopsy
findings. Kurth and colleagues10 found
a positive correlation between the
persistence of tumour cells in biopsy
specimens and the development of
metastases. However, Cox and Stoffel12
found no relationship between positive
biopsy findings and progression of
disease. In our series, of the nine pa
tients whose follow-up biopsy speci
mens either remained anaplastic or be
came more anaplastic, progression of
disease was observed in six. On the other
hand, of the 39 patients whose follow
up biopsy specimens showed improve
ment or remained well or moderate
ly well differentiated, progression was
noted in only 3. Deterioration of histo
logic pattern or persistence of anapla
sia in biopsy specimens as distinct from
a merely positive biopsy result would
appear to be a poor prognostic index.
It should be noted that although
both Kurth and associates10 and Cox
and Stoffel12 reported on stage C dis
ease, in the former series less than one
third of the patients had staging laparo
tomies and in the latter study no pa
tient underwent this procedure. In the
present report, of the seven patients
in whom distant bone or soft tissue
metastases developed, only two had
lymph nodes assessed by laparotomy
before radiotherapy. In both of these
cases lymph-node metastases were dis
covered at operation. Whenever possi
ble, pelvic lymphadenectomy should

T a b le V I I — B io p s y F in d in g s a f t e r R a d io t h e r a p y f o r L o c a liz e d A d e n o c a r c in o m a o f
th e P r o s ta te

S e r ie s
C a r lt o n a n d a s s o c ia t e s 4
K u r t h a n d a s s o c ia t e s 10
C o x a n d S t o f f e l 12
M o lle n k a m p , C o o p e r a n d K a g a n 13
N a c h t s h e im 14
S e w e ll a n d a s s o c ia t e s 15
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/

No. of
p a t ie n t s

T u m o u r fre e
ra te

34
53
37
76
17
17

65
43
81
42
41
35

F o llo w - u p , m o
1 2 - 30
32
30
12
36
4 - 38
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required to define clearly the place
of radiation therapy in the treatment
of adenocarcinoma of the prostate.

be carried out as a staging procedure
prior to curative radiotherapy.
Unfortunately, it is difficult to com
pare survival statistics obtained from
the various treatment modalities (radio
therapy, surgery, endocrine therapy),
because of (a) inadequate staging, (b)
different methods of statistical analysis,
(c) the lack of results from radio
therapy beyond the 10-year period,
(d) ' the use of adjuvant therapies in
many series and (e) the long history
of carcinoma of the prostate. At pres
ent no one treatment method appears
to offer a clear advantage over others.
On the other hand, radiotherapy is
potentially curative, is associated with
fewer complications than surgical pro
cedures and is suitable for the manage
ment of older patients with localized
disease. These advantages are appeal
ing to many. However, the persistence
of positive biopsy results following
therapy is worrisome, and opinion
varies as to the clinical importance of
this finding and whether additional
treatment is necessary. Several of our
patients had positive biopsy results
but no evidence of clinical progression
of disease at periods varying from 56
to 61 months. At present, additional
therapy is not given unless there is
objective evidence of extension of dis
ease locally or distally. More study is

We wish to thank Dr. G.F. Kipkie for
his expert review of the pathological ma
terial.
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Surgical Management of Renal Cell Carcinoma at the
Vancouver General Hospital: 20-Year Review
L.D. Su lliv a n ,

m d , fr c s [c ],

D.D. W e s t m o r e ,

Over a 20-year period 143 patients
with renal cell carcinoma were treated
surgically at the Vancouver General
Hospital. The results of simple nephrec
tomy are compared to those of radical
nephrectomy. The authors conclude that
radical nephrectomy (including node
dissection) is a useful staging proce
dure but provides little or no long
term therapeutic benefit over simple
nephrectomy. They stress the need
for new adjunctive therapy.

des cellules renales ont ete traites
chirurgicalement au Vancouver
General Hospital. Les resultats de la
nephrectomie simple sont compares
a ceux de la nephrectomie radicale.
Les auteurs concluent que la
nephrectomie radicale (incluant la
dissection ganglionnaire) est une inter
vention utile pour classifier le stade
clinique de la maladie mais qu'elle
offre peu d'avantage therapeutique
et aucun de longue duree par rapport
a la nephrectomie simple. Ils insistent
sur le besoin de nouveaux traitements d'appoint.

Au cours d’une periode de 20 ans,
143 patients souffrant d’un carcinome

From the division of urology, department
of surgery, University of British
Columbia, Vancouver, BC
Reprint requests to: University of British
Columbia, Urology clinic, Ste. 1,
855 West 10th Ave., Vancouver, BC
V5Z 1L7
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m b , b s , fr c s , f r c s ( e d in ) and

This study was undertaken to evalu
ate the possible therapeutic benefits of
adding ipsilateral node dissection
(radical nephrectomy) to the standard
/

M.G. M c L o u g h l in ,

m d , f r c s [c ]

en bloc total resection of the contents
of Gerota’s fascia (termed a “simple”
nephrectomy in our hospital). We
found the node dissection to be an
excellent staging procedure, but it did
not substantially improve survival in
our series.
Patients and M ethods

Of 243 patients with renal cell carci
noma seen at the Vancouver General
Hospital between Jan. 1, 1957 and
Dec. 31, 1976, 143 were treated sur
gically by either simple or radical
nephrectomy.
Before 1967, surgical treatment of
renal cell carcinoma consisted of sim
ple nephrectomy (in 55 patients) with
removal of the contents of G erota’s
fascia. In a few patients, some region
al nodes were examined.
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Since 1967, the standard surgical
procedure for the condition has been
radical nephrectomy (in 88 patients),
emphasizing early ligation of the renal
vessels, with en bloc dissection of the
lymphatics from the diaphragm to the
bifurcation of the aorta and vena cava.
The male:female ratio was 5:2. The
mean age of patients treated by simple
nephrectomy was 62 years and by ra
dical nephrectomy was 56 years. All
patients were followed up for at least
2 years and 80% were followed up
for 5 years.
Staging
Standard staging studies, including
angiography, were performed in all
patients who underwent radical neph
rectomy. In recent years chest tomog
raphy has been added to these studies.
The Robson staging method was
used.1,2
There were 62 patients with stage
1 (tumour confined to kidney) lesions,
24 with stage 2 (involvement of peri
nephric fat) lesions, 32 with stage 3
(involvement of renal vein or regional
lymph nodes) lesions and 25 with stage
4 (metastatic spread) lesions.
Results

The survival at 3, 5 and 10 years
for all potentially curable patients
(stages 1, 2 and 3) was 66% (63 of
95), 52% (40 of 77) and 27% (19 of
71), respectively. These percentages
are comparable to those in most
series.1-5

Surprisingly, the survival for stages
1, 2 and 3 patients combined was ac
tually shorter for those who had radical
nephrectomy than for those who un
derwent simple nephrectomy (Tables
I and 11). This finding could not be
explained on the basis of more exten
sive surgery since the operative mor
tality was only 1.5%, but was owing
in part to the fact that only 13 stage 1
patients who had radical nephrectomy
had been followed up for 5 years.
The survival for stage 2 and stage
3 patients was somewhat better with
radical nephrectomy. Survival of pa
tients with perirenal invasion (Table
III) and of those with lymph-node metastases (Table IV) was slightly im
proved when radical nephrectomy was
carried out.
For analysis of survival related to
the degree of venous invasion, patients
were considered in four groups: those
with (a) microvenous invasion, (b)
invasion of a renal vein tributary,
(c) invasion of the renal vein and (d)
invasion of the inferior vena cava. The
5-year survival in these groups was
16%, 20%, 27% and 16%, respec
tively.
There was no benefit from radical
nephrectomy in patients with invasion
of the renal vein or one of its tribu
taries.
Of six patients who had inferior
vena caval invasion there was only one
survivor at 5 years. This patient sub
sequently received irradiation for brain
metastases. He is alive 7 years after

T a b le 1— L e n g th o f S u r v iv a l o f P a tie n ts Who U n d e rw e n t S im p le N e p h re cto m y

S u r v iv a l, y r ; n o. p a tie n ts s u r v iv in g / t o t a l
fo llo w e d up a t e a c h in t e r v a l (an d % )
N o. o f p a tie n ts
o p e rate d on

S ta g e
1
2
3
4
1, 2 , 3 co m b in e d (p o te n tia lly
c u ra b le p a tie n ts )
A ll p a tie n ts

3

5

10

30
9
12
4

24/26
7/ 9
2/10
1/ 3

(9 2 )
(7 8 )
(2 0 )
(3 3 )

18/24 (7 4 )
6 / 9 (6 6 )
2/10 (2 0 )
0 / 3 (0 )

10/21
3/ 8
0/9
0/3

51
55

33/45 (7 3 )
34/48 (7 1 )

26/43 (6 0 )
26/46 (5 7 )

13/38 (3 4 )
13/41 (3 2 )

(4 8 )
(3 7 )
(0)
(0)

T a b le I I — L e n g th o f S u r v iv a l o f P a t ie n t s Who U n d e rw e n t R a d ic a l N e p h re cto m y

operation. The mean length of sur
vival of this group was 16 months and
the 5-year survival rate was 16%.
In our patients there were 25 with
stage 4 disease who underwent radical
nephrectomy. In most cases a sympto
matic primary tumour was the reason
for operation. Seven patients in whom
solitary metastases at other sites had
been removed previously, were oper
ated upon for cure. Two had solitary
lung metastases that were removed fol
lowing nephrectomy and one had a
solitary metastasis in the left femur
treated by amputation. By 5 years only
four of these patients were alive and
at 10 years there were no survivors.
Discussion

Several authors have evaluated the
therapeutic effectiveness of radical
nephrectomy with node dissection.1,2,5
Our results suggest that there may be
some benefit from node dissection in
stage 2 and stage 3 disease but the
overall effect is minimal (Tables I
and II). In this series survival was
actually shorter in those who had ra
dical nephrectomy. This is particularly
important as the operative mortality in
our series was only 1.5% (one case
in each group).
While prophylactic node dissection
seemed to be beneficial if the patient
had positive nodes the possibility re
mains that this procedure in the stage
1 cases may not always be beneficial.
It is possible that the removal of these
nodes may alter the immunologic de
fence mechanism. (The numbers are
small and of questionable validity since
they are from different eras with
changing surgical techniques and pa
thology.)
T a b le I I I — P a t ie n t s w ith P e r ir e n a l In v a s io n
S u r v iv in g 5 Y e a r s a f t e r N e p h re cto m y

P ro c e d u re
R a d ic a l n e p h re cto m y
S im p le n e p h re cto m y
T o ta l

N o. o f p a tie n ts
o p e rate d on

1
2
3
4

32
15
20
21

15/23
6/10
9/17
5/19

67
88

30/50 (6 0 )
35/69 (5 1 )

1 , 2, 3 co m b in e d (p o te n tia lly
c u r a b le p a tie n ts )
A ll p a tie n ts
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3

5
(6 5 )
(6 0 )
(5 3 )
(2 6 )

4/13
6/ 7
4/14
4/19

10
(3 1 )
(8 6 )
(2 9 )
(2 1 )

14/34 (4 1 )
18/53 (3 4 )

6 / 7 (8 6 )
6/ 9 (6 6 )
12/16 (7 5 )

T a b le IV — S u r v iv a l of P a t ie n t s w ith Lym p h Node M e ta s ta s e s a ft e r N e p h re cto m y

S u r v iv a l, y r ; no. p a tie n ts s u r v iv in g / t o t a l
fo llo w e d up a t e a c h in t e r v a l (an d % )
S ta g e

5 - y e a r s u r v iv a l
n o ./ to ta l (an d % )

3/13
2/ 6
1/14
0/18

(2 3 )
(3 3 )
( 7)
( 0)

6/33 (1 8 )
6/51 (1 2 )
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P ro c e d u re
R a d ic a l
n e p h re cto m y
S im p le
n e p h re cto m y

5-year
s u r v iv a l,
n o ./ to ta l
(an d % )

M ean
s u r v iv a l
mo ± S D *

1/6 (1 7 )

36 ± 35

0/4 ( 0 )

12 ±

8

’"S tan d ard d e v ia tio n .
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Radical nephrectomy did not im
prove the survival of patients with in
volvement of the renal vein.
Since only one of six patients with
involvement of the subhepatic vena
cava was alive at 5 years, extending
the surgery above the diaphragm and
into the heart with its attendant risks
would appear to be contraindicated.

tality are similar to those of simple
nephrectomy. The procedure may con
fer benefit to patients with involve
ment of regional nodes.
Surgical therapy seems to have
reached its limits,3,6 and further ad
vances will depend upon the develop
ment of adjunctive systemic modes of
treatment.
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Management of Primary Bladder Cancer
by a Multidisciplinary Team
W.E. C ollins, md, facs, frcs[c],* G.E. Catton, md, dmrt , FRCP[c],t
A. H ussey, m d , frcs[c ],* R.G. Baker, ph d and J.M. L ast md, dph , fracp $

Results of management of a closed
series of primary bladder carcinoma over
a 20-year period by a multidisciplinary
team are presented. Patients were
classified by the TNM method before
treatment. These experiences indicate
that stage and grade are relevant to
prognosis and treatment. The TNM
classification can be precise and
practical when used diligently by a
treatment team. Although no new
methods of treatment are offered, the
treatment now available may be
utilized to better effect if programmed
to allow care of the patients by a team,
especially if the team explores the
limits of radiation and surgery in their
hands.
On presente les resultats obtenus
sur une periode de 20 ans, par une
equipe multidisciplinaire dans le
traitement d’une serie de carcinomes
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mour, nodes, metastasis (TNM) classifcation1 before treatment was initiated.
This classification, was found to be
precise and practical.
At the beginning the four primary
objectives were: (a) to establish the
limits of transurethral excisional biop
sy of the tumour; (b) to establish the
limits of radiation therapy; (c) to dis
regard lymph nodes at surgery; and
(d) when cystectomy was indicated, to
use simple cystectomy and to remove
the urethra at the same time.
When the data were reviewed in
1962, it was obvious that many tu
mours could not be handled by either
transurethral resection or radiation
alone. So the uniform treatment pro
gram was altered and patients with
high-stage,
tumours were
This is a report of a closed series of managed by high-grade
combined
diversion,
807 patients treated for primary blad diation and cystourethrectomy.2,3 irra
der cancer. Beginning in 1952, all pa
Since 1962, the uniform treatment
tients who were admitted for initial program
been as follows.2,3 In situ
treatment were included in the series. carcinomahas(TIS)
treated by transure
Twelve patients who had not been thral excisional isbiopsy.
Patients with
staged prior to treatment were ex TIS who present with bladder
irrita
cluded. All patients were managed by tion are treated by combined diver
a treatment team consisting of urolog sion, irradiation and cystourethrec
ists, radiotherapists and a pathologist.* tomy.
Patients with tumours classified
as T1 and T2 are managed by transure
Method
excisional biopsy. Radiation ther
All tumours were staged by the tu- thral
apy is added when the tumour is ana
when there is uncertainty
*In the original team, the urologists were plastictheandtumour
has been completely
J.V. Berry and W.E. Collins, the radio that
therapists were G. Stoddart and G.E. excised. Patients having T3 tumours are
Catton and the pathologist was E. Liepa. handled by staged treatment— laparo/ THE CANADIAN JOURNAL OF SURGERY
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primaires de la vessie. Les patients
ont ete classifies, avant traitement,
selon la methode TNM. Ces
experience indiquent que le stade
et le grade sont pertinents au pronostic et au traitement. La classifi
cation TNM peut etre precise et
pratique lorsqu’efle est utilisee avec
diligence par une equipe de
traitement. Bien qu'aucune nouvelle
methode de traitement ne soit offerte,
le traitement maintenant disponible
peut etre utilise avec de meilleurs
effets s ’il est programme pour
permettre la prise en charge du
patient par une equipe, specialement
si cette equipe explore les limites
de la radiotherapie et de la chirurgie
entre ses mains.

tomy with urinary diversion, followed
by irradiation to the whole pelvis using
4000 rads over 28 days and, 6 weeks
later, simple cystourethrectomy. T4a
tumours are subjected to urinary diver
sion and irradiation. Total cystectomy
without irradiation is used for patients
with squamous cell carcinomas and
adenocarcinomas of the bladder floor.
Adenocarcinomas at the vault are re
moved by extensive partial cystectomy
with excision of urachus and umbilicus.
Findings
Survival figures are relative to the
survival of a normal population of
the same age and sex distribution (i.e.,
actuarily adjusted). Survival accord
ing to cell type is shown in Table I.
As seen in Table II, surprisingly few
tumours, upon recurrence, shifted to a
higher stage. We have data on only
74 patients on the shift in grade, which
is presented in Table III; 39 recurrent
tumours maintained the same grade as
the primary tumour, 30 recurrent tu
mours were of higher grade and 5 re
current tumours were of lower grade
than the primary tumour. As seen
in Table IV the age distribution was
the usual one with all 10 decades rep
resented. There did not seem to be
any significant correlation of age to
stage (Table V), but correlation of age
to grade (Table VI) showed that the
average age of patients with grade 1
tumours (of low-grade malignancy) is
64 years, of those with grade 2 tu
mours (of medium-grade malignancy)
69 years and of those with grade 3
Table 1— Survival Correlated w ith Tumour
Cell Type*

Cell type
Tran sition al cell
Squamous cell
Adenocarcinoma

1 yr

725
20
6

—
—
50

Age, yr

No. of patients

0 -1 0
1 1 - 20
2 1 - 30
3 1 - 40
4 1 - 50
5 1 - 60
6 1 - 70
7 1 - 80
8 1 - 90
91 -1 0 0

1
1
6
20
61
153
230
223
103
8

Classification
of tumour

FIG. 1— Five- and 10-year survival
rates by age are presented. Importance of
these data is not known.

Table II— S hift to a Higher Stage on
Recurrence*

TIS
Tl
T2
T3
T4

56
17
0

*ln 56 patients the cell type was not clearly
stated.

Table IV -A g e Distribution*

Table V - -Correlation of Age to Stage*

5 yr 10 yr
69
27
0

of stage to survival as shown in Table
VIII.
The site of the tumour in the blad
der had a definite effect on survival.
Of 94 patients with tumours involv
ing the bladder neck and prostate
45% survived for 5 years and 37%
for 10 years. Those with tumours else
where in the bladder fared much better
with 69% and 57% survival rates,
respectively.
The presence of metastases had a
considerable effect on survival.
When patients with T l, T2 and T3
tumours without metastases (688 pa
tients) were grouped together, the 5-

*Mean 66.03 yr. On the chart of 1 patient, the
age was not noted.

Classification of No. of
primary tum our patients

Survival, %
No. of
patients

tumours (highly malignant) 70 years.
Survival by age is interesting (Fig. 1);
the 5-year survival rate of patients
younger than 40 years was 93%, pa
tients between 40 and 49 years of age
76% , between 50 and 59 years 73%,
between 60 and 69 years 66%, be
tween 70 and 79 years 57% and of
those over 80 years of age 60%. The
10-year survival rates were somewhat
different: 94% of the patients younger
than 40 years survived 10 years;
75% between 40 and 49 years
survived 10 years, but patients older
than 50 years had a 10-year survival
rate which was approximately the
same, ranging from 51% to 58%.
The importance of this finding is not
known.
Survival by grade was what one
would expect (Table VII). There was
a direct relationship between grade
and survival over the 5- and 10-year
periods. There was similar relationship

8
412
159
107
99

TIS
Tl
T2
T3
T4

Average
age, yr

No. of
patients

66
63
69
70
68

8
412
159
107
99

*Stage not noted for 22 patients.

No. w ith shift
to higher stage
Table VI-—Correlation of Age to Grade

2
28
25
10
0

Grade of tumour
X
1
2
3

*ln 22 patients there was no clear statement
of stage prior to treatm ent.

Average
age, yr

No. of
patients

68
64
69
70

56
522
155
74

Table I I I — S hift in Grade
Table V II— Survival by Grade*
Grade of
recurrent
tum our

Grade of prim ary tumour
----------------------------------------------------------------------------NS
1
2

3

Total

NS*
1
2
3

56
0
0
0

481
20
14
7

127
4
15
9

69
1
0
4

733
25
29
20

Total

56

522

155

74

807

Survival, %
No. of
patients

5 yr

10 yr

1
2
3

522
155
74

83
37
25

71
22
13

*Grade not stated for 56 patients.

*N o t stated.
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Grade of
tumour
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year survival rate was 74% and the
10-year survival rate 62%, but when
metastases were present (11 patients)
there was a 2-year survival rate of
only 27% and only 1 patient survived
for 3 years. Similarly, patients with T4
tumours without metastases (80 pa
tients) had a 5-year survival rate of
22% and a 10-year rate of 21%. The
19 patients with T4 tumours who had
metastases had a 6% 5-year survival
rate but none of the patients survived
for 6 years. On the records of nine
patients there was no evidence that a
search was made for metastases.
In the charts of 52 patients there
was no clearly stated opinion as to
whether initial treatment was curative
or palliative only, but in the remainder
there was a clear statement. Treatment
was a curative attempt in 621 patients;
79% of these patients survived 5 years
and 64% survived 10 years. Survival
by the different treatment methods that
were used in a curative attempt is
shown in Table IX. The survival rates
were quite different in those who had
palliative treatment only (Table X); in
this group of 134 patients, 15% sur

vived 5 years and 11%, surprisingly,
survived 10 years.
When transurethral resection (TUR)
was done as a curative measure 85%
of the 508 patients survived 5 years
and 71% survived 10 years. When ra
diation therapy was combined with
transurethral resection, 5- and 10-year
survival rates were 64% and 37%,
respectively. The results of treatment
by TUR related to stage and grade
are presented in Table XI.
Thirty-four patients had staged uri
nary diversion, irradiation of the whole
pelvis (4000 rads over 28 days) and
simple cystourethrectomy 6 weeks lat
er; 57% survived for 5 years and 44%
for 10 years. Two of these patients had
T2 tumours, 21 had T3 tumours <»nd
the remaining 11 had T4a tumours;
51% of patients with T3 tumours sur
vived 5 years and 46% survived 10
years.
The most heartening thing about
this program has been the disappear
ance of pain in all patients. When a
cure was not possible, palliation was
most effective. We have benefited from
the experience of Mount4'8 when treat

T1S
Tl
T2
T3
T4

Average
age, yr

5 yr

10 yr

8
412
159
107
99

66
63
69
70
68

59
90
61
26
19

52
78
61
27
16

No. of
patients*
362
24
7
93
41
19

621
508
36
14
29
31

5 yr

10 yr

92
68
86
69
50
46

82
0
75
46
40
12

*ln 10 patients who had TUR the intent of
treatment was not stated.

Survival, %

No. of
patients

Survival, %

Table X I I - -Bladder Irritation in 137 Patients
following Treatment

Table IX— Survival after Treatment for Cure*

All procedures
TUR only
Surgery other than TUR
Radiation only
Radiation + TUR
Radiation 4- other operative procedure

T l .G l
T l, G2
T l, G3
T2, G1
T2, G2
T2, G3

Survival, %

No. of
patients

Treatment

Table X I— Survival following TUR

Stage and grade
of tumour

Table VIII -Survival by Stage

Classification
of tumour

ment of the primary tumour is im
possible. In other situations, trans
urethral resection of the intravesical tu
mour was effective. Urinary diversion
almost always relieves pain. Emer
gency or salvage cystectomy has been
necessary only three times. We have
been impressed with the results of
low-dose irradiation for hemostasis.
We attempted to assess residual
bladder irritation in patients after treat
ment (Table X II). This is important
because persistent bladder irritation or
the appearance of bladder irritation
may indicate that a recurrent in situ
carcinoma is changing to multiple focal
invasive cancer.7 The indication's used
for cytologic examination of the urine
were irritable bladder, hematuria, ob
vious bladder cancer, ureteral urines in
bladder cancer and at follow-up of
patients with bladder cancer.
The status of the 807 patients at
the end of the study is set forth in
Table XIII.

Average
age, yr

5 yr

10 yr

65
65
64
69
65
61

79
85
56
37
64
41

64
71
36
40
37
50

Degree of
irritation
Mild
Severe

Survival, %
No. of
patients

5 yr

10 yr

103
34

28
33

16
20

Table X III— Status of Patients at End of Study

TUR = transurethral resection.
*3 patients were lost to follow-up.
Status
Table X—Survival after Palliative Treatment Only*

Treatment
All procedures
TUR only
Surgery other than TUR
Radiation only
Radiation + TUR
Radiation -j- other operative procedure

No. of
patients

Average
age, yr

5 yr

10 yr

134
28
22
27
24
31

69
77
63
71
73
63

15
16
11
20
12
17

11
0
15
15
19
7

*2 patients did not have either surgery or irradiation
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No. of
patients

Alive and well with no disease
Alive with disease
Alive, status of disease not stated
Died
of disease
of other causes, no bladder
cancer
of other causes, bladder cancer
present
of cancer, status not known
of metastases, no bladder
cancer
Lost to follow-up (16% )

18
131

Total

807
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129
15
24
222
132
52
84
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Summary

Results of the management of a
closed series of 807 patients with pri
mary bladder carcinoma by a multi
disciplinary team are presented. All
patients were classified by the TNM
method prior to treatment and, since
1962, uniform treatment has been
used. Our experiences indicate that
stage and grade are relevant to prog
nosis and treatment. The TNM clas
sification can be precise and practical
when used diligently by a treatment
team. Although no new methods of
treatment are offered, it is suggested
that what is available may be utilized
to better effect if programmed to al
low care of patients by treatment
teams, especially if the team explores
the limits of radiation therapy and
surgery available to them. As a result:
(a) patients can face a future without
pain; (b) most patients can maintain
the use of their own bladder; (c) when
surgery or irradiation, or a combina
tion, is indicated, it can be carried
out promptly; (d) most T1 and T2
tumours can be handled by trans
urethral excisional biopsy; and (e)
staged urinary diversion, irradiation
therapy to the whole pelvis (4000 rads

over 28 days) followed 6 weeks later
by a simple cystourethrectomy yield 5and 10-year survival rates that are at
least as good as more radical irra
diation and more radical surgery.
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SESAP II Question
606. Six weeks ago a 20-year-old man first noted a painless scrotal

mass. Examination discloses a nontender 5- by 5-cm, smooth, testicular
mass which does not transilluminate. The best management would
consist of
(A) an attempt to aspirate fluid from the mass to allow better
palpation

Les textes originaux des articles et des
autres communications y compris un
nombre limite de rapports sur des cas
speciaux doivent etre rediges en double
exemplaire, en francais ou en anglais, et
accompagnes d’une lettre demandant
leur publication dans le Journal. Veuillez
les dactylographier sur une seule face
d’une feuille non reglee avec double
interligne et grandes marges.
Les principales unites de mesure doivent
etre exprimees selon le Systeme inter
national d'unites si c'est possible.
Les illustrations telles que des photo
graphies d'appareils cliniques, des radiographies, des photomicrographies, des
graphiques el des diagrammes doivent
etre fournies sous la forme d'epreuves
sur papier glace sans montage, les bordures intactss, d un format ne depassant
pas 20 X 25 cm. Chaque illustration doit
etre munie dune legende dactylographiee sur une page separee du texte de
/'article. S'il s’agit de radiographie, envoyez une copie et non /'original. S’il
s'agit d'une photomicrographie, indiquez
le contraste et I’echelle de I'agrandissement. Les lettres qui servent a identifier
les elements d'une illustration doivent
etre d'une dimension suffisante afin de
demeurer visibles lorsque les necessites
de /'impression imposent une reduction
de I'image fournie.
II ne faut pas qu'on puisse identifier un
patient grace a une illustration a moins
qu'il n'y ait expressement consenti par
ecrit; faute de permission les traits de
sa physionomie doivent etre obliteres.
Les illustrations en couleur ne seront
publiees qu'aux trais de I'auteur. Si
/’illustration provient d’une autre source,
il convient d'obtenir tant de I'auteur que
de lediteur de I'ouvrage dont elle est
tiree, I'autorisation de s'en servir aux
fins de la publication.

(B) needle biopsy
(C) orchiectomy through an inguinal incision
(D) examination of the mass through a scrotal incision; excision
if the mass proves to be a tumor
(E) administration
four weeks

of antibiotics and observation for two to

For the incomplete statement above select the completion that is best
of the five given.

II faut que les tableaux soient conformes
au format rectangulaire du Journal et
rediges sur des feuilles separees du
texte, un tableau par feuille.
Les references doivent etre citees dans
le texte au moyen d'un chiffre et groupees dans I'ordre a la fin de /’article
selon la maniere de faire adoptee par
ce Journal. Les references a des periodiques doivent etre conformes a celles
qu'adopte /’Index Medicus.

For the critique of Item 606 see page 486 of this issue.
(Reproduced by permission of the American College of Surgeons from
SE SA P 11 Syllabus: Surgical Education and Self-assessment Program
N o. 2. For enrolment in the Surgical Education and Self-assessment

Program No. 3 please apply to the American College of Surgeons,
55 East Erie St., Chicago, IL 60611.)
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Un resume qui ne doit pas depasser 125
mots doit accompagner chaque article
sur une feuille separee.
A titre d'approbation, un exemplaire du
manuscrit redige sera envoye a I'auteur
mais non les epreuves.
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CAGS PAPERS

Trans-sphincteric Approach to the Rectum
C harles F M cC ullogh,

In 28 cases the trans-sphincteric
approach has been used to remove
lesions of the lower and mid-rectum;
in 4 cases the combined abdominal and
trans-sphincteric approach was used.
Complications were minor and were
easily treated and the operation was
well tolerated by poor-risk patients.
No patient had altered anal continence.
The author emphasizes the need for
careful identification and reconstruction
of the anatomical structures.
The trans-sphincteric approach gives
excellent exposure of the mid- and
lower rectum and has been particularly
useful in managing large villous
adenomas. The trans-sphincteric
approach alone is not adequate for the
treatment of cancer, but makes possible
sphincter-preserving resections of
lesions that might otherwise be

treated by more radical procedures,
structures anatomiques.
L'abord trans-sphincterien donne une
excellente exposition du rectum moyen
et inferieur et il a ete particulierement
utile dans le traitement des gros
adenomes villeux. L’abord transsphincterien seul n'est pas suffisant
dans le traitement du cancer. Cet abord
rend possible des resections sans
atteinte du sphincter, des lesions qui
devraient autrement etre traitees
par des interventions plus radicales.

Surgeons operating on a fistula in ano
are careful to avoid cutting the deep
portion of the external sphincter ani
muscle for fear of producing anal in
continence. In this situation their fears
are warranted; most of us recall patients
who have been rendered incontinent
following such a procedure. Excision
of the septic fistula allows the muscles
to retract and become nonfunctional,
the defect is bridged by scar tissue and
the patient is left with some degree of
incontinence. However, obstetricians
have noted that a complete tear through
the anal sphincter, caused by uncon
trolled delivery of the fetal head is
usually followed by prompt healing and
complete restoration of anal function
if the tear is repaired immediately.
Incision through the sphincter
muscles apparently does not cause in
continence if the muscles are accurately
replaced and sutured. Indeed, Bevan1
in 1917, reported a posterior midline
approach to the rectum with or with
out removal of the coccyx, and, in
1970, Mason2 described a trans-sphinc
teric approach lateral to the coccyx to
expose the rectum.
Faced with the problem of managing
a patient with a large villous adenoma
of the mid-rectum that was too large
and too high to be easily removed
through the anus, yet too low to make

Dans 28 cas, I’abord trans-sphincterien
a ete utilise pour I’ablation des lesions
du rectum moyen ou inferieur; dans
4 cas, d’abord abdominal et transsphincterien a ete employe. Les
complications ont ete banales et furent
facilement traitees et I’operation
a ete bien toleree par des patients
a risque eleve. Aucun patient n’a
souffert d'une atteinte de la continence
anale. L'auteur souligne la
necessity d’une identification et d'une
reconstruction soigneuses des
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Presented at the 2nd annual meeting
of the Canadian Association of General
Surgeons, Montreal, PQ, Feb. 7, 1979
*Director, department of surgery,
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Reprint requests to: Dr. C.F. McCulloch,
311 Palliser Square W, Calgary,
Alta. T2P 1K1
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anterior resection possible, I read
Mason’s accounts2’3 with interest. Biop
sy of my patient’s tumour had been
done on several occasions and each
time the specimen had been reported as
benign. An abdominoperineal resection
or an abdominoendorectal resection for
a lesion that was probably benign was
not warranted, so the trans-sphincteric
approach was used. The lesion was
easily exposed and excised, and it
proved to be benign. The patient made
an uncomplicated recovery and was
fully
continent.
This experience
prompted use of the trans-sphincteric
approach for rectal lesions in other
cases.
Patients, Surgical Technique
and Results

Between Jan. 1, 1973 and Dec. 31,
1978, 28 patients were operated on
using this approach. Their ages ranged
from 36 to 75 years. The pathological
diagnosis was benign villous adenoma
in 11 cases, adenomatous polyp in 8,
adenomatous polyps with atypia in 2,
carcinoid tumour in 2 and villous ade
nocarcinoma in 1. The distal margin
of the lesions ranged between 3 and 8
cm from the anal verge. The size of
the lesions varied from 2 cm in dia
meter to those completely encircling
and extending along the rectum for
several centimetres. The most proximal
margin of a tumour resected by the
trans-sphincteric route alone was 13 cm
from the anal verge.
Of the 28 patients a combined ab
dominal and trans-sphincteric approach
was used in 4. In each case the left
colon, sigmoid and rectum were mobil
ized by the abdominal approach. The
rectum and colon including the tumour
were then delivered and excised
through a trans-sphincteric exposure
and a low end-to-end anastomosis was
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easily made. This was done for carci
noma in two of the four cases. The
diagnoses in the four cases were “poly
poid carcinoma” in one, “malignant
ulcer, 1 cm in diameter” in one, and
“extensive benign villous adenoma” in
two.
Twelve of the 28 patients were
over 60 years of age. Some were obese
and some, for other medical reasons,
were not good candidates for surgery.
Before admission to hospital for oper
ation, most patients had undergone
sigmoidoscopy and roentgenography
after a barium enema. A biopsy of the
rectal lesion had been done, and the
distance of the lesion from the anal
verge had been recorded. The degree
of anal continence was recorded upon
admission. Patients were placed on a
low-residue diet without milk or milk
products for 72 hours before operation.
Mechanical bowel preparation was ac
complished with enemas and laxatives
and an antibiotic preparation was usual
ly given— though the necessity for it
is questionable. (In two cases, no an
tibiotic was given and no wound infec
tion occurred.)
At operation patients are placed
in the prone position with the trunk
flexed (the jack-knife position). The
buttocks are taped apart and the
perineal area and buttocks prepared
and draped. It is helpful to outline
the coccyx and lower sacrum and the
line of incision with a sterile marking
pencil. The incision is made on
the left side just lateral to the
lower sacrum and coccyx and is car
ried down to the posterior midline at
the anal verge. It is quite easy to iden
tify each anatomical structure which
is carefully tagged with a colour-coded
clamp applied to a marked suture, be
fore being incised. This is most im
portant to ensure exact anatomical
apposition of structures when the
wound is being closed. If the muscle
layers are not tagged at this stage
accurate apposition may be difficult or
impossible because the cut ends retract.
The three parts of the external sphincter
ani muscle are evident and are tagged.
The puborectalis muscle and the lower
innermost part of the levator ani
muscle are identified and tagged. The
fourth sacral nerve lies under the
levator ani muscle and well lateral to
the incision and can therefore be
avoided. When the rectum is entered
by incising the muscular tube and
mucosa (also tagged), the exposure of
the mid- and lower rectum is excellent.
On closing, each layer is apposed by
approximating the colour-coded clamps.
The muscle layers are closed with in
terrupted absorbable sutures and the
skin is closed with interrupted sutures.
Postoperatively, the wound is left
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exposed after 24 hours and is kept dry
with the use of a heat lamp for 10
minutes twice a day. Sitz baths are
not given and the area is cleansed as
required with a cleansing agent. Pa
tients have noted remarkably little dis
comfort. They are allowed up the day
following operation.
Intake is advanced from liquids to a
full diet over a period of 1 week.
Rectal thermometers, suppositories and
digital examination are avoided in the
early postoperative period. Bowel func
tion usually begins spontaneously after
4 to 5 days. Bulk-producing laxatives
may be used if necessary.
There were three complications of
the operative procedure in the 24 pa
tients whose operation was by the
trans-sphincteric approach alone. One
patient had a large fecal fistula which
closed spontaneously after 2 weeks and
two patients had superficial wound
abscesses that required simple drainage.
Discussion and Conclusions

It is apparent that because of senility
or local anal conditions, some patients
have anal incontinence. This must be
assessed preoperatively, in order to
judge the effect of the operation on
continence. In this study it was found
that the degree of anal continence was
unaltered by trans-sphincteric opera
tions, but, since incontinence was some
times present, had careful evaluation
not been made preoperatively, the oper
ation might have been blamed for
results which, in fact, were optimal
for that patient.
Before using the trans-sphincteric
approach it is particularly important to
evaluate carefully the rectal lesion in
question. The trans-sphincteric ap
proach with local excision is not a
cancer operation. Therefore, it is im
portant to remember that the villous
adenoma may have one or more areas
of invasive carcinoma within it. In
assessing a villous adenoma, mobility
and induration are important factors.
Although multiple biopsy specimens
may be reported as benign, only exam
ination of the entire lesion by the
pathologist will give the final answer.
The surgeon must be prepared to do
a more radical operation if he finds
evidence of a malignant condition at
operation. The treatment of small can
cers by local excision is not a subject
of discussion in this paper.
The
trans-sphincteric
approach
makes possible sphincter preserving re
section of lesions that might previously
have been treated more radically. The
operation is particularly well tolerated
by poor-risk patients: the three com
plications in our series were man
aged without permanent sequelae.
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It is emphasized that careful iden
tification and reconstruction of the
puborectalis muscle, the external
sphincter, the levator ani muscle and
the rectal wall will lead to primary
healing and maintain continence. When
attention is paid to these details, this
operation is safe and well suited to the
management of a select group of lesions
in this area.
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Randomized Sequential Trial of Parenteral Nutrition
in Healing of Colonic Anastomoses in Man
R.M. P reshaw, md , frcs [c], R.P. A ttisha, mb , frcs ( edin ), frcs [c],
W.J. H ollingsworth , md, frcs [c] and J.D. T odd, md

Adults who underwent elective colonic
resection with anastomosis for both
benign and malignant disease were
randomly assigned to control or treated
groups. Treated patients received daily
50 m l/kg of amino acid solution
containing either 10 or 25 g /d l glucose
by central or peripheral vein plus 500 ml
of commercial soybean emulsion for
24 hours before operation and for 5
consecutive days after. Patients in
both groups were examined by roent
genography after a water-soluble
contrast enema, between 10 and 14
days after operation, and the integrity
of the anastomosis was assessed
radiologically without knowledge
of the treatment given.
Results were assessed by sequential
analysis. After 21 pairs of subjects
were entered, a boundary was crossed
making the area favourable to
treatment inaccessible, and the trial
was terminated. Forty-seven patients
were included in the trial: there were
four anastomotic leaks in 23 control
subjects and eight leaks in 24 treated
subjects. The authors conclude that
intensive perioperative parenteral
nutrition in patients who undergo routine
elective colonic resection does not
improve the rate of healing of colonic
anastomoses.

amines contenant 10 ou 25 g /d l de
glucose plus 500 ml d'une emulsion
commerciale de soya pendant les
24 heures qui ont precede I'operation
et les 5 jours consecutifs qui ont
suivi. Les patients des deux groupes
ont passe un examen radiologique
apres un lavement avec une substance
de contraste hydrosoluble, de 10 a
14 jours apres I'operation, et I'integrite
de I'anastomose a ete evaluee
radiologiquement sans connaitre le
traitement.
Les resultats ont ete evalues par
analyse sequentielle. Apres I'inclusion
de 21 paires de sujets, on a croise
une limite rendant inaccessible I'aire
favorable au traitement, et i'essai
a ete interrompu. Quarante-sept
patients ont ete inclus dans I'etude:
il y a eu quatre fuites anastomotiques
chez les 23 sujets temoins et huit
fuites chez les 24 sujets traites.
Les auteurs concluent que I'alimentation parenterale intensive dans
la periode peri-operatoire chez les
patients qui subissent une resection
non urgente du colon ne semble
pas affecter la vitesse de guerison
de I'anastomose colique.

Assessment of anastomotic integrity
after colonic resection by roentgenographically opaque enemas in the post
operative period has been utilized by
Goligher1-3 to study details of the sur
gical technique. We have adapted this
method to investigate the value of in
tensive parenteral nutrition in the peri
operative period in patients subjected
to elective colonic resection.

Des adultes qui ont subi une
resection non urgente du colon avec
anastomose pour des maladies
benignes ou malignes ont ete assignes
au hasard a un groupe temoin et
a un groupe traite. Les patients
traites ont repu quotidiennement
par une veine centrale ou peripherique,
50 m l/kg d’une solution d'acides

Patients and Methods
Eleven general surgeons at two Cal
gary hospitals permitted us access to
patients who underwent elective colonic
resection for benign and malignant di
sease. We excluded patients older than
75 years and patients recognized preoperatively to have signs or symptoms
of congestive cardiac failure. Of 79
patients interviewed, 8 were excluded
because of demonstrable cardiac fail
ure, 7 were judged incapable of provid
ing informed consent and 17 patients
refused to enter the trial. The remain
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ing 47 patients were assigned to treated
or control groups according to the last
digit of their hospital registration num
ber: those with odd numbers were
treated and those with even numbers
entered the control group.
The 23 control patients were treated
in the usual manner as ordered by the
attending surgeon, except that roent
genography after a water-soluble con
trast barium enema was performed
between 10 and 14 days after the
procedure. This was performed by a ra
diologist who had no knowledge of the
treatment given. For the purposes of
this study, identification of any extra
vasation of contrast material outside the
bowel lumen in the area of the an
astomosis was accepted as a “leak”
and failure on the part of the radiologist
to demonstrate extravasation was clas
sified as “non-leak”.
Treated patients received high vol
ume, intensive parenteral nutrition
starting 24 hours before operation and
continuing for 5 days after operation.
We found no difference in the fre
quency of contrast extravasation at the
area of the anastomosis between the
two groups. The solutions administered
were a commercial mixture of L-amino
acids (Travasol®, 2.5 g/dl) with either
10 or 25 g/dl glucose. These were ad
ministered intravenously in a dosage of
50 ml/kg body weight every 24 hours
by either peripheral (10 g/dl glucose) or
central (25 g/dl glucose) vein. Because
of the poor quality of peripheral veins
in most subjects, 21 of the 24 treated
patients had a central venous catheter
inserted preoperatively for the supple
mental nutrition, in each case by per
cutaneous subclavicular puncture. Each
subject in addition was given 500 ml
of a commercial soybean emulsion
(Nutralipid®) intravenously daily. For
a 70-kg subject, the daily intake by the
intravenous route was therefore 50 g
of lipid, 70 g of amino acid protein,
and either 350 g (peripheral vein) or
700 g (central vein) of glucose.
Finally four patients (one treated and
three control) had total nitrogen balance
studies performed in the perioperative
period; urine, stool and nasogastric suc
tion material were analysed for nitrogen
by the micro-Kjedahl method4 and in
take was calculated from known values
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for intravenous fluids and from dietary
tables.
Each subject was asked for his or her
estimate of weight loss before admis
sion, and preoperative and postoper
ative weights were compared. Total
lymphocyte counts and hemoglobin,
total protein and serum albumin values
were measured before and after oper
ation. Results were assessed as the
radiologists’ reports became available.
Paired subjects were entered into a
skewed sequential analysis:5 boundaries
were determined assuming a frequency

FIG. 1—Sequential analysis: pairs of
subjects entered as described by Armitage.5
Restricted skew design (two-tailed) with
2a = 0.05, 1-/3 = 0.95, 61 = 0.80,
N = 35.

of leaks among controls of 30% and
among treated patients of 15%. A twotailed closed design was selected with
2a = 0.05, 1-/3 = 0.95, 61 = 0.80,
N = 35.
Results

Forty-seven patients were success
fully entered into the trial and under
went roentgenography after a watersoluble contrast enema between 10 and
14 days postoperatively. A small pneu
mothorax developed in one patient
after an attempt to insert a subclavian
catheter percutaneously, but this re
solved spontaneously; there were no
deaths associated with the trial. In
one treated patient clinical signs of
anastomotic disruption developed, con
firmed radiologically, which required a
defunctioning colostomy. None of the
other patients with roentgenographic
anastomotic leaks received any specific
therapy.
The trial was terminated after 21
pairs had been entered; at this point a
boundary was crossed making the area
favourable to the treatment inaccessible
(Fig. 1) and in our opinion it was un
ethical to continue the trial merely to
determine if the period of parenteral

Table 1—Comparison of Preoperative and Postoperative Laboratory Values
in Treated and Control Patients
Treated (n = 24)
Measurements
Total protein, g/dl
Serum albumin, g/dl
Hemoglobin, g/dl
Total lymphocytes, X 10°/l
Body weight, kg
Age, yr

Preop

Discussion

Control (n = 23)

Postopf

Preop

6.1 ± 0.6*
5.8 ± 0.5
3.7 ± 0.5
3.2 ± 0.7
13.1 ± 1.3
12.6 ± 2.3
1.18 ± 0.28 1.35 ± 0.14
71.5 ± 5.7
67.6 ± 4.2
66 ± 4

Major surgery is accompanied by a
variable period of increased catabolism

Postop

6.4 ± 0.4
6.0
3.6 ± 0.2
3.3
12.6 ± 1.0
12.5
1.46 ± 0.27 1.31
73.0 ± 2.3
70.5
69 ± 6

±
±
±
±
±

nutrition could be shown to be worse
than the standard postoperative ther
apy. In all there were eight radiological
ly demonstrated “leaks” in 24 treated
patients and four in 23 controls.
Further analysis of the subgroups
within this trial provided no further
useful information. In particular, 19
patients were identified who claimed a
weight loss greater than 4.5 kg in
the 6 months before surgery; as ex
pected, most of these patients had
cancer of the large intestine. Of these
19 subjects, 8 were controls and 2 of
these demonstrated a leak; of the
11 patients in the treated group 3 had
a leak. Mean concentrations of total
protein, serum albumin and hemo
globin, and total lymphocyte counts
were similar in both groups preoperatively and appear little changed post
operatively (Table I). Table II notes
the details of the operative procedures
performed and lesions identified. There
was no appreciable excess either of
patients with cancer or of low anterior
resections in either group.
Fig. 2 shows nitrogen balance in four
patients, one treated and three controls.
As expected, the period of intensive
parenteral nutrition was accompanied
by a positive nitrogen balance in the
treated subject, in contrast to the ex
pected postoperative negative nitrogen
balance in the three control patients.

0.9
0.8
2.5
0.22
5.6

*Mean ± standard error of the mean.
(Postoperative values obtained between day 7 and 12.

Table II—Operative Procedures and Diagnosis in Treated and Control Patients

Procedure
Right hemicolectomy
Segmental resection
Anterior resection
Colectomy with ileorectal anastomosis

Diagnosis
Cancer
Other
Cancer
Diverticulosis
Other
Cancer
Diverticulosis
Other

Treated, no.
(no. with
anastomotic leak)

Control, no.
(no. with
anastomotic leak)

7 (1 )
1 (1 )
3 (1 )
1 (1 )

5 (1 )
1
2
2
1
7 (2 )
3 (1 )
1

7 (3 )
4 (1 )
1

24 (8)
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1
F IG . 2—Nitrogen balance in four sub
jects (selected at random so that one was
in treated group and three in control
group). Asterisk indicates postoperative
roentgenography after contrast enema.

23 (4)
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of the colonic anastomosis was made
without knowledge of the patient’s
treatment.
Bozzetti, Terno and Longoni13 found
that the collagen content of perineal
biopsy specimens after abdominoperi
neal excision of the rectum was in
creased by intensive parenteral nutri
tion, but they did not present clinical
data to support their claim that wound
healing was thereby facilitated. In
malnourished rats, Steiger and associ
ates14 recorded an improvement in the
tensile strength of colonic anastomoses
when parenteral nutrition was given im
mediately after operation. Irvin15 con
firmed this finding in rats who were
starved to lose one third of their body
weight, but could find no advantage
for supplemental nutrition in lesser de
grees of malnutrition.
It can therefore be argued that
changes in the rate of healing of colonic
anastomoses might have been observed
if we had selected patients who were
profoundly depleted nutritionally be
fore operation. We cannot dispute this
but note that there were no differences
in the frequency of anastomotic leaks
in subjects who claimed a preoperative
weight loss of greater than 4.5 kg
whether or not they had received pa
renteral nutrition. It is also clear that
either more prolonged or more inten
sive nutritional support might have de
creased the frequency of anastomotic
leaks in the treated group. The period
of nutritional support we selected was
influenced by the expense of the solu
tions used, and the real difficulty in de
ciding whether additional days of
hospitalization would prove of long
term benefit to the patient. Fig. 2 sug
gests that the 6-day period of nutri
tional supplementation used was suf
ficient to alter favourably the nitrogen
balance.
These conclusions refer only to the
apparent failure of intensive perioper
ative parenteral nutrition to influence
the number of postoperative an
astomotic leaks in patients who under
go elective colonic resection and should
not be construed as evidence against the
use of parenteral nutrition in other cir
cumstances.

associated with a negative nitrogen bal
ance.6,7 It has been claimed that the
negative nitrogen balance in this period
can be diminished or even reversed by
intensive intravenous administration of
amino acids alone8 or mixtures of
amino acids plus glucose or lipid.9 It is
clear that accepted methods of pre
paring patients for elective colonic sur
gery combined with current methods
of postoperative care may allow only
minimal intake of protein and energy
sources for as long as 7 to 10 days.
In this trial, we attempted for 6 days
to give high-volume parenteral nutrition
with solutions containing amino acids,
glucose and soybean emulsion to mod
ify the patient’s response to major
colonic resection with anastomosis. We
found that the frequency of leakage
from these anastomoses in the post
operative period did not differ in sub
jects randomly assigned to control or
treated groups.
Similar trials of intensive perioper
ative nutrition in patients who undergo
major surgery have produced conflict
ing results. Although Abel and col
leagues,10 by preoperatively identify
ing malnutrition in patients who under
went major cardiac surgery, could pre
dict an increased frequency of com
plications, they could not show any
change in the complication rate or the
duration of hospitalization after 5 days
of nutritional therapy in the postoper
ative period. When this study was
extended to subjects with malignant
gastrointestinal conditions, intensive pe
rioperative nutritional supplementation
failed to lessen the frequency of com
plications.11 Collins, Oxby and Hill12
claimed an improvement in the rate of
healing of perineal sinuses after abdo
minoperineal excision of the rectum
in patients receiving parenteral nutri
tion with amino acids and glucose com
pared with a control group of patients
receiving amino acids alone, and an
other control group of patients who
had no specific nutritional support.
Each of these studies used subjective
methods to identify postoperative com
plications, and, as far as can be deter
mined, no attempt was made to conceal
the method of treatment from the ob
server assessing the results. In the
study reported here, the radiologic pre
sence or absence of a leak at the site
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hospitals who permitted entry into this
trial, and to the radiologists who read the
postoperative contrast roentgenograms.
Micro-Kjeldahl nitrogen analyses were
performed by Maria Tesanovic of the
special chemistry department, Foothills
Hospital.
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Elastin and Granulation Tissue
C. T elfer , b sc,* G.M. L ees , md, FRCs[c],f M. C hambers, m serf
and H .T.G . Williams , mb , ch b, frcs , facs, frcs [c]§

The contraction of granulation tissue
is an important factor in wound healing.
The tract of an abdominal drainage
tube closes at the rate of 1 m m /h once
the tube is removed. Specialized
myofibroblasts are generally believed
to be responsible for this process and
the presence of elastin in granulation
tissue has been debated for many years.
A 3-mm polyethylene tube was
inserted through the left lobe of the
liver in 41 rats. A tube of granulation
tissue formed around the plastic. This
granulation tissue was isolated, after
periods ranging from 8 to 20 days,
by removing the left lobe of the liver
and scraping away the surrounding
liver tissue.
Biochemical assay for elastin revealed
that normal hepatic tissue does not
contain any detectable amount of
elastin. All 41 samples of granulation
tissue contained elastin with a mean
value of 8.5
10-6 g of elastin per
milligram of tissue. Normal rat aorta
contains 31.4
10~6 g of elastin per
milligram of tissue.
These tubes of granulation tissue
w ere histologically normal and the
presence of elastin was recognized
using elastin stains. The exact role of
elastin in granulation tissue is
uncertain but this experiment clearly
demonstrates its generation and
presence there.

x

x

La contraction du tissu de granulation
est un facteur important dans la
cicatrisation des blessures. Le passage
d’un drain abdominal se referme a la
vitesse de 1 mm /h une fois que le tube
est retire. On croit generalement
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que des myofibroblastes specialises sont
responsables de ce processus alors
que la presence d’elastine dans le tissu
de granulation est debattu depuis
plusieurs annees.
Un tube de polyethylene de 3 mm
a ete insere dans le lobe gauche du
foie chez 41 rats. Un tube de tissu
de granulation s'est forme autour du
plastique. Ce tissu de granulation
a ete isole apres des periodes allant
de 8 a 20 jours, par prelevement
du lobe gauche du foie et raclage du
tissu hepatique environnant.
La mesure biochimique de I’elastine
a revele que le tissu hepatique normal ne
contient aucune quantite decelable
d’elastine. Les 41 echantillons de tissu
de granulation contenaient tous de
I’elastine a la concentration moyenne
de 8.5
10-6 g d’elastine par
milligramme de tissu. L'aorte du rat
normal contient 31.4 X 10 6 g d'elastine
par milligramme de tissu.
Ces tubes de tissu de granulation
etaient histologiquement normaux et la
presence d’elastine a ete reconnue
par des colorants de I’elastine. Le role
exact de I’elastine dans le tissu de
granulation est incertain mais cette
experience demontre clairement
sa generation et sa presence dans le
tissu de granulation.

x

John Hunter was perhaps the first to
emphasize the importance of wound
contraction. Since his time, and partic
ularly in recent years, intensive in
vestigative effort has been devoted to
wound healing and early reduction
(contraction) in the size of a wound.1’6
After a brief “latent period” of 1 to 2
days, there is a progressive reduction in
size of full thickness “granulating”
wounds so that by 7 days after injury
the wound size is reduced by 50% to
60%. This can be admirably demon
strated in the closure of tracts left after
removal of a gastrostomy tube. These
tracts close at the rate of approximately
1 mm/h and are effectively sealed in
less than 24 hours, irrespective of the
size of the tube, so that lost tissue is
replaced and epithelialization com
pleted speedily.
The power of a wound to contract
rests in the granulation tissue but the
mechanism is incompletely understood.
Collagen has no innate contractile abil
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ity and wound contraction proceeds
normally in scorbutic animals.7 More
over, granulation tissue contains re
latively little collagen during the stage
of active wound contraction.4,8 In the
myofibroblast a potential cellular me
chanism of contraction exists. The
evidence supporting the myofibroblast
theory is strong, both on a pharma
cologic and ultrastructural (i.e., electron
microscopic) basis.3-5 However, recent
work by Ehrlich, Grislis and Hunt2
suggests that the myofibroblast does not
have the sole (or even dominant) con
tractile force.
Until recently, little attention has
been paid to the part elastin and elastic
fibres may play in wound contraction.
Studies have concentrated on the his
tologic demonstration of elastic tissue
in healing skin wounds.9-11 The ap
pearance of the first elastic fibres in
granulation tissue depends upon such
variables as staining technique, the
nature of the tissue under study and
random sampling errors. Their appear
ance has been reported as early as 8
days after wounding by Schwartz10
and as late as 56 days by Williams.11
All these studies concentrated on heal
ing skin wounds and it is theoretically
possible that “migration” of elastic
fibres from more lateral unwounded
skin structures may introduce a source
of error. We set out to demonstrate
the presence of elastin in granulation
tissue from a structure which in its
normal uninjured state has no chem
ically detectable elastin.
Materials and Methods

The formation of granulation tissue
was induced in the liver of 41 adult
male Wistar rats. Under intraperitoneal
sodium pentobarbital anesthesia, a mid
line laparotomy was performed. A
short piece of polyethylene tubing (dia
meter 3 mm) was placed through the
substance of the left lobe of the liver.
Following this, the liver, with the tube
in place, was returned to the peritoneal
cavity. At periods ranging from 8 to
20 days the animals were sacrificed and
the segment of liver with the polyethy
lene tubing was retrieved. The core of
granulation tissue which had formed
around the tube was carefully dissected
from the surrounding normal liver
(Fig. 1).
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The isolated segment of granulation
tissue was then studied by light micro
copy using both elastin and non-elastin
stains (hematoxylin and eosin, Masson’s
trichrome and Weigert’s resorcin-fuchsin
stains). Biochemical assay for elastin
content was performed on all samples
using a modification of the method of
Naum and Morgan12 (employing 5 M
guanidine hydrochloride followed by
enzymatic degradation and autoclav
ing). As a control, the elastin micro
assay was carried out on 13 normal
uninjured rat livers. In addition, rat
aorta, which has a high elastin content,
was also studied. No attempt was made
to correlate elastin content with the
age of the granulation tissue nor to de
monstrate the presence of oxytalan
(“pre-elastic”)9 fibres during the early
stages of granulation tissue formation.
Results
The biochemical assay when applied

to specimens of whole isolated granula The elastin content appeared to be most
tion tissue produced consistently posi abundant in the more mature granula
tive results— a mean elastin content of tion tissue. The elastin fibres were not
8.5 X 10"6 g/mg of tissue (range 0 to uniformly distributed throughout the
21.7 X 10'6 g/mg) (Table I). In the 13 entire thickness of the granulation
samples of normal uninjured liver no tissue tract but were concentrated
elastin could be detected. In the seven towards the outside (Fig. 5). To confirm
specimens of rat aorta, the mean value that contraction did occur in this expe
rimental model we inserted the poly
of elastin was 31.4 X 10'6 g/mg. The
three samples with no biochemically ethylene tube in the liver substance and
detectable elastin were obtained at the left it in situ within the peritoneal
beginning of our study when only a cavity for 10 days as in the usual pre
small portion of the tissue was assayed. paration. Two animals were then exWe subsequently modified the tech
nique so that the whole tube of granu
lation tissue was used in the assay for
the remaining 38 animals. The histo
gram (Fig. 2) shows a bell-shaped dis
tribution of values around the mean.
Examination of stained sections using
light microscopy confirmed the pre
sence of apparently normal granulation
tissue with abundant collagen, new
vessels and fibroblasts as demonstrated
in preparations stained with hema
toxylin and eosin and with Masson’s
trichrome stain (Figs. 3 and 4). Elastic
fibres were identified without difficulty
using Weigert’s resorcin-fuchsin stain.

Table I—Elastin Content in Tissue from
Normal Uninjured Liver, from Aorta and
from Granulation Tissue Preparation
Elastin content,
X lO -6 g/mg
Tissue

FIG. 1—Insertion of polyethylene tube
in left lobe of liver. Inset to right shows
isolation of granulation tissue tract from
surrounding normal liver substance.

Liver
Aorta
Granulation
tissue

No. of
samples

Mean

Range

13
7

0
31.4

0
21.5 - 37.9

41

8.5

0

FIG. 3—Granulation tissue preparation
in rat liver, showing normal hepatic par
enchyma (at bottom) and granulation tis
sue with fibroblasts, collagen and new
vessels (hematoxylin and eosin, reduced by
52% from x250).

-21.7

987-

ELASTIN CONTENT (XlO 0 g/mg of tissue)
FIG. 2—Histogram depicting elastin content in granulation tissue from rat liver.
Mean content of elastin was 8.5 x 10 6 g/m g of tissue.
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FIG. 4—Granulation tissue preparation
in rat liver. Cellular elements are present
including fibroblasts and endothelial cells
plus collagen fibres (Masson’s trichrome
stain, reduced by 52% from X250).
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tract could be identified thereby in
dicating activity of the contractile
mechanism of granulation tissue.
Conclusions
Rat liver contains no biochemically
detectable elastin using the modified
technique of Naum and Morgan. The
samples of granulation tissue formed in
the liver all contained biochemically
detectable elastin and overall amounts
were approximately one third of the
amount of elastin present in the wall
of the aorta. Histologic examination
showed that the elastin was concen
trated in the outer one half of the
granulation tissue, nearest the host
tissue. The properties of resiliency,
elasticity and tensile strength13 suggest
that elastin could play a role in wound
contraction.
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Surgical patients don’t always eat
what they get.
Surgical patients are at nutritional risk,
and picking at their food is only one of the
factors involved. Fasting before surgery,
restricted post-op diets, latent
deficiencies and illness are other causes
which can put surgical patients under
severe nutritional stress.

Patients may need more than ‘diet as
tolerated’ when they’re about to undergo
surgery, or during convalescence from
surgery. They need a food that’s
complete, easy to take, easy to serve, and
flexible enough to be used in all surgical
situations.

s

Predictive Value for Survival of Lymphocytes and
Polymorphonuclear Leukocytes in Patients with Sepsis
J.A. M cC redie, m ch, frcs[c], frcs, frcs ( edin ), facs,* T.W. A ustin , md, FRCP[c],f
R.L. H olliday, md, frcs[c ]* and W.J. Sibbald, md, FRCP[c]t

To study their value in predicting
prognosis, tests were performed on
peripheral blood lymphomononuclear
cells and polymorphonuclear leukocytes
in 34 critically ill patients with sepsis.
Initially, the number of lymphomono
nuclear cells was reduced by 32%
compared with healthy control subjects
and was 42% lower in those who died
than in survivors. The values remained
low in those who died. The numbers of
T and B cells, determined by rosette
formation using sheep and mouse
erythrocytes, did not change during the
period of observation. Initially, K cell
activity was decreased by 48% compared
with normal activity. In those younger
than 65 years, K cell activity was 68%
lower in patients who later died than in
survivors. It returned to normal at
20 to 30 days and decreased in those
who died. Polymorphonuclear leukocyte
adherence was decreased by 50%
compared with healthy control subjects
and tended to be lower in those who
died. Chemotactic migration of poly
morphonuclear leukocytes and intra
cellular killing of Staphylococcus aureus
and Pseudomonas aeruginosa were not
impaired. It was concluded that the
lymphomononuclear cell count, K cell
activity and adherence of polymor
phonuclear leukocytes were decreased
in patients with sepsis and that the
values were useful in predicting
prognosis.
Dans le but d’etudier leur valeur
previsionnelle pour le pronostic, des
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epreuves ont ete effectuees sur les
cellules lymphomononucleaires du sang
peripherique et sur les leucocytes
polymorphonucleaires chez 34 patients
critiquement malades souffrant de
septicemie. A I'origine, le nombre de
cellules lymphomononucleaires etait
reduit de 32% comparativement a des
sujets temoins sains et etait de 42%
inferieur chez ceux qui sont morts, par
rapport aux survivants. Ces valeurs
demeurerent faibles chez ceux qui sont
decedes. Le nombre de cellules T et B
determine par la formation de rosettes
a I'aide d'erythrocytes de mouton et de
souris n'a pas change durant la periode
d’observation. Au debut, I’activite
des cellules K etait reduite de 48%
comparativement a I'activite normale.
Chez les patients de moins de 65 ans,
I’activite des cellules K etait 68%
plus faibles chez les patients qui sont
decedes par la suite, que chez les
survivants. Elle est revenue a la normale
apres 20 a 30 jours et diminua chez
ceux qui sont decedes. L’adherence
des leucocytes polymorphonucleaires
etait diminuee de 50% par rapport
aux sujets temoins sains et tendait
a etre plus faible chez ceux qui sont
morts. La migration chimiotaxique des
leucocytes polymorphonucleaires et la
destruction intracellulaire du
Staphylococcus aureus et du
Pseudomonas aeruginosa n'etaient pas
alterees. On conclut que le compte de
cellules lymphomononucleaires, I’activite
des cellules K et I'adherence des
leucocytes polymorphonucleaires etaient
diminues chez les patients souffrant de
septicemie et que ces valeurs etaient
utiles pour etablir le pronostic.

Innate and adaptive humoral and cel
lular resistance are important in deter
mining the establishment and course of
infections. Immunoglobulins, comple
ment and polymorphonuclear leuko
cytes (PMNL) play the major role in
controlling bacterial sepsis, and T cell
lymphocytes (T cells) and large mono
nuclear cells are mainly responsible for
resistance to viral and fungal infections.
B cell lymphocytes (B cells), on sensi
tization by specific bacterial cell anti
gens, become plasma cells and they in
turn produce the immunoglobulins.

Patients critically ill with severe bac
terial infections have abnormalities in
the number and function of lympho
cytes and PMNL that could seriously
affect prognosis. Meakins and as
sociates1 showed that surgical patients
who had a decrease in cell-mediated
immunity had an increase in postoper
ative infections and mortality when
compared with healthy control sub
jects. They determined the delayed hy
persensitivity response to five recall
antigens and defined anergy as the abil
ity to respond to only one or none of
the antigens. Also, they found that
polymorphonuclear chemotactic mig
ration was decreased in anergic pa
tients.
There is a population of non-T, nonB cell lymphocytes that lyse nonisogenic cells in the presence of anti
target cell antibody,2 a reaction known
as antibody dependent cellular cytotoxi
city (ADCC). When nucleated target
cells are used, this reaction is mediated
by nonimmune lymphocytes known as
“killer” or K cells. The role of K cells
in sepsis is not known.
We have determined the number of
lymphomononuclear (LMN) cells, T
and B cells, the function of K cells, and
adherence, chemotaxis and intracellular
killing of PMNL in the peripheral blood
of patients critically ill with sepsis. The
values were determined during the
course of sepsis to find out if they
aided in predicting prognosis.
Methods

We studied 34 patients (23 men and
11 women) with sepsis who were ad
mitted to the critical care/trauma unit
of Victoria Hospital, London, Ontario.
Their ages ranged from 18 to 83 years
(mean 53 ± 3.2 years). All were critic
ally ill, had a source of infection and
a febrile response, and most had posi
tive results from blood cultures. Pa
tients with negative results of blood
cultures were included when they
had previously been given antibiotics.
Most patients had a Swan-Ganz
catheter inserted to monitor pulmonary
and systemic hemodynamics. These
patients had an increased cardiac out
put and low peripheral resistance, char
acteristic of sepsis.

VOLUME 22, NO. 5, SEPTEMBER 1979 / THE CANADIAN JOURNAL OF SURGERY

447

The patients were studied from the
time of admission to the unit until the
septic state resolved and they were
discharged from the unit, or until they
died. The control group consisted of
healthy individuals matched with the
34 patients for age and sex.

To correct for lymphopenia, the num
ber of lytic units per 106 cells was mul
tiplied by the ratio of LMN cells times
the total leukocyte count. The results
were expressed as lytic units times 10s
mastocytoma cells per millilitre of
blood.

Lymphomononuclear Cells
The number of LMN cells in the
peripheral blood was the total leuko
cyte count times the percentage of the
cells in the differential smear. For
rosette formation, lymphocytes were
isolated from the peripheral blood
using Ficoll-Hypaque®. Equal volumes
of lymphocytes and sheep red blood
cells were incubated at 37°C for 15
minutes. The supernate was removed
and a portion of the residue placed on
a slide and 200 lymphocytes were
examined microscopically for rosette
formation. A rosette was defined as
the presence of three or more sheep
erythrocytes in contact with a lym
phocyte. The results were expressed as
per cent rosette formation. Early
rosettes were those present after in
cubation for 1 hour and total rosettes
those present after 18 hours. We made
this distinction because early rosettes
may be a family of functional T cells
while the total count identifies all the
lymphocytes that have T cell markers
on their surface. B cells were deter
mined from rosette formation using
mouse erythrocytes.
The ADCC test was performed as
described previously.3 Murine P-815
mastocytoma cells were incubated with
sodium chromate. Antimastocytoma cell
antibody was produced in the rabbit.
Mastocytoma cells labelled with chromium-51, antibody and peripheral blood
lymphocytes were incubated for 3
hours at 37°C. Control samples for
measurement of maximal release of
isotope had hydrochloric acid added.
Isotope release was determined in the
supernate using a well-type scintillation
counter.
Lysis was calculated as follows:

Polymorphonuclear Leukocytes
Adherence of PMNL was determined
with heparinized whole blood by the
method described by MacGregor.4 The
percentage of cells that adhered to
nylon fibres was determined by placing
the cells in a Pasteur pipette (Scien
tific Products Division, American Hos
pital Supply Corp., McGraw Park, IL)
containing 80 mg of fibres packed to
a height of 15 mm. The value was cal
culated as follows:

% specific 61Cr
release

E R ~ SR y
M R — SR

where ER is experimental release, SR
is spontaneous release and MR is
maximal release.
The ratio of the number of lympho
cytes to mastocytoma cells required to
lyse 50% of 10 000 cells was defined
as 1 lytic unit. An increase in lytic
units signified a decrease in the num
ber of mastocytoma cells lysed by a
given number of lymphocytes. The re
ciprocal of the number of lytic units
to lyse 50% of 106 mastocytoma cells
was used so that an increase in value
signified an increase in ADCC activity.
448

% adherence =

X 100,

where CA is the number of cells in the
affluent and CE is the number of cells
in the effluent.
For assays of polymorphonuclear
leukocytic chemotaxis and intracellular
killing, isolated cells were suspended in
Krebs-Ringer phosphate (KRP) solution
at pH 7.45 containing 0.006 M glucose
and 0.35% bovine serum albumin
(Sigma Chemical Co., St. Louis, MO).5
Chemotactic attractant was prepared
from the bacteria-free supernatant of
an 18-hour growth of Escherichia coli
in Medium 199®.6 It was diluted to 25%
by volume with KRP solution and
placed in the lower compartment of
a Boyden chamber (Schleicher &
Schuell, Inc., Keene, NH). Polymor
phonuclear leukocytes, 2.5 x 106, were
placed in the upper compartment which
was separated from the lower by a
membrane filter GmbH, pore size 3
mji (Sartorius Membran Filter, Got
tingen, West Germany). The chambers
were incubated for 3 hours in a humid
ified environment at 37°C. The filters
were then removed, fixed, stained and
examined. The average number of cells
that had migrated to the undersurface
of the filter membrane was determined
at a magnification of 440 X in five
random fields within the area of a
Whipple micrometre disc (Canlab Ltd.,
Toronto, Ont.). This number was the
chemotactic migration value.
In the bactericidal experiments, hos
pital strains of Staphylococcus aureus
and Pseudomonas aeruginosa were
grown for 18 hours in trypticase soy
broth (Difco Laboratories, Detroit, MI).
The organisms were separated by cen
trifugation, washed and resuspended in
0.9% sodium chloride at a concentra
tion to yield 2.0 x 107 colony forming
units per millilitre. To 0.1 ml of the
suspension of organisms was added
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0.5 ml of PMNL (2.0 x 107), 0.3 ml of
KRP and 0.1 ml of AB serum as a
source of opsonins. The mixture was
then placed in capped plastic culture
tubes (Falcon, Oxnard, CA) and agita
ted at 37°C on an Ames aliquot mixer
(Fisher Scientific Co. Ltd., Don Mills,
Ont.). Controls did not contain PMNL
cells. A zero-time specimen was
taken and 0.1-ml aliquots were removed
after incubation for 15, 30, 60 and 120
minutes. The specimens were diluted
with distilled water and placed on pourplates. The number of colonies was
counted after incubation at 37°C for
24 hours. The assays were performed in
duplicate and the results expressed as
the average of the two values.
Comparisons were made between the
values recorded at the time of admis
sion to the unit when the patients were
critically ill and at the time of their
recovery and discharge or before
death. Student’s r-test, with Yates’ cor
rection, was used for the statistical an
alyses and a probability of less than 5%
was accepted as significant. Values
were expressed as the mean ± stand
ard error of the mean.
Results

The most frequent origins of the sep
sis in the 34 patients studied were the
abdomen, burns and peripheral vascular
surgery (Table I). The infections were
mostly bacterial; a few were fungal but
there were no protozoal or viral infec
tions. In survivors, the mean interval
between admission and discharge was
24 ± 3.4 days; in those who died, it
was 14.9 ± 4.0 days. The mortality
was 47% from the complications of un
controllable sepsis, such as respiratory,
renal or hepatic failure.
At the time of admission to the unit,
the number of LMN cells was de
creased by 32% compared with healthy
control subjects (P < 0.01) (Table II).
In survivors, the values had returned to
normal by the time of discharge from the
unit but they remained low throughout
the illness in those who died. The pro
portion of monocytes present (0 to 5%)
was not related to survival or death, in
dicating that lymphopenia was the sig-

Table 1— Origin of Sepsis

Origin
Abdomen
Burns
Peripheral vascular surgery
Multiple trauma
Pneumonia
Gynecologic operations
Congestive heart failure
Other

No. of
patients
6
5
5
4
4
3
2
5
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Table II— Number of Lymphomononuclear (LMN) Cells, Early T, Total T and B Cells and Function of K Cells in Peripheral Blood of Patients with Sepsis
Upon admission
Controls
LMN cells, no.
Early T
cell rosettes, %
Total T cell
rosettes, %

2200

± 72
(34)

Survived
1906

± 360f
(16)

54.1 ± 3.5
(11)

54.6 ± 2.9
(18)

64.9 ± 2.9
(10)
6.9 ± 1.1
( 8)

B cell
rosettes, %
Kcell
activity, lytic units X 10° cells/ml

16.1 ± 1.8*
(34)

Upon discharge or before death
Died

1102

Survived

± 151f
(18)

2476

Died

± 460
(16)

1210

± 268
(18)

55.9 ±
3.8
(16)

62.0 ±
3.0
(18)

60.3 ±
(16)

66.8 ± 2.8
(18)

63.3 ±
(16)

3.2

66.8 ±
(18)

2.8

65.9 ±
3.9
(16)

11.6 ± 1.8
(17)

16.2 ±
(15)

2.9

11.1 ±
(16)

2.3

11.5 ±
(13)

2.8

6.5 ±
(16)

1.8J

5.2

2.0 ±
(16)

0.6f

7.4 ± 2.1*
(17)

12.3

±
(17)

4.8

Probable difference (Student’s /-test) : *P < 0 .0 1 , | P <0.05, fP < 0 .0 2 .

nificant prognostic factor. Early T and
total T cell numbers were normal in
itially and did not change during the
period of observation (Table II). The
percentage of B cells was normal and
tended to increase in those who died
(Table II). The difference, however, was
not significant.
K cell activity was decreased by 48%
at the time of admission (P < 0.01)
and in the group as a whole was
similar in those who lived and who died
(Table II). However, in those under
65 years of age, there was a greater
decrease in those who later died than
in those who survived (P < 0.05, Fig.
1). This initial value was therefore
predictive of later death or survival. In
survivors, there was a return to normal
at 20 to 30 days; in those who died,
the final values were 68% lower than
the initial values (P < 0.02). •
The first values for adherence of
PMNL were decreased by 50% and
values in patients who survived did
not differ from those in patients
who died (Fig. 2). In patients who

survived, the values had returned to
normal when they were retested an
average of 31 days later at the time of
discharge from the unit. The results
were the same for both sexes and in
those younger or older than 65 years.
Antibiotics, large doses of corticoste
roids and central intravenous hyper
alimentation had no effect (Table III).
There was no change in chemotactic
migration during the period of observa
tion (Table IV). Intracellular killing of
S. aureus was not affected by sepsis.
Killing of P. aeruginosa remained nor
mal when incubation was for 15, 30
or 60 minutes but Was increased when
the incubation time was 120 minutes
(P < 0.05).
Discussion

We found that sepsis was associated
with a decrease in the number of LMN
cells in the peripheral blood. Most of
the patients in whom the decrease was
55% (1100/mm3) or in whom a de
crease persisted ultimately died. The

simple observation of the number of
LMN cells in the peripheral blood was
extremely useful in indicating the sev
erity of sepsis, in predicting prognosis
and in monitoring the clinical course
of the patient. This finding was in agree
ment with the observation in untreated
patients with Hodgkin’s disease that
patients who died had a LMN cell
count of less than 14 0 0 /mm.3’7 Similarly
Meakins and colleagues1 found that the
lymphocyte count was decreased in an
ergic surgical patients and that in this
group of patients there was a high fre
quency of sepsis and death.
Monitoring of early and total T cells
and B cells, using rosette formation,
was of no value in predicting prognosis
in patients with sepsis. Meakins and
associates1 found that the percentage
of T cell rosettes was decreased in
anergic surgical patients and that those
with a decrease had a high frequency
of Subsequent sepsis. The two popula
tions differed only in that our patients
had established sepsis, whereas the pa
tients in the series reported by Meakins
had infections subsequently.
There are conflicting reports on the
role of B cells in surgical patients. Gug
genheim and Buechler,8 working with
rats, and Hill and colleagues9 found
that malnutrition caused a decrease in
the number of B cells, while Wunder,
Table II I — Effect of Antibiotics, Steroids and
Central Intravenous Hyperalimentation on
Percentage Adherence of Polymorphonu
clear Leukocytes (PM NL) in 34 Patients with
Sepsis

FIG. I—K cell activity in patients with
sepsis under and over 65 years of age
(probable difference, Student’s /-test,
*P > 0.05, ® P < 0.05).
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FIG. 2—Adherence of polymorphonu
clear leukocytes to nylon fibres deter
mined in patients with sepsis on admission
and at time of discharge from unit or be
fore death (probable difference, Student’s
/-test, *P <0.01, A = not significant).

Treatment

Given

Not given

Antibiotics

33.7 ± 4.7
(24)
37.3 ± 6.1
(7 )

31.5 ± 11.1
(10)
27.9 ± 5.5
(27)

35.1 ± 7.9
(9)

36.7 ± 5.2
(25)

Steroids
Hyperalimentation
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Table IV— Intracellular Killing (%) of Staphylococcus Aureus and Pseudomonas Aeruginosa by PMNL

Organism
S .

aureus

P. aeruginosa

4

Upon admission

Time
(min)

Controls

15
30
60
120

53.0
77.7
88.4
96.3

15
30
60
120

66.2
85.2
93.7
97.7

Probable difference (Student’s Z-test) :

*

P

<

±
±
±
±

6.1
4.9
2.4
0.5*

Total
60.3
77.8
85.5
90.5
66.7
88.5
96.7
99.3

±
±
±
±
±
±
±
±

Survived

5.3
4.0
2.0
2.1

57.2
77.5
83.1
89.0

3.3
1.5
0.8
0.1*

65.2
85.4
94.9
99.5

dr
dr
dr
dr

dr
dr
dr
dr

Died

Upon discharge

11.3
8.7
5.7
5.8

62.1 ± 5.8
77.9 ± 4.4
86.9 ± 3.5
91.4 ± 1.5

50.0 ± 13.0
73.9 ± 7.4
88.9 ± 3.9
95.9 r t 2.0

5.1
3.5
1.8
0.2

67.7 ± 4.5
90.4 ± 1.0
97.8 ± 0.5
99.4 ± 0.1

57.2
72.6
91.9
96.5

±
±
±
±

9.7
9.0
3.7
1.9

0.05.

Stinnett and Alexander10 found no
change. Our results show that in the
marked catabolic state associated with
sepsis, the number of B cells is normal
and does not change during the course
of the disease.
In those under 65 years of age, K
cell activity was decreased in patients
with systemic sepsis, was lower in those
who died (P < 0.05) and continued to
decrease as the general condition dete
riorated. It has already been noted
that K cell activity is decreased in
healthy people older than 65 years.11
The results of our study indicated that
sepsis is not associated with major de
fects in K cell function in the group as
a whole. The decrease in critically ill
patients with sepsis may be due to the
direct toxic effects of the infections on
the K cells or their progenitors or to
the marked increase in tissue cata
bolism. It is not known if improvement
of K cell activity will also improve the
prognosis.
It has been assumed that im
munologic surveillance is performed
mainly by T cells. There is increasing
evidence that K, natural killer (NK) and
large mononuclear cells may play more
important roles.12 Athymic mice have
few T cells but do not have an increase
in non-lymphoreticular cancers. A
greater number of malignant lymphoreticular tumours and skin cancers are
found in patients with congenital defi
ciencies of T and B cells than in the
normal population but few mesothelial
or epithelial tumours are found, and
patients with sarcoidosis and leprosy'
have fewer T cells but no increase in
the frequency of cancer. If immu
nologic surveillance by T cells is im
portant there should be an increase in
non-lymphoreticular cancers in these
patients. T cell deficiency is generally
associated with an increase in fungal,
viral and protozoal infections and B cell
deficiency with an increase in bacterial
infections. The predominantly bacterial
infections seen in our study in patients
with decreased K cell activity suggest
450

± 13.1
± 7.5
± 4.0
± 1.1

that K cells may also play a role in
bacterial infections, but to what extent
we can only speculate.
We found that adherence of PMNL
was decreased in patients with sepsis.
Lentnek, Schreiber and MacGregor,13
however, observed increased adherence
in patients with inflammatory diseases,
including localized sepsis. The dif
ference in results was unlikely to
be accounted for by differences
in methodology. They used a lighter
weight of nylon fibres than we
did but this should have decreased
rather than increased adherence. Treat
ment could affect the results. We
found that results in males and females
did not differ and that the use of
antibiotics, steroids and central intra
venous hyperalimentation had no effect
on adherence, suggesting that the
decrease in PMNL adherence was the
direct result of sepsis and not of any
coincidental treatment. Also, since the
values returned to normal in survivors,
it is unlikely that the impairment pre
ceded the illness. The importance of a
decrease in adherence of PMNL is not
known. It may indicate that the cell
is unable to adhere to the capillary
endothelium prior to its passage through
the wall of the vessel in response to a
chemoattractant. For example, alcohol
causes a decrease in adherence14 and
also inhibits migration of PMNL into
Rebuck skin windows. Therefore the
number of PMNL that reach a septic
focus may be reduced. Additional
simultaneous studies are required of
adherence, migration using the skin
window technique and chemotactic re
sponse.
We used heparinized whole blood for
our studies on adherence of PMNL. The
effect could therefore be produced by
PMNL or plasma. MacGregor4 showed
that the effect of steroids on adherence
is mediated by plasma, and that washed
cells adhere normally. We are cur
rently investigating the effect of plasma
on adherence.
In contrast to our results, Meakins
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and coworkers' found that sepsis caused
a reduction in chemotactic migration
of PMNL. The techniques used were
not similar. We determined the number
of PMNL that had migrated to the un
dersurface of the chemotactic mem
brane after 180 minutes. Maximal mig
ration was measured at that time.15
Meakins and his group1 measured the
distance migrated after 120 minutes,
in which case it is possible that the
rate of migration was reduced yet total
migration could have remained normal.
Christou, Meakins and MacLean16 found
that there was a chemotactic inhibitory
factor in the serum of normal and an
ergic patients and that there was an
additional inhibitory factor in those who
were anergic. They postulated that the
decrease in chemotaxis they observed in
anergic patients was responsible for the
increase in sepsis.
Bactericidal function of PMNL in
patients with sepsis may be unim
paired1,17 or decreased.18 We found that
killing of S. aureus was normal and so
was killing of P. aeruginosa when in
cubation was for 15, 30 or 60 minutes.
It was increased, however, when in
cubation was for 120 minutes.
We thank Dr. R. MacDonald, Lau
sanne, Switzerland for setting up the anti
body-dependent cellular cytotoxicity test,
Mrs. M. Boisvert for the polymorphonu
clear cell assays, Mrs. S. Wood for the
lymphocyte studies and Mrs. M. Alderson
for typing the manuscript and preparing
the figures.
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BOOK REVIEWS
is 40 pages long. This controversial sub
ject certainly deserves an exhaustive dis
cussion. The approaches of many promi
nent workers in this field are presented
in detail along with the rationale of their
method of management. Millard de
scribes the period when total resection
of the maxilla was used, resection of the
vomer and setback, the years of disap
proval of these techniques and finally
presurgical orthodontic treatment for the
protruding premaxilla. It is apparent that
controversy still exists and that all the
questions are not yet answered.
The first 31 chapters consider primary
deformity and its correction. Millard
makes it clear that definitive surgery on
a lip should be performed at the primary
operation. This is indeed a philosophy
worth striving for although often difficult
to achieve.
In the second section on secondary bi
lateral cleft deformities 23 chapters cover
the management of these perplexing prob
lems, many of which have resulted from
inadequate primary surgery, but many,
such as a short columella, are inherent
in the anomaly itself.
The third section on rare clefts is rela
tively short, particularly so, considering
that it deals with some of the most dif
ficult reconstructive problems a surgeon
faces. It does, however, make the book
more complete and has a good biblio
graphy to direct the reader to other
original articles.
This book goes back to 1957 when the
“Principles and Art of Plastic Surgery”
by Sir Harold Gillies and D. Ralph Mil
lard was published. The artistic presen
tation is similar in both publications and
the authority of the authors comes
through very strongly. Millard has given
much credit to earlier workers in this
field and has enriched the book with

CLEFT CRAFT. The Evolution of its
Surgery. III. Bilateral and Rare Deforities. D. Ralph Millard, Jr. 922 pp.
Illust. Little, Brown and Company,
Boston, 1977. Price not stated. ISBN
0-316-57138-5.

This book from one of the leading au
thorities on cleft lip and palate is ad
vertised as authoritative, sometimes irrev
erent, often humorous but always
sagacious in its assessment of bilateral
and rare clefts. It is indeed all of that.
It takes the reader through the embry
ology, anatomy and surgical history of
the subject from its beginning to the
present. It is well illustrated with diagrams,
drawings and photographs, and has an
excellent bibliography and index. It con
tains much historical information and
good factual advice on the management
of these difficult problems but it is not
a book for the novice. For the uninitiated,
the abundance of historical information
and numerous viewpoints presented might
confuse rather than clarify. Periodically,
the author does summarize sections to
give a rational approach; an excellent
example of this is the chapter entitled
“Outline of my approach to secondary
bilateral cleft lip rhinoplasty”. In the
preceding 11 chapters the author has out
lined in detail the problems of nasal de
formity in bilateral cleft lips and the
various approaches to its management.
In this chapter he pulls it all together in
six pages, dealing specifically with tip
flatness and columella shortness, columella
retraction, reduction rhinoplasty, submu
cous resection, shortness of vestibular
lining, alar base deformities and retroposed maxilla.
Although most chapters are quite short
the chapter on the projecting preroaxilla
VOLUME 22, NO. 5, SEPTEMBER 1979
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many of their pencil portraits. This book
is not for the novice or uninitiated in the
field but is a must for every surgical ref
erence library and should be readily avail
able for senior residents in plastic sur
gery.
A.D. C ourtemanche, md, frcs [c]
306 Laurel Medical Centre,
888 West 8th Ave.,
Vancouver, BC
CORONARY
ARTERY
SURGERY.
John L. Ochsner and Noel L. Mills.
275 pp. Illust. Lea & Febiger, Philadel
phia; The Macmillan Company of Can
ada Limited, Toronto, 1978. $31.25.
ISBN 0-8121-0620-2.

This book, dealing with the various aspects
of coronary artery surgery, is very nicely
laid out with excellent illustrations and
is easily read. The 15 chapters encompass
major considerations in preoperative
evaluation, patient selection and prepara
tion for surgery, the various operative
techniques, the major anesthetic consi
derations,
postoperative
management,
combined operations and reoperation.
Accepted techniques are well described
in a step-wise fashion while controversial
techniques are avoided.
Cardiac surgical residents will find
that the book is an excellent resume of
the subject. It also contains useful infor
mation for practising cardiovascular sur
geons, cardiologists, cardiovascular nurses
and paramedical personnel especially op
erating-room nurses.
W.J. K eon,

md, frcs [c]

Chief, division of cardiothoracic surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
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ORIGINAL CONTRIBUTIONS

Treatment of Carotid Cavernous Fistula by Intravascular
Occlusion Using a Balloon Catheter
N.A. R u s s e l l , m d ,
W. P ryse -P h il l ip s ,

The surgical treatment of carotid
cavernous fistula gradually evolved into
a “trapping” technique. This technique
includes ligation of the cervical internal
carotid artery, clipping of the intra
cranial portion distal to the fistula and
often embolization of the isolated
segment. The development of
embolization techniques using intra
vascular balloon catheters greatly
simplified this treatment.
The authors report a case of
spontaneous carotid cavernous fistula
in which obliteration was achieved by
an intracarotid balloon catheter. This
was inserted by direct puncture of
the carotid artery, which had been
exposed by a simple neck incision. The
patient's visual acuity was preserved.
The efficacy, ease and safety of this
method are emphasized.
Le traitement chirurgical de la fistule
caverneuse carotidienne a progressivement evolue vers une technique de
“piegeage”. Cette technique comprend
la ligature de I'artere carotide interne
cervicale, le clip de la partie intracranienne distale a la fistule et, souvent,
I’embolisation du segment isole. Le
developpement des techniques
d’embolisation utiiisant les catheters
intravasculaires a ballonets a grandement
simplifie ce traitement.

From the divisions of *neurosurgery,
t diagnostic radiology and tneurology,
St. John’s General Hospital and
Memorial University of Newfoundland,
St. John’s, Nfld.
Presented at the 45th annual meeting of
the Royal College of Physicians and
Surgeons of Canada, Quebec City, PQ,
Jan. 22, 1976
Reprint requests to: Dr. N.A. Russell,
Ste. 201, Wedgewood Medical Centre,
Wedgewood Park, St. John’s,
Nfld. A1A 2M7
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frcs [c ], facs ,* M.A. M angan , m d , b CH,f
m d , f r c p [c ] | and L.K. S harm a , m d , f r c s *

Les auteurs signalent un cas de
fistule caverneuse carotidienne
spontanee ou I'obliteration a ete reussie
grace a un catheter intracarotidien
a ballonet. Celui-ci a ete insere par
ponction directe dans la carotide
qui avait ete exposee par une simple
incision du cou. L'acuite visuelle du
patient a ete preservee. L'efficacite,
la facilite et la securite de cette
methode sont soulignees.

The management of carotid cavernous
fistula has challenged the ingenuity of
surgeons since Travers1 in 1809 first
reported the successful treatment of
such a case by ligation of the common
carotid artery. In the ensuing years,
numerous attempts have been made to
devise a definitive form of treatment.
These have included embolization
alone,2 or in combination with “trap
ping,”3,4 electrothrombosis of the
sinus5-7 and direct repair of the fistula
during cardiac standstill.8,9 The most
successful and widely practised is the
“trapping” technique described by
Hamby and Gardner3 and Jaeger.4
The successful use of a balloon
catheter to occlude a carotid cavernous
fistula was first reported in 1971 by
Prolo and Hanberry.10 They used a
no. 3 French Fogarty balloon catheter,
passed it through the internal carotid
artery to the site of the fistula and
inflated it with positive contrast m a
terial thus obliterating the fistula.
Others11-14 have since reported success
with this method.
The case reported here was treated
in this way. The fistula remains oblit
erated 2 years after the procedure and
the patient has had no ill effects from
the permanently implanted balloon
catheter.
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Case Report
On July 15, 1975 a 54-year-old, righthanded woman experienced severe pain
in her left eye associated with a loud
“whooshing” sound in her left ear. The
pain and noise persisted and after 2 days
the eye began to close.
She was admitted to the St. John’s
General Hospital on July 25, 1975.
Examination showed complete loss of
function of the left third cranial nerve
and dysesthesia in the distribution of the
first and second divisions of the fifth
cranial nerve. There was no exophthalmos.
Visual acuity was normal. A loud bruit
could be heard all over the head, maxi
mally over the left orbit. A diagnosis of
a spontaneous carotid cavernous fistula
was made and was confirmed by bilateral
carotid angiography (Fig. 1).
On Aug. 13, 1975, under general
anesthesia and with electroencephalographic (EEG) monitoring, the left cer
vical carotid bifurcation was exposed.
Tapes were passed around the internal,
external and common carotid arteries. A
16-gauge Angiocath (Desereta Pharma
ceuticals Canada Ltd., Port Credit, Ont.)
was inserted into the proximal internal
carotid artery. An 18-gauge Angiocath
was then inserted into the bifurcation of
the artery immediately below this.
Through the 18-gauge Angiocath, 15 ml
of Renografin-60® was injected and an
giograms were made. A no. 3 French
Fogarty embolectomy catheter was then
passed by way of the 16-gauge Angiocath
into the internal carotid artery.
The guide wire was withdrawn and
enough Renografin-60® was injected to
allow visualization of the catheter, which
was maneuvered into the intracavernous
portion of the carotid artery with fluor
oscopic control. After the balloon was
inflated with Renografin-60®, auscultation
over the left orbit indicated that the bruit
was no longer audible. Repeat angio
graphy, however, showed that the fistula
was only partially occluded. The catheter

THE CANADIAN JOURNAL OF SURGERY

borough, Ont.). The redundant portion of
the catheter was cut off. The catheter was
fastened to the artery with a purse-string
suture and the protruding end buried in
the undersurface of the sternomastoid
muscle. The common carotid artery was
ligated.
Upon awakening from the operation,
the patient noted that both the pain and
the bruit had disappeared. After several
days, the third nerve palsy began to re
gress, so that 1 week after the operation,
the patient could open her eye. Visual
acuity remained normal. Skull roentgeno
grams taken on Aug. 15, 1975, showed

was therefore withdrawn and the 16gauge Angiocath was replaced by a 15gauge one. Through this, a no. 4 French
Fogarty catheter was inserted and
threaded easily up to the fistula. Angio
graphy after inflation of the balloon de
monstrated that the fistula was totally
occluded (Fig. 2).
Interestingly, the balloon had herniated
into the fistula, plugging it and leaving a
portion of the internal carotid artery
patent. The Angiocath was withdrawn
over the catheter, the end of which was
occluded with two medium-sized clips
(Ligaclips, Ethicon Sutures Ltd., Peter

the contrast-filled balloon unchanged in
size and position in the left paracellar
region (Fig. 3). Antibiotic therapy con
sisting of ampicillin (1 g q6h) and cloxacillin (1 g q6h) was maintained for 10 days
after operation. She was discharged from
hospital on Aug. 30, 1975.
At follow-up examination 2 years later,
all signs of the fistula were absent and
there was no neurologic abnormality.
Skull roentgenograms showed only a
remnant of contrast material present at
the site of the balloon (Fig. 4).
D iscu ssion

The technique described above is a
simple and safe way of obliterating a
carotid cavernous fistula. Intraoper
ative fluoroscopy and angiography allow
accurate balloon placement and demon
strate the degree of obliteration of the
fistula. In our case, the importance
of fluoroscopy and angiography is
illustrated by the fact that with the
initial small balloon, the fistula was
not completely obliterated, even though
the bruit had disappeared. In the post
operative period, the status of the
contrast-filled balloon can be readily

FIG. I— Carotid arteriogram (subtraction study) demonstrating carotid cavernous
fistula with brisk shunting via cavernous sinus into ophthalmic vein (white arrow).
Shunting is also shown occurring through infraophthalmic vein (black arrow) into
venous channels in nasopharynx.

FIG . 3— Lateral skull roentgenogram
showing contrast-filled balloon in place.

FIG. 2— Intraoperative carotid arteriogram showing contrast-filled balloon obliter
ating carotid cavernous fistula. There is some filling of supraclinoid carotid
(large arrow) and ophthalmic (small arrow) arteries.
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FIG. 4— Lateral skull roentgenogram
taken at 2-year follow-up shows only
remnant of contrast material in presum
ably deflated balloon.
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Antiemetic Stemetil shown to haw
beneficial effect on LOS tone
Aspiration of acid into the lungs remains a
common cause of death associated with gen
eral anaesthesia. The lower oesophageal
s p h in c te r (L O S ) is sa id to be a m a jo r
mechanism which maintains competence of the
gastro-oesophageal junction, and several drugs
commonly used during anaesthesia may influ
ence LOS tone, thereby increasing or decreas
ing the tendency to regurgitation.
Reporting in the July 1978 issue of the British
Journal of Anaesthesia, researchers demon
strated that Stemetil (prochlorperazine) an an
tiem etic used com m only before and after
surgery, significantly increases LOS tone with
out affecting oesophageal pressure. The resul
tant increase in Barrier Pressure (BP) de

creases the tendency to regurgitation. The in
vestigators measured an average increase of
BP from 2.31 kPa to 3.36 kPa (P<0.005) in 8
volunteers following the I.V. administration of
12.5 mg Stemetil.1

jk
h

f

This information further enhances Stemetil’s
reputation as a pharmacologically complete an
tiemetic. In addition to its effect on LOS tone,
Stemetil’s multi-level antiemetic action promptly
stem s nausea and vom iting of central or
peripheral origin. Its anxiolytic action2 inhibits
cortical impulses associated with “ psychological
vomiting”. Its C.N.S. action directly blocks the
chem oreceptor trigger zone,3 4 raising the
threshold for impulses arriving at the medullary
vomiting center.

Stemetil in
Radiation Sickness
The results of a trial involving 45 patients who
developed nausea and vomiting following radia
tion therapy showed that Stemetil was effective
in all of the patients within 1-2 days, with good to
excellent results.
Stemetil was administered in a dosage of 10 mg
b.i.d. after the onset of nausea and vomiting,
and was continued for 5-10 days after symp
toms ceased. The only side effect was drowsi
ness, which might not have been drug related.5
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References: Brock-Utne, J. G. et al.: The action of commonly used
antiemetics on the lower oesophageal sphincter. British Journal of
Anaesthesia, no. 50, 295-298, July 1978. 2. Peterfy, G. and Pinter, J.:
Current Therap. Res., 14 , (9), 590-598, September 1972. 3. Goodman,
L. and Gilmour, A.: The Pharmacological Basis of Therapeutics, 5th Ed.,
161, 1975. 4. Today’s Drugs: British Medical Journal, 1, 481, February
21, 1970. 5. Dutta, A. K.: Study of Prochlorperazine (Stemetil) in radia
tion sickness, Antiseptic Vol. 73, no. 1, pp 16-18, 1976.
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followed by plain skull roentgeno
grams.
We ligated the common carotid
artery as described in other reports.11*12,14
This is probably not necessary and
certainly increases the risk of cerebral
ischemia.15 The catheter can he ade
quately fastened to the vessel with a
purse-string suture and the proximal
protruding end occluded by metal clips.
This procedure appears to prevent de
flation of the balloon, at least until
thrombosis of the fistula occurs. Intra
operative EEG monitoring will warn
of cerebral ischemia. Superficial tem
poral to middle cerebral artery bypass
has been used before occlusion of the
fistula to protect the blood supply to
the endangered hemisphere (Ford R,
Richardson P, Anderson D: Unpub
lished data, 1978).
Two years after operation, skull ro
entgenograms of our patient showed
that the balloon had deflated; how
ever, the patient remained asympto
matic, suggesting that the fistula had
been obliterated by thrombus.
A detachable balloon has been
developed14,16 which can be left in the
defect in the artery, obliterating the
fistula while preserving the arterial
lumen. This happened fortuituously in
our case, the balloon actually herniat
ing into the arterial wall defect and
occluding the fistula, while sparing a
portion of the lumen of the internal
carotid artery.
As reported by others,1012 we found
that the flexible catheter easily nego
tiated the curves of the carotid artery.
Our patient’s visual acuity remained
normal, presumably because of the
beneficial hemodynamic effect of pre
serving flow through the ophthalmic
artery, while at the same time lowering
intraocular venous pressure.10’17
We found that a no. 4 French
Fogarty catheter passed easily through
the 14-gauge Angiocath and that
direct puncture of the artery with the
needle was simpler than performing an
arteriotomy. As we suspected, and as
subsequently been shown,13 this proce
dure may be performed by a percuta
neous technique.

Stemetil
prochlorperazine

Indications: nausea and vomiting of various
etiologies: gastrointestinal disorders, drug
intolerance, motion and radiation sickness,
post-operative conditions, pregnancy, vertigo
and migraines.
Dosage: Adults, oral route - Usual effective
dosage is 5 to 10 mg, 3 or 4 times daily; in very
mild cases, a single dose of 5 to 10 mg is often
adequate. 'Spansule' Capsules: one or two
every tw elve hours. This dosage may be
increased as required by increments of 10 mg
every 2 or 3 days until symptoms are
controlled. For maintenance therapy the dosa
ge should be reduced to the minimum
effective dose. Because of the lower pediatric
dosage requirements, the 'Spansule' Capsules
are not intended for use in children. Rectal
route - 1 or 2 suppositories of 25 mg per day.
Children: oral and rectal routes - up to 10 mg
per day in divided doses according to body
weight.
Parenteral route (not to exceed 40 mg per day)
- In general practice: 5 to 10 mg I.M ., 2 or 3
times a day. In surgery: 5 to 10 mg I.M., 1 to 2
hours before anesthesia. Repeat once during
surgery if necessary. Post-operatively, same
dose of 5 to 10 mg I.M., repeated e very 3 to 4
hours. M a y be given I.V. during and after
surgery in the infusion solution at a concen
tration of 20 mg per litre. In obstetrics: 10 mg
I.M . during first stage of labor; subsequent 10
mg doses as needed. Post partum: the usual
total daily dose is 15 to 30 mg orally or I.M.

Contraindications:

Com atose or deeply
depressed states of the C N S due to hypnotics,
analgesics, narcotics, alcohol, etc.; hypersen
sitivity to phenothiazines; blood dyscrasias;
bone marrow depression; liver damage.

Warnings and precautions: etiology of vomit
ing should be established before using the
drug as its antiemetic action m ay mask
symptoms of intracranial pressure or intestinal
obstruction. Patients with a history of convul
sive disorders should be given an appropriate
anticonvulsant w h ile on therapy. Tardive
dyskinesia may occur in patients on long-term
therapy. If used with C N S depressants, the
possibility of an additive effect should be
considered. Use with great caution in patients
with glaucoma or prostatic hypertrophy. The
drug may impair the mental and/or physical
abilities required for the performance of
potentially hazardous tasks such as driving a
car or operating machinery, especially during
the first few days of therapy. Keep in mind that
all medications should be used cautiously in
pregnant patients, especially during the first
trimester.
Side effects: extrapyramidal reactions, dis
turbed temperature regulation and seizures
have been encountered. Other side effects due
to phenothiazine derivatives should be borne
in mind; for complete list, see product
monograph.
Overdosage: no specific antidote; symptoma
tic treatment. If a pressor agent is required,
norepinephrine may be given (not epine
phrine as it may further depress the blood
pressure).
Dosage forms: tablets 5, 10 and 25 mg; am
poules 2 ml/10 mg; liquid 5 mg per teaspoon
ful (5 ml); suppositories 5 and 10 mg. 'Span
sule' Capsules, 10 mg.

Summary
Occlusion of a carotid cavernous
fistula was achieved by an intracarotid
balloon catheter which was inserted
by direct puncture of the exposed carotid
artery. The patient’s visual acuity was
preserved and all symptoms and signs
of the fistula werq. absent at follow-up
2 years later, despite collapse of the
balloon. We suggest, particularly since
a detachable balloon has recently been
developed, that this is the preferred
method of treatment for carotid ca
vernous fistula.

Complete information upon request
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Percutaneous Transfemoral Retrieval of the “ Runaway”
Ventriculoatrial Shunt
C.E.U. E kong, mb , bs,* Y .H . G abriel, mb , bs, frcs[c]* and J.F. L opez , md , FRCp[c]f

A 22-year-old man with a ventriculoatrial
shunt was admitted to hospital for
investigation of headache, nausea and
vomiting. During a procedure done to
convert the ventriculoatrial shunt to
the ventriculoperitoneal type, the shunt
tubing was inadvertently cut in the
neck. The atrial end was found to have
migrated into the right atrium. It was
recovered by percutaneous cardiac
catheterization through the femoral
vein. The patient tolerated the procedure
well. The authors believe that this
method of retrieval is easier and
carries less operative risk than
previously reported methods.
Un jeune homme de 22 ans porteur
d'une derivation ventriculo-auriculaire
a ete hospitalise pour investigation
d’une cephalee, nausees et
vomissements. Au cours d’une inter
vention pratiquee dans le but de
transformer une derivation ventriculoauriculaire en derivation ventriculoperitoneale, la tubulure de derivation
fut sectionnee par inadvertance au
niveau du cou. On s'apercut que
I’extremite auriculaire avait migre dans
I'oreillette droite. Elle fut recouvree
par catheterisme cardiaque percutane
dans la veine femorale. Le patient
supporta bien I’intervention. Les auteurs
croient que cette methode de
recuperation est plus facile et
comporte moins de risques operatoires
que les methodes prealablement
decrites.

retrieved by thoracotomy or more re
cently5,6 by cardiac catheterization
through the internal jugular vein. We
present the case history of a patient in
whom the atrial catheter was recovered
by percutaneous transfemoral cardiac
catheterization.

A 22-year-old man was admitted for the
10th time to the University Hospital, Sas
katoon, on Jan. 18, 1978. He complained
of intermittent headaches, nausea and
vomiting which had started 1 month ear
lier. His first hospitalization had been in
1973 for treatment of a head injury re
sulting in intracerebral, subdural and epi
dural hematomas of the right cerebral
hemisphere. These were removed sur
gically. Subsequently cerebrospinal fluid
rhinorrhea developed due to a fistula,
which was repaired, and later he had
hydrocephalus, which was treated by in
serting a ventriculoperitoneal shunt. The
shunt had been revised several times over
the years because of blockage of the
tubing. At the time of this admission a
ventriculoatrial shunt was in place.
On physical examination the Holter
shunt reservoir appeared to be emptying
slowly but filling rapidly, suggesting
a block of the atrial end, which was
confirmed by radioisotope scanning. On

Jan. 23, 1978, the patient underwent oper
ation to convert the ventriculoatrial shunt
to a ventriculoperitoneal shunt. During
the procedure the shunt tubing was in
advertently cut in the neck. The ventri
cular end was noted to be patent and
leaking cerebrospinal fluid. The atrial end
could not be located. A tunnel was found
in the subcutaneous tissue from which
the shunt tubing had retracted inferiorly.
An intraoperative roentgenogram of the
neck and chest (Fig. 1) showed the upper
end of the radiopaque shunt tubing to be
10 cm cephalad to the right clavicle. Fur
ther dissection down the tunnel failed to
discover the shunt tubing. The proximal
tubing was connected to a Codman Accuflo abdominal shunt tubing (Codman &
Shurtleff, Inc., Randolph, MA) and placed
in the peritoneal cavity. On Jan. 25 we
again attempted to retrieve the tubing by
dissection in the lower part of the neck,
but to no avail. An intraoperative roent
genogram showed the upper end of the
tubing resting 2 cm cephalad to the
clavicle (Fig. 2).
On Jan. 26 an open-tipped no. 8 Teflon
catheter was introduced into the right
femoral vein under local anesthesia. This
was passed up to the superior vena cava
under fluoroscopic control. A curved safe
T-3 wire guide (Cook Inc., Scarborough,
Ont.) was then bent double and the loop
thus formed was passed through the
catheter until about 6 cm of it protruded

FIG. 1— Intraoperative roentgenogram
of neck and chest (Jan. 23, 1978) made
after shunt tubing was cut. Upper end of
distal tubing is seen 10 cm above clavicle
(higher arrow). New ventriculoperitoneal
shunt is in situ (lower arrow).

FIG. 2— Intraoperative roentgenogram
of neck and chest (Jan. 25, 1978) made
during second attempt to retrieve tubing
from neck. Top of cut shunt tubing (arrow)
is now 2 cm cephaled to right clavicle.

Case Report

Migration of the atrial catheter into the
heart is a known,1-5 but relatively un
common, complication of ventriculo
atrial shunting. It may occur as
a result of spontaneous disconnection
of the catheter from the ventricular
part or during revision of the shunt.
In the past this complication has been
left untreated in the hope that it would
not cause embolization,4 or has been
From the departments of *clinical
neurological sciences (division of
neurosurgery) and (medicine (division
of cardiology), University Hospital,
Saskatoon, Sask.
Reprint requests to: Dr. C.E.U. Ekong,
1802-25 Charles St. W, Toronto, Ont.
M 4Y 1R6
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beyond the catheter tip. It was then
maneuvered as a snare under fluoroscopic
control until the shunt tubing was trapped
between the wire and the Teflon catheter
(Fig. 3). The catheter, wire and shunt
tubing were then pulled out of the femoral
vein en bloc. The patient tolerated the
procedure well. His recovery was smooth
and he was discharged home on Feb. 4,
1978.
Discussion
Catheterization of the right atrium
through the femoral vein is a relatively
simple procedure, especially in adults.
Its use for retrieval of cardiac foreign
bodies was first suggested by Tatsumi
and Howland.5 By catheterizing the
heart with a Teflon catheter and using
a wire snare, a major thoracic opera
tion is averted. It should be possible
after a few attempts under fluoroscopic
control, to anchor the runaway shunt
catheter to the cardiac catheter by
trapping it between the wire and
cardiac catheter.
The first reported case of recovery
of a shunt catheter from the atrium by
cardiac catheterization was that of
Tatsumi and Howland5 who used the
internal jugular vein from which the
shunt had escaped. McCulloch and
Cartledge6 used a flexible rongeur for
ceps successfully through the same
vein. We believe that there is a poten
tial danger in this approach as a throm
bus may be dislodged and enter the
heart in the process of catheterization
or introduction of the rongeur forceps.
Some neurosurgeons prefer to leave
the catheter in the heart or internal
jugular vein as long as the patient

has no symptoms. This may be dan
gerous since septicemia and throm 
boembolic complications may de
velop.7'9 Cardiac tamponade, erosion
and penetration of the cardiac wall and
cardiac arrythmia5 are other well-docu
mented occurrences. In our opinion a
free portion of a shunt catheter should
not be left in the atrium but should be
removed as soon as possible by femoral
venous catheterization.
Retrieval of the catheter under fluor
oscopic control would have been im
possible if the catheter had not been
radiopaque. It is, therefore, most im
portant to use radiopaque atrial shunt
tubes or tubes with radiopaque markers
for all ventriculoatrial shunt proce
dures.
We thank A. Jean MacGregor, assistant
professor of medicine and medical illus
trator, for illustrating the retrieval proce
dure in Fig. 3 and Mrs. M. Faulkner
for secretarial assistance.
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A Major A d van ce in Controlling
U pper Gastrointestinal
Bleeding
J5 • *

Thgamel
(cimetidiiie)
Rapidly Controls
Bleeding
In hemorrhage due to
stress lesions, bleeding stopped
in most patients within 2-6 hours
after treatment with 'Tagamet'
began, and endoscopic reassess
ment at 24 hours showed that
57 out of 61 patients (93.4%) had
stopped bleeding.1
In an additional study with
'Tagamet' it was concluded "that
cimetidine is an effective agent for
controlling bleeding from hemor
rhagic gastritis, even in situations
where other medical and surgical
measures failed".2

Permits Conservative
Surgical Decisions
"The histamine H 2-receptor
antagonist, cimetidine, was used
in 27 patients with erosive gastritis,
and bleeding ceased in 24. There
is a prospect that such agents
will obviate the necessity of total
gastrectomy in the occasional
resistant cases in favour of conser
vative surgery."3

The H2 Receptor
Antagonist
/ .,
,«!% . v

INJECTION

J>

Tagamet
(ciinetidine
Tablets and In jectio n
(Product Monograph available to practitioners on
request.)
PHARMACOLOGICAL CLASSIFICATION
Histamine H 2 -Receptor Antagonist
CHEMISTRY
Chemical Name:
Cimetidine is N"-cyano-N-methy\-N’-[2 d( 5-methyllH-imidazol-4-yl) methyl] thio] ethyl] guanidine.
Structural Formula:
✓ ch 2sc h 2ch 2nhcnhch 3
CH3

Xc

HN^ N

II

N -C = N

Molecular Formula: C,oH,6N6S
ACTION
Cimetidine competitively inhibits the action of
histamine at the histamine H2 receptor, and thus
represents a new class of pharmacological agents,
the histamine H2-receptor antagonists.
Cimetidine is not an anticholinergic agent.
Studies have shown that cimetidine inhibits both
daytime and nocturnal basal gastric acid secretion.
Cimetidine also inhibits gastric acid secretion
stimulated by food, histamine, pentagastrin, caf
feine and insulin. Its ability to inhibit gastric acid
secretion via this unique mechanism of action
permits a new approach to the treatment of acidrelated gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral adminis
tration. The plasma half-life is approximately two
hours. The principal route of excretion is the urine.
T he degree and duration of inhibition of basal
and stimulated gastric acid secretion is doserelated; the data suggest that 80% or higher
inhibition throughout a 24 hour period can be
achieved by a dosage regimen of 300 mg four
times daily given with meals and at bedtime.
Cimetidine 300 mg reduced total pepsin output as
a result of the decrease in volume of gastric juice.
The drug had no effect on the rate of gastric
emptying or lower esophageal sphincter (LES)
pressure.
INDICATIONS AND CLINICAL U SE
'Tagamet' (cimetidine) is primary therapy for
conditions where the inhibition of gastric acid
secretion is likely to be beneficial, such as:
—Duodenal ulcer
—Non-malignant gastric ulcer
—Gastroesophageal reflux disease
—Management of upper gastrointestinal
hemorrhage
—P athological h y p ersecretio n associated
with Zollinger-Ellison Syndrome, systemic
m astocytosis and m ultiple en d o crin e
adenomas.
CONTRAINDICATIONS
There are no known contraindications to the use of
'Tagamet' (cimetidine).
PRECAUTIONS
Use in Pregnancy; Nursing M others: There has
been no experience, to date, with use of 'Tagamet'
(cimetidine) in pregnant patients. Reproduction
studies performed in rats, m ice and rabbits have
revealed no evidence of impaired fertility or harm
to the fetus due to 'Tagamet'. Studies have
demonstrated that 'Tagamet' crosses the placental
barrier. It is also secreted in the milk of animals.
'Tagamet' should be used in pregnant or lactating
patients or women of childbearing potential only
when, in the judgment of the physician, the antici
pated benefits outweigh the potential risks.
Use in Children: Clinical experience in children
is limited. Therefore, 'Tagamet' (cimetidine) ther
apy cannot be recommended for children unless,
in the judgment of the physician, anticipated
benefits outweigh the potential |risks. In very
limited experience, 20-40 mg/ kg per day has
been administered in divided doses by mouth or
intravenously.
U se in Im paired R en al F u n c tio n : B ecau se
'Tagamet' (cimetidine) is excreted by the kidney, a
reduced dosage should normally be administered
to patients with impaired renal function. (See
DOSAGE AND ADMINISTRATION)
Drug Interaction: In patients on coumarintype an ticoagulants, fu rth er prolongation of
the prothrombin time has been observed with
concomitant 'Tagamet' administration. For this
reason, close monitoring is recommended, and
adjustment of the anticoagulant dose may be

necessary when these drugs are administered
concomitantly.
Use in G astric U lcer: Symptomatic response to
'Tagamet' does not preclude the presence of a
gastric malignancy.
AD V ERSE REACTIONS
Mild and transient diarrhea, muscular pain,
dizziness and rash have b een reported in a
small number of patients during treatment with
'Tagamet' (cimetidine). A few cases of reversible
confusional states have been reported usually in
elderly, severely ill patients such as those with
renal insufficiency or organic brain syndrome.
Overdosage may have played a role in some
cases. These confusional states generally cleared
within 24 hours of drug withdrawal. There have
been reports that a few patients have developed
mild non-progressive gynecomastia during pro
longed treatment. No evidence of induced
endocrine dysfunction was found, and the con
dition remained unchanged with continuing
'Tagamet' treatment. Rare cases of fever and
intersitial nephritis which cleared on drug with
drawal, have been reported. Som e increases in
plasma creatinine and serum transaminase have
been reported.
OVERDOSAGE
In cases reported to date, involving oral ingestion
of up to 10 grams of 'Tagamet' (cimetidine), no
untoward effects have been noted and recovery
has been uneventful.
Treatment: The usual measures to remove un
absorbed material from the gastrointestinal tract,
clinical monitoring and supportive therapy should
b e employed. Studies in animals indicate that
assisted respiration may be of value and that any
tachycardia may be controlled by administration
of a beta-blocker.
DOSAGE AND ADMINISTRATIONADULTS
(Experience with 'Tagamet' in children is limited
and it has not been evaluated in clinical studies—
s e e PRECA U TIO N S).
In clinical studies 'Tagamet' (cimetidine) has been
used in divided doses of up to 2400 mg a day.
DUODENAL U LC ER
T he recommended adult oral dosage for duodenal
ulcer is 300 mg four times a day, with meals and
at bedtime.
While healing with 'Tagamet' often occurs during
the first week or two, treatment should b e con
tinued for at least four weeks unless healing has
been demonstrated by endoscopic examination.
While some patients may require concomitant
antacids initially, 'Tagamet' alone has been shown
to promote rapid relief of symptoms.
Daily maintenance therapy may be used for those
patients who would benefit from a reduction of
gastric acid secretion, as well as those patients
who are known to suffer frequent recurrence
of duodenal ulcers. Following healing, mainten
ance therapy for periods of 6 to 12 months may
b e initiated at a reduced frequency of dosage,
with the last daily dose taken at bedtime. After
this period of maintenance, patients should b e
reassessed periodically, preferably by endoscopy.
NON-MALIGNANT GASTRIC ULCER AND
GASTRO ESOPH AGEAL R E F L U X D ISEASE
T he recommended adult oral dosage for nonmalignant gastric ulcer and gastroesophageal
reflux disease is 300 mg four times a day, with
meals and at bedtime. While healing of nonmalignant gastric ulcer may occur within the first
two weeks, treatment should b e continued fo r at
le a s t six w eek s unless healing has been demon
strated by endoscopic examination.
While some patients may require concomitant
antacids initially, 'Tagamet' alone has been shown
to promote rapid relief of symptoms.
M ANAGEMENT O F U P PER
GASTROINTESTINAL HEMORRHAGE
In patients with upper gastrointestinal bleeding
of sufficient magnitude as to require blood
transfusions, 'Tagamet' should b e administered
parenterally, preferably by intravenous injection
or intermittent infusion until 48 hours after active
bleeding has stopped. At this time an oral dosage
regimen may be instituted and should b e con
tinued for at least 7-10 days.
Recommended dosage for oral administration:
300 mg every 6 hours.
Recommended dosage for intramuscular injec
tion administration: 300 mg every 6 hours. Inject
the entire contents of a 2 ml ampul.
Recommended dosage for intravenous injec
tion administration: 300 mg every 6 hours. Dilute
'Tagamet' in Sodium Chloride Injection (0.9%) (or

other compatible i.v. solution) to a total volume of
20 ml and inject over 1-2 minutes.
Recomm ended dosage for interm ittent in tra
venous infusion administration: 300 m g every
6 hours. Dilute 'Tagamet' 300 mg in 100 ml of
Dextrose Injection (5%) (or other com patible i.v.
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase
dosage. W hen this is necessary, the increases
should b e made by more frequent administration
of a 300 mg dose, but total daily'dosage should
not exceed 2400 mg.
DOSAGE ADJUSTM ENT F O R PATIENTS
WITH IMPAIRED REN A L FUN CTIO N
Usage in patients with severely impaired renal
function has been very limited. Cim etidine halflife has b een determined in patients with varying
degrees of renal insufficiency to be:
Creatinine C learance Cim etidine Half-life
50-80 ml/min.
2.6 hr.
10-50 ml/min.
2.9 hr.
< 1 0 ml/min.
3.7 hr.
On this basis, the recom m ended dosage in those
patients who have creatinine clearance rates
lower than 10 ml/min., including those who are
anephric, is 300 mg every 12 hours orally or by
intravenous or intramuscular injection. Should the
patient's condition require, the frequency of
dosing may b e increased to every 8 hours or even
further with caution.
Hemodialysis: Greater than 80% of a 300 mg intra
venous dose is cleared in a single 4 hour period of
hemodialysis. It is completely cleared in an 8 hour
period.
Peritoneal Dialysis: Peritoneal dialysis does not
appear to remove cimetidine to any appreciable
extent.
PATHOLOGICAL H Y P E R S E C R E T O R Y
CONDITIONS (eg. Zollinger-Ellison Syndrom e)
Recomm ended adult oral dosage: 300 m g four
times a day with meals and at bedtim e. In som e
patients, it may b e necessary to administer 3 00 mg
doses more frequently to control symptoms.
D osage should b e adjusted to individual patient
needs, but usually should not exceed 2400 m g per
day. If intravenous administration is required, the
dosage schedule should b e the same as that rec
ommended for control of upper gastrointestinal
bleeding.
SP EC IA L C A SES
In patients in whom control of gastric acid secre
tion is desirable, the recom m ended oral dosage of
'Tagamet' is 300 mg four tim es a day, with meals
and at bedtime. If intravenous administration is
required, th e dosage schedule should b e th e same
as that recom m ended for control of upper gastro
intestinal bleeding.
Stability of injectable form: Tagam et' Injection
when added to or diluted with most intravenous
solutions, such as Sodium Chloride Injection
(0.9%) or D extrose Injection (5% or 10%), is stable
for 48 hours at normal room temperature.
'Tagamet' Injection should not b e refrigerated.
AVAILABILITY
Tablets: Pale green, circular, biconvex, film
coated tablets, each containing cimetidine 300 mg
(monogrammed S K F T13). Bottles of 100 tablets.
Injection: E ach 2 ml dose contains cim etidine
HC1 eouivalent to 300 mg of cimetidine, in S terile
Water for Injection. Preserved with phenol, 0.5%.
Ampuls of 2 ml, packaged in 10's.
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Bibliography available to physicians and pharma
cists upon request.
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Involvement of Small Intestine in Familial Polyposis Coli
D A. W a r m in g to n ,

R.B. P assi,

m b , b c h , f f pa t h , m r c path and

Extracolonic intestinal manifestations
of familial polyposis coli have been
described in recent years, but the
exact frequency is still unknown.
To date the more common sites of
extracolonic polyposis appear
to be stomach and duodenum with true
adenomas being somewhat rare in jeju
num and ileum. The authors report a
further two cases of ileal polyposis in
siblings from a family with familial
polyposis coli and conclude that
this condition cannot be
considered as a disease exclusively
of the large bowel. They emphasize
that examination of the upper
gastrointestinal tract and small
bowel must be included in the investiga
tion and follow-up of patients with
familial polyposis coli.
Les manifestations intestinales extracoliques de la polypose colique
famiiiale ont ete decrites au cours
des dernieres annees, mais leur
frequence exacte demeure inconnue. A
ce jour, les foyers les plus communs de polypose extracolique
semblent etre I’estomac et le duodenum,
alors que les adenomes veritables
sont quelque peu rares dans le jejunum
et I'ileon. Les auteurs signalent deux
nouveaux cas de polypose ileale
chez des membres d'une famille
atteinte de polypose colique famiiiale,
et ils concluent que cette
maladie ne peut pas etre consideree
comme une maladie du gros intestin
exclusivement. Ils soulignent que
I'examen des voies gastro-intestinales
superieures doit etre inclus dans I’investigation et le controle ulterieur
des patients souffrant de polypose
colique famiiiale.

md,
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gested that the two conditions are the lications, from the Japanese group in
same disease.1
particular, have drawn attention to the
The existence of extracolonic lesions, occurrence of stomach, duodenal and
in the form of stomach and small bowel small bowel involvement in cases of
polyposis, in cases of familial polyposis familial polyposis coli.1,68
coli is a notion which, until recently,
Whether the generalized polyposis
was not generally accepted. The classic represents a variant of the common
concept of familial polyposis has been form of the disease as we know it,8
one of large bowel involvement with or whether, as the Japanese workers
little or no expectation that polyps will and others have suggested, the ap
be present in the rest of the bowel; parent dearth of such cases merely
at best the occurrence of polyps in represents a failure to detect the condi
the upper gastrointestinal tract of these tion, are points still to be clarified.
patients was thought to be extremely
With regard to anatomical distribu
rare, if indeed it ever occurred.2,3
tion of the extracolonic polyps, recent
Hauser was the first, in 1895, to publications support the apparent trend
describe the presence of multiple indicated by earlier reports that the
polyps of the stomach and small intes stomach and duodenum are the most
tine in a case of familial polyposis coli.4 common sites followed by jejunum and
Over the next 75 years, sporadic re ileum. At present, the ileum in cases of
ports of this phenomenon were pub familial polyposis coli appears to be
lished as is aptly demonstrated in the (he least common of these extracolonic
analysis of Hoffman and Goligher5 in sites of polyposis. We present a fur
1971. According to the figures they ther two cases of ileal involvement.
obtained, the commonest sites for extra The patients, a man and a woman,
colonic polyp formation were stomach were siblings from a family with known
and duodenum in 11 and 10 instances familial polyposis.
respectively, followed by jejunum and
Case Reports
ileum with 5 reported instances in
each. (These figures represented a filCase 1.— In 1952 at the age of 26
tered-down analysis of the literature to years, on the basis of existing familial
that time, with exclusion of cases not polyposis, a 52-year-old man had underclearly examples of familial polyposis.)
More recently, a number of pub-

Familial polyposis coli is a well-known
condition inherited through autosomal
dominant transmission and character
ized by multiple adenomatous polyps
of the large intestine. The disease may
be associated with Gardner’s syndrome
(hyperplasia and neoplasia in other
tissues) and indeed, it has been sugFrom the divisions of pathology and
surgery, University Hospital, University
of Western Ontario, London, Ont.
Reprint requests to: Dr. D.A. Warmington,
Health Sciences Centre, Department of
pathology, University of Western
Ontario, London, Ont. N6A SCI
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FIG. 1— Ileal villotubular adenoma
(hematoxylin and eosin, reduced by
50% from X100).
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FIG. 2— Ileal adenoma with admixture
of normal and abnormal glands (hema
toxylin and eosin, reduced by 51 %
from X 100).
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gone colectomy and ileorectal anastomosis.
Following the operation and in the interim
period of 26 years, recurring rectal polyps
were dealt with by means of electrofulguration and the patient remained clinically
well. In February 1978 a segment of bowel
including a 2.5-cm ileal cuff was removed
because of a carcinoma found at the up
per end of the rectal stump. In addition
to the carcinoma, the rectal mucosa con
tained numerous polyps, ranging from 2
to 6 mm in diameter. Close inspection
of the ileal cuff disclosed a diffuse
nodularity of the mucosal surface; in
dividual nodules did not exceed 1 to 2
mm in size. Histologic examination con
firmed the presence of a rectal carcinoma
with involvement of paracolic lymph
nodes. The rectal polyps were tubular
adenomas with no evidence of malignant
change. Sections from the ileal cuff (Figs.
1 and 2) clearly demonstrated further
adenoma formation, but now unequiv
ocally involving small intestinal mucosa.
The polyps were in close proximity to
each other, in some instances with only
a microscopic segment of normal mucosa
intervening. The majority of the lesions
were of simple tubular pattern, occasion
ally with villotubular variation. In each
instance Paneth cells were readily iden
tified in adjacent mucosa. Loss of mucosal
villi was an early feature in some areas
and the surface of these lesions was
moderately flat. The overall appearance
of the small bowel adenomas was iden
tical to that of their large bowel equiva
lents. No evidence of malignant change
was found in the small bowel polyps.
The intervening segments of ileal mucosa
were histologically unremarkable.

anastomosis 24 years previously. As was
the case with her brother, follow-up man
agement had been that of frequent ob
servation with fulguration of recurring
rectal polyps. In March 1978 on the basis
of dysplastic changes found in several
polyps recently removed, an abdomino
perineal resection was performed. Nu
merous adenomas were present in the
rectal mucosa and a superficial carcinoma
was also found on histologic examination.
The accompanying ileal cuff (2 cm in
length) demonstrated a patch of mucosal
granularity measuring 0.3 cm in maximal
dimension. Histologic examination of
this granular area (Figs. 3 and 4) dem
onstrated small bowel tubular adenomas.
In this instance the ileal lesions were
not as numerous as in the case of her
brother and some of the polyps contained
lymphoid deposits deep to the adenomas.
Further histologic study of the lesions
revealed that they were identical to the
small bowel lesions seen in case 1 and
to their large bowel counterparts. The
remainder of the ileal mucosa was free
of adenomatous change.
Discussion and Conclusions

With regard to the microscopic
morphology of ileal polyps in cases of
familial polyposis, previously docu
mented cases frequently demonstrated
marked lymphoid hyperplasia, either
alone or in combination with true
adenomas.6'7'9,10 Of our two patients,
the brother had true adenoma form a
tion while the sister had lymphoid hy
perplasia in association with adenomas,

Case 2.—Following the diagnosis of
familial polyposis at the age of 15
years, this 39-year-old woman, the
sister of the patient in case 1, had
undergone total colectomy with ileorectal

but this did not account for false polyp
formation on its own. (Two other
members of this family have marked
ileal lymphoid hyperplasia but without
true adenoma formation.)
The concept that familial polyposis
is exclusively a disease of large bowel
can no longer be accepted1,5"8 and we
have presented two further cases of
ileal adenoma form ation in patients
with familial polyposis coli. These
findings emphasize the need for upper
gastrointestinal tract and small bowel
examination, both as part of the ori
ginal work-up and in the follow-up
of patients with familial polyposis coli.
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'Nipride' is indicated for producing controlled hypotension during
anesthesia to reduce bleeding in surgical procedures where deemed
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individual basis.
Contraindications
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in water without preservatives. Not for direct injection. Infusion rates
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Fatalities due to cyanide poisoning have occurred following sodium
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be helpful if too high levels of thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect
of sodium nitroprusside than are normotensive subjects. Patients
receiving concomitant antihypertensive medications (especially
hydralazine or hexamethonium) are more sensitive to the hypotensive
effect of sodium nitroprusside and the dosage of 'Nipride' should
be adjusted downward accordingly.
The following Warnings apply to the use of 'Nipride' for controlled
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dimin
ished. If possible, preexisting anemia and hypovolemia should be
corrected prior to employing controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation
perfusion ratio. Patients intolerant of additional dead air space
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partial pressure.
4. Resistance and tachyphylaxis occur more frequently in normoten
sive patients infused with sodium nitroprusside. Induction of delib
erate hypotension in healthy young individuals may prove to be
more difficult than in other segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the
purpose of controlled hypotension during anesthesia a rebound
hypertension has been observed on rare occasions.

Adequate facilities, equipment and personnel should be available
for frequent and vigilant monitoring of blood pressure. When the infu
sion is slowed or stopped, blood pressure usually begins to rise imme
diately and returns to pretreatment levels within one to ten minutes.
It should be used with caution and initially in low doses in elderly
patients, since they may be more sensitive to the hypotensive effects
of the drug.
If, in the clinical situation, stress induced by pain or manipulation
is reduced or eliminated during 'Nipride' infusion, the patient could
experience a greater than expected reduction in blood pressure
unless the rate of infusion is adjusted downward as required.
‘Nipride’ tends to deteriorate in the presence of light. Therefore, the
infusion bottle should be wrapped with aluminum foil or other opaque
material. Solutions of 'Nipride' should not be kept or used longer
than four hours. 'Nipride' in aqueous solution yields the nitroprusside
ion, which reacts with even minute quantities of a wide variety of
organic and inorganic substances to form usually highly coloured
reaction products (blue, green or dark red). If this occurs, the infusion
should be replaced as quickly as possible.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache,
restlessness, agitation, muscle twitching, retrosternal discomfort and
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo
minal pain, confusion and somnolence have been noted with too
rapid reduction in blood pressure. These symptoms rapidly disap
peared with slowing of the rate of infusion or temporary discontinua
tion of infusion and did not reappear with continued slower rate
of administration.
Irritation of the injection site may occur. Methemoglobinemia and
one case of hypothyroidism following prolonged therapy have been
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing
deliberate hypotensive surgery must be restricted to carefully
selected cases. There is a possibility of an abnormal response
occurring in normotensive patients. In this event, the infusion of
‘Nipride’ should be discontinued immediately. (See Warnings).
The contents of a 50 mg ‘Nipride’ vial should be dissolved in 3 ml
of sterile dextrose in water without preservatives. No other diluent
should be used. Depending on the desired concentration, all of the
prepared stock solution should be diluted in 500 or 1000 ml of 5 per
cent sterile dextrose in water and promptly wrapped in aluminum
foil or other opaque material. Both stock solution and infusion solu
tion should be freshly prepared and any unused portion discarded.
The freshly prepared solution for infusion has a very faint brownish
tint. If it is highly coloured, it should be discarded. (See Precautions).
The solution should not be kept or used longer than four hours from
initial reconstitution. The infusion fluid used for the administration
of ‘Nipride’ should not be employed as a vehicle for simultaneous
administration of any other drug.
Nipride' dosage varies considerably from patient to patient, hence
the need for individual titration. The infusion should be started at
the lower dosage range, 0.5 ug/kg/m inute and increased by
0.2 /ig/kg/m inute every 5 minutes until the desired reduction in
blood pressure is obtained. The blood pressure usually starts to drop
immediately or at least within a few minutes. Continuous monitoring
of the blood pressure is necessary. Blood pressure should not be
allowed to drop at too rapid a rate and systolic pressure should not
be lowered below 60 mm Hg.
1
Infusion rates greater than 8 /xg/kg/minute should rarely be used.
The maximum recommended dose is 800 fig/m inute.
'Nipride' should be administered by an infusion pump, micro-drip
regulator or any similar device that will allow precise measurement
of the flow rate. Avoid extravasation. The rate should be adjusted
to maintain the desired hypotensive effect, as determined by frequent
blood pressure determinations.
For the use of 'Nipride' in the treatment of hypertensive crises please
refer to the Product Monograph.
Supply
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The safety of 'Nipride' in women who are or who may become preg
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Early Surgical Management of Acute Cholecystitis
Stuart D. A rchibald,

Between 1971 and 1977, 361 patients
underwent early elective cholecystec
tomy for acute cholecystitis, and the
complications and mortality were
studied according to the length of
time from admission to operation. A
substantially greater proportion of the
complications, and the only
deaths, occurred in the patients operated
upon more than 7 days after admission.
The mortality rate was 0.6%. Nine
additional high-risk patients under
went cholecystostomy. There were
four postoperative deaths in this group,
all related to the debilitating under
lying conditions. The mortality for the
entire series was 1.6%. These results
compare favourably with those follow
ing delayed elective operations for
acute cholecystitis. Early elective
operation, using cholecystectomy when
possible and cholecystostomy when
necessary, is recommended for general
use in experienced hands. This practice
is safe and sound particularly when the
diagnosis is made more certain preoperatively by the use of intravenous
cholangiography.
Entre 1971 et 1977, 361 patients ont subi
une cholecystectomie non urgente
precoce pour cholecystite aigue, et les
complications et la mortalite ont ete
etudiees en fonction de I'intervalle
ecoule entre I'hospitalisation et
('operation. Un nombre significativement
plus grand de complications et les
seuls deces sont survenus chez
les patients operes plus de 7 jours
apres I'hospitalisation. La mortalite a
ete de 0.6%. Neuf autres patients
a risque eleve ont subi une cholecystostomie. II y eut quatre deces postoperatoires dans ce groupe, tous relies
aux maladies debilitantes intercurrentes.
Pour cette serie, la mortalite globale
a ete de 1.6%. Ces resultats se
comparent favorablement a ceux qui
suivent des operations non urgentes
retardees pour cholecystite aigue.
Une operation non urgente precoce,
recourant a la cholecystectomie si
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possible et a la cholecystostomie si
necessaire est recommandee pour
utilisation generate entre des mains
experimentees. Cette pratique est
sure et valable, surtout lorsque le
diagnostic est rendu plus certain,
avant I'operation, par I'emploi de la
cholangiographie intraveineuse.

There has been continued dispute over
the timing of operation in the manage
ment of acute cholecystitis. Three ap
proaches have been recognized: emer
gency operation, delayed elective oper
ation and early elective operation. Op
eration carried out as an emergency,
formerly recommended when it was
thought that the treatment of acute
cholecystitis ought to parallel that of
acute appendicitis,1 is now usually
reserved for salvage of deteriorating
patients who initially have been man
aged expectantly.2 Delayed elective
operation is that performed 6 to 12
weeks after the conservatively managed
acute cholecystitis has subsided. Propo
nents of this approach3 argue that
operations can then be performed after
elective investigation, when patients
have finally recovered from the acute
cholecystitis and at a time when opera
tion is easiest. Early elective operation
consists of definitive surgery, performed
in the first few days of the acute at
tack, as soon as the diagnosis is estab
lished and the patient optimally pre
pared.4
During the past 9 years at St.
Michael’s Hospital, Toronto, acute
cholecystitis has been managed by early
elective operation and now constitutes
the most common reason for laparo
tomy in acute abdominal conditions.
Most cases have been treated by
cholecystectomy, with cholecystostomy
reserved for the few patients whose
general condition was unusually pre
carious. A review of our experience in
the 7-year period 1971 to 1977 is
presented to assess the morbidity and
mortality associated with this ap
proach.
Patients and Method

A retrospective review was conducted
of all patients in whom acute chole
cystitis was diagnosed between Jan. 1,
1971 and Dec. 31, 1977, inclusive,
VOLUME 22, NO. 5, SEPTEMBER 1979
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and who underwent operation during
the acute illness. There were 370
patients; 211 were female and 159
were male, giving a femaleimale of
1.3:1. Their ages ranged from 17
to 89 years (means 51 years) and
140 (38%) patients were over 60
years of age. The diagnosis was made
clinically. In most recent cases, the
diagnosis was confirmed preoperatively
by 2-hour infusion cholangiography,5
with tomography at the completion of
the infusion and 6 hours later. At
operation, the morphologic changes of
acute cholecystitis were obvious in all
instances. The patients who had
cholecystectomy were grouped accord
ing to the time at which operation
was performed after admission to hos
pital. The time of admission to hos
pital rather than of the onset of symp
toms was selected as the starting point,
because the latter could not be ac
curately determined from the records
in all cases. In the great majority of
those for whom this could be ascer
tained, the duration of symptoms be
fore hospitalization was less than 24
hours. In order to determine whether the
timing of early elective operation sig
nificantly influenced morbidity or mor
tality, the 361 patients who underwent
cholecystectomy were studied in three
groups: group 1, 199 patients who
were operated on within 72 hours of
admission; group 2, 121 patients who
underwent operation between 72 hours
and 7 days after admission; and group
3, 41 patients who were subjected to
operation more than 7 days after
admission.
In the last group, the delay of oper
ation usually occurred in patients ad
mitted to a nonsurgical service with
unrecognized cholecystitis, and the
longest time interval from admission to
operation was 18 days. Thus group 3
does not include any patients who had
“delayed elective operation” as defined
above.
There were only nine cholecystostomies, too few to allow analysis by
groups, and these are considered
separately.
Results

Intravenous cholangiography was
performed in 192 patients and gave
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“positive” results in 157 (82%), show
ing lack of filling of the gallbladder
but opacification of the extrahepatic
biliary tree on tomography. Twentyeight studies failed to demonstrate
either the gallbladder or bile ducts.
There were no false-positive results.
Only seven examinations gave false
negative results, in which the gallblad
der was opacified, but the diagnosis of
acute cholecystitis was nevertheless
confirmed at operation, which was per
formed because of clinical findings.
Thus in the cases in which the biliary
tree was demonstrated, cystic duct ob
struction was diagnosed with 96%
accuracy. Only one serious allergic
reaction occurred and this readily re
sponded to treatment.
Cholecystectomy alone was per
formed in 282 patients, and both
cholecystectomy and exploration of
the common bile duct in 79 (21%).
All patients had intraoperative assess
ment of their extrahepatic ducts and
an operative cholangiogram was ob
tained when indicated, using the same
criteria as in an elective cholecystec
tomy.
Postoperative complications (Table
I) were most common in group 3 and
of similar frequency in groups 1 and
2. Wound infection was the most fre
quent complication and was minor in
all cases. Bile drainage was prolonged
in four patients; in one patient it was
due to a dislodged T tube and caused
peritonitis, requiring reoperation. In
none of these cases did retained com
mon bile duct stones coexist. How
ever, three other patients had retained
stones. Three patients had either a
subhepatic or subphrenic abscess. In
two of these the presentation was in
the early postoperative period; the
third patient presented 3 months postoperatively with obstructive jaundice
from extrinsic compression of the com
mon bile duct (no retained stones were

found). Rare complications were pneu
monia, atelectasis, myocardial infarc
tion, pulmonary embolism, septicemia,
rectus sheath hematoma qnd postoper
ative urinary retentior. The overall
complication rate was 11.9%.
The mean hospital stay was 11.1
days.
There were two deaths in the series,
both in group 3, giving a mortality
within the three groups of 0.6%. One
82-year-old woman died of myocardial
infarction as the culmination of a
stormy course which included the de
velopment of a subphrenic abscess.
The other patient was an elderly man
who had a prolonged course of sepsis
preoperatively, before transfer from
another hospital. The operation, which
was undertaken shortly after treat
ment was
instituted
for
septic
shock, was followed by multiorgan
failure.
Nine cholecystostomies were per
formed, constituting 2.4% of our op
erations for acute cholecystitis. The
mean age of patients in this group
was 69 years. Three of the patients
were admitted to hospital for another
reason, and acute cholecystitis devel
oped during their hospitalization. The
hospital stay for the other six patients
averaged 35.8 days. In every case,
cholecystostomy was done because of
the very poor general condition of
the patient. In no instance was chole
cystostomy performed because of the
technical difficulty of cholecystectomy.
Operation was carried out under local
anesthesia in three patients. Four
(44%) of the nine patients died postoperatively, raising the overall mortali
ty to 1.6% for the entire series of
patients.
Discussion

One of the objections to early oper
ation in acute cholecystitis has been

T a b le l — P o sto p erative Com plications A ffe c tin g 361 P atien ts fo llo w in g E arly Elective
C holecystectom y
Group
1
C om plications

(n = 199)

2
(n = 121)

3
(n = 41)

T o ta l
(N = 361)

11
1
2
2
1
0
0
0
0
0
0

6
1
0
0
1
0
1
1
0
1
0

6
2
1
1
1
1
0
1
1
0
1

23
4
3
3
3
1
1
2
1
1
1

17

11

15

43

Wound infection
Prolonged bile drainage
R etained common bile duct stones
In tra p e rito n e a l abscess
P neum onia or atelectasis
M yocardial infarction
Pulm onary em bolism
Septicem ia
Rectus sheath hem atom a
U rin a ry retention
M u ltio rg an fa ilu re
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the performance of unnecessary proce
dures because of the inability to make
a definitive diagnosis on clinical
grounds alone.3 The intravenous cho
langiogram, in our experience, supplies
valuable confirmatory evidence of
cystic duct obstruction in acute chole
cystitis and may reveal stones within
the common duct. No inference can
be drawn from a cholangiogram that
fails to demonstrate either ducts or
gallbladder. Using the slow infusion
technique, adverse reactions to the
contrast media have been minimal.5
We do not recommend that intrave
nous cholangiography supplant opera
tive cholangiography when the latter
is otherwise indicated. Some authors6
have reported that ultrasonography is
a useful, noninvasive, diagnostic study
in acute cholecystitis, which can dem
onstrate stones within the gallbladder,
and sometimes hydrops, perforation
and abscess. However, this test does
not assess gallbladder function or cys
tic duct obstruction. Its role in acute
cholecystitis remains undetermined.
An important finding in the present
series was the absence of damage to
the hepatic vessels or bile ducts. Simi
larly, no such injuries were reported
in other series7,8 when early elective or
emergency operation2 was employed.
We found no prohibitive technical dif
ficulties in doing the definitive sur
gery. This agrees with the findings
of others, who have noted the ready
plane for dissection provided by the
edema of the acute inflammation, in
many cases.9 In the uncommon event
that technical difficulties render chole
cystectomy or exploration of the com
mon bile duct too hazardous, chole
cystostomy, with drainage of the com
mon bile duct when necessary, pro
vides a reasonable temporizing proce
dure.10,11 However, our decision to per
form a cholecystostomy was made
preoperatively in every case, based on
the predicted inability of the patient
to withstand a more major procedure.
The deciding factors were the presence
of other serious medical conditions
and advanced age. These factors are
known to increase morbidity and mor
tality.3’11 In none of the patients who
died after cholecystostomy was death
caused by a biliary complication, such
as inadequate drainage in the presence
of unrecognized ascending cholangitis,
a danger previously reported.1214 Some
surgeons15 have recommended more
frequent use of cholecystostomy in man
aging acute cholecystitis. However, with
this approach, the surgeon cannot as
sess the biliary tree thoroughly (parti
cularly when local anesthesia is em
ployed for the procedure) and there is a
risk of stones being retained in the
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gallbladder or common bile duct (in
27% of patients according to one
report16), or both. Also this operation
may be attended by specific complica
tions accounting for significant mor
bidity and mortality,17 which, in many
cases, necessitate a second definitive
procedure.10 F or these reasons, the use
of cholecystostomy in the early elective
operative management of acute chole
cystitis should be limited.
Postoperative complications were
more common in our series when op
erations were performed more than
7 days after admission to hospital,
an observation also made by others.9
When operations were delayed up to
7 days after admission there was no
significant difference in complication
rates. This supports the concept that
early elective operations should be
done as soon as the patient can be
adequately
prepared.8,18
Although
Wright and Holden18 noted an increase
in morbidity and mortality if an early
elective operation was delayed more
than 4 days after the onset of symp
toms, and M cArthur and associates8
reported occasional technical difficul
ties when operating more than 4 days
after the onset of the disease, neither
Essenhigh19 nor van der Linden and
Sunzel20 found any optimal time period
for early operation. These varied re
sults may simply reflect the differences
in criteria used for the timing of oper
ation. Early elective operation and de
layed operation have been attended
by similar complication rates.7,21 How
ever, when early elective operation is
performed without delay other than
that required for proper resuscitation
and diagnostic measures, the number
of emergency procedures performed
while patients are deteriorating will
decrease. The frequency of unex
pected urgently performed procedures
in worsening patients, reported to
be as high as 30% ,22 is a recognized
shortcoming of conservative manage
ment; this may necessitate an increase
in the number of cholecystostomies
performed, and consequently an in
crease in morbidity and mortality.2
One of the advantages, verified in
the present study, of early operative
treatment over delayed elective oper
ation in acute cholecystitis, has been
the shortened hospital stay7,8,21,23 with
consequent socioeconomic benefit. F ur
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thermore, elective definitive operation
carried out early obviates the risk of
recurrent attacks of cholecystitis,7 each
with its pain and attendant dangers,
such as perforation of the gallbladder,
and avoids the problem of patient
refusal of a delayed elective operation
which has been reported in up to
25% of patients.7
Finally, like others, we have shown
that early elective operation for acute
cholecystitis can be performed with
as low a mortality as delayed elective
operation.7’10,18
F or these reasons, we believe that
the early elective operative approach to
to the treatment of acute cholecystitis is
a safe and sound practice and we ad
vocate its general use in experienced
hands. It avoids the dangers associated
with delay, exposes the patients to no
increased morbidity or mortality, and,
when patients are adequately prepared,
carries a minimal risk of unnecessary
operation and shortens the period of
hospitalization, thus reducing cost. We
believe that cholecystostomy retains a
place in patients whose general condi
tion is jeopardized by other serious
illness, or in the rare instance in which
technical operative difficulties prohibit
cholecystectomy.
Summary

Three hundred and sixty-one cases
of acute cholecystitis were treated by
definitive early surgery. The complica
tion rate was 11.9%
and the
mortality 0.6% . Complications and
mortality were greater when opera
tion was deferred for more than 7 days
following admission. Nine high-risk
patients were treated with cholecystos
tomy, with a mortality of 44% . Deaths
were due to the associated conditions.
Intravenous cholangiography was a
useful diagnostic adjunct. Our experi
ence is supported by the recent litera
ture.
We thank Dr. Donald J. Currie for
his constructive suggestions in the pre
paration of the manuscript.
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Septicem ia in cancer.
when do

tsults are critical...

Pyopen
Pseudomonas aeruginosa has long been recognized as a major cause of septicemia in cancer patients.1
However, the introduction of PYOPEN* (carbenicillin) has had a significant impact on the management of
these infections.1The true value of PYOPEN can best be appreciated when the survival rate of patients with
Pseudomonas septicemia treated with PYOPEN is compared with the survival rate of those treated with
gentamicin or polymyxin.
Ten days after onset of infection, over 80% of patients treated with PYOPEN were still alive compared to
only 50% of those who had been treated with gentamicin and 28% who were treated with polymyxin.1
PYOPEN is a better choice for the treatment of septicemia particularly in immunosuppressed cancer patients.
1. Bodey, Gerald P. and Victorio Rodriguez, Advances in the Management of Pseudomonas aeruginosa Infections in Cancer Patients, Europ. J. Cancer, Vol. 9, pp. 435-441,
Pergamon Press 1973. For brief prescribing information see page 489
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Aspirin Prophylaxis of Venous Thromboembolic Disease
following Fracture of the Upper Femur
G .M . C hannon, b sc, m b , ch b , frcs( edin )* and A .M . W iley , m b , m ch , frcs, FRcsfc]f

In a prospective study of 51 patients
w ith fractures of the femoral neck,
aspirin was used as a prophylactic
measure against thromboembolic
disease.
Thrombi were detected by cuff
impedence plethysmography, Doppler
ultrasonography and ascending
venography. Thrombi were identified
in 20 (39.2% ) of the patients. There
was no significant difference between
the frequency with which thrombi
occurred in men and in women. Blood
salicylate values were the same for
patients who had and who did not have
thrombi. There were no instances of
pulmonary embolism. The frequency
of deep vein thrombosis was
comparable to that in a previous series
of untreated patients from the same
centre. It appears from this study that
in these cases prophylaxis against
venous thromboembolism using aspirin
in a dosage of 600 mg b id is ineffective.
Dans une etude prospective chez 51
patients souffrant d'une fracture du
col femoral, I’aspirine a ete utilises
comme mesure prophylactique des
accidents thromboemboliques.
Les thrombi ont ete deceles
par plethysmographie a impedance,
par ultrasonographie de Doppler
e t par phlebographie ascendante.
Des thrombi ont ete identifies
chez 20 (39.2% ) des patients. II
n’y a eu aucune difference signi
ficative entre la frequence des thrombi
observes chez les hommes et chez
les femmes. Les salicylemies etaient
les memes chez les patients qui
ont eu des thrombi et chez ceux qui
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n’en ont pas eu. II n'y a eu aucun
cas d'embolie pulmonaire. La frequence
des thromboses veineuses profondes
a ete comparable a celle d’une
serie precedents de patients non
traites du meme centre. De cette
presente etude, il semble que I’aspirine
a la dose de 600 mg deux fois par
jour soit inefficace comme prophylaxie
des thromboembolies veineuses
dans ces cas.

Venous thromboembolism is a frequent
complication in current surgical prac
tice, particularly in orthopedic surgery
after procedures on the hip joint. The
frequency o f fatal pulmonary embolism
has been reported as approximately
2 % after hip arthroplasty1,2 and at
least 5 % 3,4 after hip fractures. A fre
quency o f deep vein thrombosis as
high as 57% has been reported after
knee surgery5 and 47% after tibial
fractures.6 In hip surgery the high fre
quency is due to severe predisposing
factors including age, obesity, limited
mobility, reduced venous flow, exten
sive trauma and the duration o f the
surgical procedure.7
In recent attempts to prevent this
condition, drugs that alter platelet ac
tivity received considerable attention.
Venous thrombi were thought to be
form ed by the enmeshment o f red
blood cells in a fibrin lattice. However,
histologic studies have shown platelet
aggregates, which suggest that they
have a role in the initiation o f throm
bosis.8,9 Some platelet studies support
this concept.10,11
O f the drugs used to alter platelet
activity, aspirin has been most often
studied, because it is easy to use, is in
expensive and has few side effects. The
results, however, have been contro
versial. After general surgical proce
dures Clagett and associates12 showed
a beneficial effect o f aspirin using
phlebography for diagnosis. Loew and
associates13 and Weber, W o lff and
Bromig14 had a similar result in
patients who underwent general sur
gery. In studies on orthopedic patients,
Harris and colleagues15 found aspirin
as effective as warfarin (using phlebo
graphy for diagnosis), and Jennings,
Harris and Sarmiento16 showed clin
ically that thromboembolic phenomena
were reduced by using aspirin. Hey
and associates17 used ultrasonography
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and demonstrated a lower rate o f
thrombosis after giving acetylsalicylic
acid, and Zekert, Kohn and Vormittag18
reported a substantial reduction in the
number o f patients who had fatal pul
monary embolism. M ore recently, Har
ris and associates19 have reported a
protective effect o f aspirin after hip
surgery in men older than 40 years.
However, some workers20,21 believe
that aspirin does not exert an anti
thrombotic effect. The Medical Re
search Council trial22 showed no bene
ficial effect and this was supported by
the recent study o f Stamatakis and
associates.23
Our study investigated the effect o f
aspirin prophylaxis on a high-risk group
o f patients who were admitted to T o 
ronto Western Hospital with fractures
o f the femoral neck and trochanteric
regions. These patients were investi
gated postoperatively by flow studies
and venography. We hoped also to
demonstrate any sex variation that
might exist in the degree o f protection
provided by aspirin therapy.

a

\
i

A

*
Patients and Methods

All patients admitted to the Toronto
Western Hospital between Jan. 1, 1978
and June 30, 1978 with a fracture o f
the femoral neck or subtrochanteric
region were considered for inclusion
in the study. Patients excluded were:
those with proven peptic ulceration or
aspirin sensitivity, those receiving anti
coagulants or steroids for intercurrent
disease and those receiving a high reg
ular dose o f aspirin for any condition,
patients known to have blood dyscrasia
and those who had undergone surgical
treatment o f varicose veins o f the lower
limb which would make subsequent
phlebograms difficult to assess. Fiftyseven patients entered the study, but 6
were later dropped (3 died within 10
days o f operation from unassociated
conditions, venography could not be
performed on 2 because o f peripheral
vascular disease and dye sensitivity
and 1 patient was removed from the
trial when a history o f peptic ulcera
tion was obtained from a relative).
Fifty-one patients (11 men, 40 wom 
en) were therefore available for study.
Their ages ranged from 47 to 99 years
(mean 77 years).
On admission, treatment was started
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In the past,penicillins were not considered as products of first choice in the treatment of anaerobic infections, such as
bacteroides, and consequently, other potentially more toxic therapeutic agents were used.
Now, PYOPEN* (carbenicillin), one of the newer broad-spectrum semisynthetic penicillins, offers advantages previously
unavailable in this type of therapy.
Recent studies1-2-3have shown that PYOPEN is effective in 94.1% of cases of pelvic infections due to anaerobic and/or
mixed gram-negative aerobic infections. PYOPEN is not only effective, it is also free from dose-related toxicities, and
provides the traditional margin of safety common to all penicillins.
So, for relatively safe and convenient therapy for both aerobic and anaerobic infections, whether single or mixed...
consider PYOPEN.

W-

1. Swenson. Robert M. and Bennett Lorber, Antimicrobial Agents and Chemotherapy. Vol. 9. No. 6, June 1976. pp. 1025-1027.
2. Fiedelman. William and C. Douglas Webb, Current Therapeutic Research, Vol. 18. No. 3. September 1975, pp. 441-451.
3. Thadepalli. Haragopal, Current Therapeutic Research, Vol. 20, No. 4. October 1976, Section 2, pp. 589-603.
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with aspirin (600 mg of buffered acetylsalicylic acid orally bid). If for any
reason oral administration was not
possible before operation, aspirin sup
positories were given using twice the
oral dose (1200 mg). Before adminis
tering the medication we took blood
samples in a search for unsuspected
side effects of aspirin and also per
formed a salicylate assay. The time
between injury and operation was
noted. The time spent in hospital be
fore operation averaged 2.5 days (in
cluding delays of 9 to 14 days in three
patients because of general medical
conditions).
All but five fractures were sustained
within the home. All types of femoral
neck fracture were included: subca
pital (18 fractures), basal (4 fractures)
and trochanteric or subtrochanteric (29
fractures). The method of repair used
was dictated by the current treatment
practice, so that there were 14 patients
who underwent femoral head replace
ment (Austin Moore prosthesis inserted
by the “Southern exposure” with the
patient lying on one side) as well as
those who had internal fixation by nail
plate (30 patients), Enders nails (5 pa
tients) and Knowles pins (2 patients).
At operation, the patient position
used, the presence of anesthetic hypo
tension and duration of surgery were
recorded, together with the measured
blood loss, amount of fluid replaced
and any tendency for increased
oozing at the operative site. Hypoten
sive anesthesia was not employed and
no other prophylactic anticoagulant
measure was applied intraoperatively.
In the postoperative period the dura
tion of bed rest before mobilization was
recorded. Patients were again given
aspirin (600 mg bid). Each patient un
derwent a screening test for platelet
aggregation with epinephrine to ensure
that aspirin had been absorbed and to
demonstrate an alteration in platelet
activity. Blood was taken for salicylate
assay 24 hours and 8 days after oper
ation.

Doppler recordings were made from
the common femoral vein, popliteal
vein and posterior tibial vein at the
ankle. Positive results were recorded
when there was no signal, suggesting
complete occlusion, or an abnormal
signal, suggesting obstruction proximal
to the recording site.
Impedence plethysmography was car
ried out using a two-cuff technique.
The presence of deep vein thrombosis
was diagnosed by variation in the
maximum venous outflow, which sug
gests high resistance collateral flow.
The method of venography was es
sentially that of DeWeese and Rogoff.24
To overcome the problems associated
with this technique when used in el
derly patients, a tilting table with cen
tre prop was used. Renografin-76® in
dextrose was infused through an intra
venous line in the dorsum of the foot.
Films were taken with the table tilted
at 30° from the horizontal, and a final
film was occasionally used with the
patient in a supine position. The criteria
for a diagnosis of venous thrombosis
were: the recognition of a well-defined
defect, and no visualization of popli
teal, superficial femoral or common
femoral veins with good visualization
of the proximal and distal veins, to
gether with the presence of collateral
vessels.
The end point of the study was the
presence or absence of a deep vein
thrombosis as diagnosed by veno
graphy. Patients with venographically
demonstrated lesions in femoral or pel
vic veins were given heparin by con
stant infusion and subsequently re
ceived anticoagulants orally. If the
thrombi were confined to calf veins, a
program of support and mobilization
was instituted. The presence of proven
pulmonary emboli (by blood gas meas
urements and lung scanning) was ac
cepted as presumptive evidence of deep
vein thrombosis. Management of these
patients was carried out according to
current practices.
For several reasons it was impos
sible to include a control group in this
study. Comparable untreated series
have been reported from this hospital
in which the patients were managed in
an identical way under the care of the
same surgical teams.4,25 They vary only
in a temporal way from the patients
in this study and therefore have been
used for comparison.

were carried out by a trained tech
nician in the flow laboratory associated
with the cardiovascular unit. All such
studies were followed within 24 hours
by venography. The results of the non
invasive techniques corresponded with
those of venography in 29 instances,
but in 10 others (all above the knee)
a positive result of Doppler study or
plethysmography, or both, was not
confirmed by venography (false posi
tives). On the other hand seven posi
tive results from venography (all be
low the knee) were obtained when the
noninvasive method gave a negative
result.
Results

The average operating time for in
sertion of a Moore prosthesis was 1
hour, 40 minutes and for a pin-andplate procedure, 2 hours. A number
of the patients were treated by residents
in training, while for others the staff
surgeon performed the operation.
Intraoperative blood loss was calcu
lated by weighing sponges and was
similar to that reported in previous
studies from this centre when no anti
coagulant was used.25 Excessive oozing
was not noted and serious wound
hematomas did not develop.
The patients were mobilized early
and, on average, were able to sit out
of bed 5 days after operation. Walking
on the affected leg was encouraged
on the 8th day for patients who had had
a pin-and-plate operation and on the
14th day for those who had had a
Moore prosthesis inserted.
Postoperatively the epinephrine ag
gregation test showed that aspirin had
altered platelet aggregation in each
case. Serum salicylate values varied
considerably ranging from 15 mg/dl
to 0.1 mg/dl (1.0860 mmol/1 to 0.0072
mmol/1. In four cases serum concen
trations were not measurable on at
least one occasion despite a positive re
sult from the platelet aggregation study.
The mean salicylate value was 3.5 mg/
dl (0.2534 mmol/1); in those who re
mained free of thrombi the mean value
Diagnosis
was 3.6 mg/dl (0.2606 mmol/1).
The diagnosis of deep vein throm
Thrombi were identified venograph
bosis was made using a combination
ically in 20 (39.2%) patients. In four
of techniques. The patients were
patients thrombi formed above the
assessed clinically on a regular
knee; two had numerous thrombi in
basis. If there was any suspicion of
the common femoral vein, one had a
deep vein thrombosis, venography was
small superficial clot in the superficial
performed immediately.
femoral vein and a fourth had throm
If there was no clinical suspicion of
bus
in the deep femoral vein.
Invasive and Noninvasive
the presence of a clot, a combined
Seventeen
patients had thrombi in
Investigations
flow study and ascending venography
the veins below the knee (sural, pero
Although it was not the purpose of neal, anterior and posterior tibial
were done in a 24-hour period 9 days
after operation, so that we could com this study to compare the accuracy of veins). In two patients thrombi devel
pare the diagnostic methods. The flow noninvasive techniques for studying oped in the long saphenous vein.
study comprised Doppler ultrasono venous flow with that of venography,
Heparin was given for femoral vein
graphy and cuff impedence plethysmo certain conclusions were obvious.
lesions. No thrombi were identified
graphy.
Doppler studies and plethysmography in the pelvic veins.
470
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Traditional treatments have all involved a significant risk of dose-related toxicities. The introduction of
PYOPEN'(carbenicillin) was an important therapeutic advance, providing the safety of penicillin, combined with
bactericidal effectiveness against Pseudomonas aeruginosa and other gram-negative organisms.
“...it would appear that carbenicillin is effective in modifying the course of a Pseudomonas
surface culture in bum patients.” 1

>■
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In severe and overwhelming Pseudomonas infections so often found in burn patients, PYOPEN provides a logical choice
of therapy—effectiveness without dose-related toxicities and the traditional margin of safety common to all penicillins.
So, for the treatment of Pseudomonas infections in burns... consider PYOPEN.
1. Copeland, C harles E., C a rb e n ic illin th e ra p y in burn p a tie n ts , Burn U nit, G eneral Surgery, M ercy H ospital,
P ittsburgh, Pa, U.S.A. Proceedings o f th e Sym posium N ew York, N.Y. J u ly 1 2 ,1969,Excerpta Medica F o u n d a tio n .
For b rie f p re scrib in g in fo rm a tio n see page 489
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Sex Ratio
Of the 11 men, thrombi formed in
4 (36.4% ); three clots were in calf
veins and one in the deep femoral vein.
In 16 (40% ) of the 40 women veno
graphy gave a positive result, 13 had
thrombi in calf veins, 3 at higher levels
(Table I).
N o instance of pulmonary embolism
was recorded during the study.
One patient suffered a cerebrovas
cular accident 8 days postoperatively
and a second incident 14 days later.
The first incident occurred while the
patient was receiving aspirin.

Discussion
The results of this study suggest that
aspirin in the dosage that we used has
no significant effect on the occurrence
of deep vein thrombosis in patients
after operation for fracture of the fem
oral neck. The diagnosis in each case
was based on venography, which is gen
erally accepted to be the best diagnostic
method available. In almost 40% of
our patients thrombi developed while
aspirin was being given. In previous
studies4,25 using the same facilities, sur
gical teams and diagnostic techniques
without prophylactic measures, the fre
quency of thrombosis was 40% and
49% . These figures are similar to those
in other reported studies.26,27
We could not demonstrate any sig
nificant difference in the incidence of
thrombi between men and women.
Throm bi developed in 4 (36.4%) of
11 men in this study compared with 16
(40% ) of 40 women. All the men were
about 40 years of age. The discrepan
cy between our figures and those of
other w orkers'9 cannot be completely
accounted for, even allowing for dif
ferences in the timing of investigation
and the diagnostic methods used.
A ttention has been directed to the
absence of pulmonary emboli in this
series. U nder the condition of this trial
an expected figure of 2.3% for pul
monary embolism did not materialize
although the number of cases is insuf
ficient to allow any firm conclusions
based on statistical significance. How
ever, it was possible that the “above
average” intensity of investigation of
the elderly patients prompted “earlier

than average” use of heparin, with its
attendant benefits.
This work was financed by a grant
from the Ontario Geriatric Research So
ciety to whom we extend our gratitude.
We also thank Dr. D. Pantalony, hema
tological service, Toronto Western Hos
pital, who provided invaluable guidance,
his staff and technical assistance in the
platelet studies and aspirin assays.
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In the past, penicillins were not considered as products of first choice in the treatment of anaerobic infections, such as
bacteroides, and consequently, other potentially more toxic therapeutic agents were used.
Now, PYOPEN* (carbenicillin), one of the newer broad-spectrum semisynthetic penicillins, offers advantages previously
unavailable in this type of therapy.
Recent studies123 have shown that PYOPEN is effective in 90.3% of cases of intra-abdominal infections due to anaerobic
and/or mixed gram-negative infections. PYOPEN is not only effective, it is also free from dose-related toxicities, and
provides the traditional margin of safety common to all penicillins.
So, for relatively safe and convenient therapy for both aerobic and anaerobic infections, whether single or mixed...
consider PYOPEN.
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Treatment of Unilateral Iliac Artery Disease
by Femorofemoral Bypass Grafting
N athan M. Sheiner,

Between Jan. 1, 1970 and June 30, 1977,
50 men and 23 women underwent
femorofemoral bypass grafting. The
average age of the group was 64.7 years.
The procedure was performed for
disabling claudication in 50 patients and
for limb threatening ischemia in 23.
Knitted Dacron grafts were used in all
but two patients. The operative mortality
was 4.1% and the late mortality 21.9%.
There were six complications related
to the prostheses, three infected
grafts and three false aneurysms.
Thrombosis of the graft occurred in
15 patients; the graft was successfully
revised in 2. The cumulative 5-year
patency rate determined by life-table
methods was 73.4%. The causes of
failure appeared to be well defined and
unilateral iliac artery disease. The
donor iliac artery, poor runoff through
a diseased deep femoral artery on the
recipient side and infection of the
graft. This study indicates that femoro
femoral bypass has a definite place in
the management of patients with
unilateral iliac artery disease. The
procedure can be performed on selected
patients with a low operative mortality
and an acceptable patency rate.
Entre le 1er janvier 1970 et le
30 juin 1977, 50 hommes et 23 femmes
ont subi un pontage femoro-femoral.
L'age moyen du groupe etait de
64.7 ans. L'intervention a ete entreprise pour soulager une claudication
invalidante chez 50 patients ou pour
corriger une ischemie menacant la
survie du membre dans 23 cas.
Des greffons de Dacron tricote ont
ete utilises chez tous les patients,
sauf deux. La mortalite operatoire a
ete de 4.1% et la mortalite tardive
de 21.9%. II y a eu six complications
reliees a la prothese, trois infections
du greffon et trois faux §pevrismes.
Une thrombose du greffon est survenue
chez 15 patients; le greffon a ete
repare avec succes dans deux cas. Le
taux de patence a 5 ans determine
au moyen de tables actuarielles

From the department of surgery,
Jewish General Hospital and McGill
University, Montreal, PQ
Reprint requests to: Dr. N.M. Sheiner,
Department of surgery, Jewish General
Hospital, 3755 Cote St. Catherine Rd„
Montreal, PQ H3T 1E2
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a ete de 73.4%. Les causes d'echecs
ont semble etre bien definies et
comprenaient une maladie non reconnue
de I'artere iliaque donneuse, un
mauvais ecoulement dans une artere
femorale profonde maiade du cote
receveur et I'infection du greffon. Cette
etude indique que le pontage
femoro-femoral possede une place
definie dans le traitement des pa
tients souffrant de maladie unilateral
de I'artere iliaque. Cette intervention
peut etre pratiquee sur des patients
choisis avec une mortalite ope
ratoire faible et un taux de
patence acceptable.

Stenosis or occlusion of one iliac artery
is usually managed by iliac endarterec
tomy or aortofemoral bypass grafting.
Either of these operations can be a
formidable undertaking in the patient
with associated disease of the cardiac,
pulmonary, renal or cerebrovascular
system. In 1960, McCaughan and
Kahn1 introduced the principle of a
crossover graft to treat the patient with
unilateral occlusive disease of the ilio
femoral artery. They anastomosed a
Dacron graft to the left external iliac
artery and placed the graft in an extraperitoneal plane superior to the bladder
and then through the right femoral
canal to the right popliteal artery above
the knee where the distal anastomosis
was performed. A third anastomosis
was then carried out between the graft
and the proximal end of the right deep
femoral artery. They proposed this
crossover procedure as an alternative
to aortopopliteal bypass in poor-risk
patients. In 1962, Vetto2 reported the
use of a femorofemoral subcutaneous
graft in 10 patients with unilateral iliac
artery disease. By 1966, he had in
creased his series to 38 patients and
had 32 early successes and no late
graft failure.3 Since these initial reports
many others have appeared in the lite
rature and the procedure of femoro
femoral bypass has achieved relatively
widespread acceptance.4"15
We started using this procedure in
January 1970 and have used it increas
ingly since that time. We now report our
experience with the procedure over an
8-year period.
Patient Data

Jack Z eltzer ,

md

1977, 50 men (average age 68 years)
and 23 women (average age 61.8 years)
underwent femorofemoral bypass graft
ing. The average age of the entire goup
was 64.7 years. The age distribution is
set forth in Table I. Many patients had
one or more associated conditions
(Table II) that may have increased the
morbidity and mortality of conventional
intra-abdominal revascularization oper
ations. In the initial years of this study,
femorofemoral bypass was restricted to
patients with unilateral iliac disease
who presented with rest pain, ischemic
ulcers or gangrene and who were con
sidered to be poor risks for conven
tional revascularization procedures be
cause of the presence of associated di
seases. In the later years, the indications
for femorofemoral bypass were ex
tended to include all patients who
were over the age of 65 years. Further
more, disabling claudication was also
considered an indication. Good-risk
patients younger than 65 years were
still operated on by conventional means.
Of the 73 patients, femorofemoral by-

T a b l e 1 - - A g e D i s t r i b u t i o n o f 73 P a t i e n t s W h o
H a d F e m o r o fe m o r a l B y p a s s G r a ftin g

N o . o f p a tie n ts
Age, yr

(a n d % )

4 0 -4 9

5

(6 .8 )

5 0 -5 9

18

( 2 4 .7 )

6 0 - 69

25

( 3 4 .3 )

7 0 -7 9

23

(3 1 .5 )

2

( 2 .7 )

80

73 ( 1 0 0 )

T a b le
W ho

I I — A s s o c ia te d
Had

D is e a s e s

F e m o ro fe m o ra l

in

P a tie n ts

B ypass

G r a ft in g

N o . o f p a tie n ts
D is e a s e

(a n d % )

D ia b e te s

23 (3 2 )

H y p e rte n s io n

39 (5 3 )

C o ro n a r y a r t e r y d is e a s e

56 ( 7 7 )

C e r e b r o v a s c u la r
in s u ffic ie n c y
P u lm o n a r y d is e a s e

5 (7 )
20 (2 7 )

C h r o n ic r e n a l d is e a s e

8 (1 1 )

O th e r

7 (1 0 )

Between Jan. 1, 1970 and June 30,
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pass was performed in 50 for disabling
claudication and in 23 for limb-threat
ening ischemia. Of the latter group, rest
pain was present in 14, ischemic ulcers
in 6 and gangrene of one or more toes
in 3. Four of the 73 patients had pre
viously undergone unilateral aortofemoral bypass and subsequently di
sease developed in the opposite iliac
artery. Three other patients had occlu
sion of one limb of a previously in
serted aortobifemoral bypass graft.
Angiographic Findings
In all 73 patients translumbar or re
trograde femoral arteriograms were
obtained. Left iliac artery disease was
present in 40 patients and right iliac
artery disease in 33 patients. Small ab
dominal aortic aneurysms were present
in two patients. There was associated
femoropopliteal disease in 36 patients.
Operative Technique
The technique of femorofemoral by
pass has been well described.3,4’li!’15 The
procedure can be carried out under
local, epidural or light general anesthe
sia. The graft can be of autogenous
saphenous vein or knitted Dacron. In
the present series, 71 of the grafts were
8-, 9-, or 10-mm knitted Dacron and
autogenous saphenous vein in the other
2. Since approximately 50% of patients
with iliac artery disease also have ob
struction of the superficial femoral
artery, special attention must be paid
to the deep femoral artery on the re
cipient side. If this artery is stenotic
at its orifice, the arteriotomy in the
common femoral artery should be con
tinued across the stenotic orifice and
the bypass graft then tailored to extend
onto the deep femoral artery as a patch.
If the disease in the deep femoral artery
extends distally beyond the first 1.5 cm
of the vessel then endarterectomy and
autogenous venous patch angioplasty
of the deep femoral artery is performed
and the graft is anastomosed more
proximally to the common femoral ar
tery. Alternatively, the graft can be
anastomosed directly to the deep
femoral artery.
The tension of the graft when it is
in place is important. If the graft is too
short, excessive tension will result in
traction on both the donor and recipient
arteries with resultant turbulence and
possible thrombosis. Excessive tension
may also cause dehiscence of the an
astomosis and false aneurysm forma
tion. If the graft is too long, buckling of
the graft may occur and this, too, may
lead to thrombosis.
Operative Procedures

In 68 of the 73 patients, the proce
dure was limited to a femorofemoral or
femoral-to-deep femoral artery bypass.
VOLUME 22, NO. 5, SEPTEMBER 1979 /

tients, successful revision of the graft
was achieved in 2. Three other patients
in this group had successful revascular
ization by another procedure— two by
axillofemoral bypass and one by aortofemoral bypass. Of the total group of
73, revascularization ultimately failed
in 12 patients (10 patients who could
not be revascularized by either revision
of the graft or by an alternative proce
dure and 2 patients in whom a patent
graft was removed because of infec
tion). Of this group of 12 patients, 8
underwent major amputation, above the
knee in 6 and below the knee in 2.

In three patients, an extended deep
femoral endarterectomy with saphenous
vein patch angioplasty was performed
on the recipient side. In one patient the
femorofemoral bypass was combined
with a femoropopliteal vein bypass on
the recipient side and in one other
patient, the femorofemoral procedure
was combined with a femoropopliteal
vein graft on the donor side.
Results

Mortality
The early (up to 30 days postoperatively) mortality was 4.1% and the
late mortality 21.9% during a follow
up period that averaged 35.1 months.
The causes of death are indicated in
Table III. Eleven of the 19 deaths
were due to myocardial infarction.
Complications
The complications of the operation
are listed in Table IV. In six instances
the complication involved the graft’
three were false aneurysms and three
were infected grafts. All three infected
grafts were patent; in one case the
patient was successfully managed by an
iliofemoral bypass through the ob
turator foramen with removal of the
infected graft but in the other two,
above-knee amputation was required
following removal of the infected graft,
and both patients ultimately died as a
result of amputation. All three patients
with false aneurysms underwent suc
cessful repair of the aneurysms.
Graft Thrombosis
Graft thrombosis was the most com
mon complication and occurred in 15
patients—within 30 days in 3, between
30 days and 1 year in 7, 1 and 2 years
in 2, 2 and 3 years in 1 and after 3
years in 2 patients. Of these 15 pa

Relief of Symptoms
All 11 patients with rest pain who
underwent successful revascularization
had relief of this symptom. Ischemic
ulcers healed in all patients who had
patent grafts, and local amputations
were successful in managing the three
patients with gangrenous toes. Of the 50
patients presenting with intermittent

Table IV— The Early and Late Complications
of Femorofemoral Bypass
Complication
Early
Minor wound infection
Major wound infection
(infected graft)
Myocardial infarction
Gastrointestinal
bleeding
Pneumonia
Mesenteric thrombosis
Thrombosis of graft
Late
False aneurysm
Thrombosis of graft

No. of patients

3
3
2
2
1
1
3
3
12*

*2 successful revisions.

Table III —The Time and Causes of Death in the 19 Patients Who Died following
Femorofemoral Bypass
Time of death

Cause

No. of patients

No. of patients

0 - 30 d

3

Myocardial infarction
Pneumonia
Gastrointestinal bleeding

1
1
1

31d - 1 yr

4

Myocardial infarction
Sepsis

2
2

1 - 2 yr

3

Myocardial infarction

3

2 - 3 yr

3

Myocardial infarction
Aortoenteric fistula

2
1

6

Myocardial infarction
Carcinoma
Cerebrovascular accident
Respiratory failure

3
1
1
1

> 3 yr
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claudication, 33 of the 46 with patent
grafts were totally relieved of their
claudication or demonstrated marked
improvement. The remaining patients
improved sufficiently that no further
operation was required.
P atency R ate

In this series, the two patients who
had grafts that occluded but were suc
cessfully revised were considered to
have patent grafts. The three patients
who had infected grafts that were re
moved, though patent, were considered
to have occluded grafts. The cumulative
5-year patency rate as determined by
life-table methods was 73.4% (Fig. 1).
Discussion

A review of several reported series of
femorofemoral bypass grafting in the
English literature (Table V) reveals a
moderate variation in the patency rates
of these grafts. The 4-year patency rate
of 53% reported by Eugene, Goldstone
and M oore8 is somewhat lower than
those reported in other series. Our 5year cumulative patency rate was
73.4% and included in the group of
patients with occluded grafts were three
patients whose patent grafts were re
moved because of infection. If we were
to exclude these three patients the 5year patency rate would exceed 80%
and would be comparable to the 80.8%
5-year patency rate reported by Brief
and associates.5
The causes of failure in our series ap
pear to be well defined and include Un100 -

90

-

80

-

5
“
<

| 70
<
1
>

60

40

-

FIG. 1— Cumulative patency of feniorofenioral grafts determined by life-table
methods.

recognized disease in the donor iliac
artery, poor runoff through a diseased
deep femoral artery on the recipient
side and infection of the graft. The
problem of unrecognized iliac artery
disease on the donor side has been over
come to a large extent by a more care
ful angiographic assessment of the
donor iliac artery with the aid of
oblique views, and by measuring the
pressure in the donor iliac artery at
the time of operation. The problem of
poor runoff by way of a diseased deep
femoral artery is currently managed by
the more frequent use of extended deep
femoral endarterectomy and of com
bined femorofemoral and femoropopliteal or femorotibial bypass on the reci
pient side. G raft infection in our series
occurred in patients with infected
ischemic ulcers or gangrenous toes and
may be prevented by a longer period
of preoperative antibiotic therapy,
combined with more intensive local
therapy to the infected ischemic ulcer.
Conclusion

From our experience we conclude
that femorofemoral bypass grafting is a
very satisfactory procedure for man
aging selected patients with unilateral
iliac artery disease and can be carried
out with a relatively low operative mor
tality and with acceptable long-term
patency rates.
The indications for this procedure
have gradually been extended on our
service and it is now used for: (a) all
patients with unilateral iliac artery di
sease who require revascularization
because of disabling claudication,
ischemic rest pain, ischemic ulcers or
gangrene and who are over the age of
65 years; (b) for patients who are
younger than 65 but who are consi
dered poor-risk candidates for conven
tional revascularization operations be
cause of severe coronary artery disease,
chronic obstructive lung disease, ad
vanced renal disease, cerebrovascular
disease, etc.; (c) patients in whom intra
abdominal revascularization is contrain
dicated because of intra-abdominal sep
sis or tumour, numerous intra-abdom
inal adhesions, infection of the upper
abdominal wall or the presence of a

T a b le V — A S u m m a ry o f Som e R e p o rts o f Fem o ro fem oral B y p a s s

A u th o r
V e tto , 1966:*
S e th i an d a s s o c ia te s , 197514
B r ie f an d a s s o c ia te s , 1975s
P le c h a and P o rie s, 1976*3
E u g e n e , G o ld sto n e and M oore, 19778
S h e in e r , A s h b y and Z e lt z e r , p re s e n t s e r ie s
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N o. o f
p a tie n ts

P a te n c y ra te , %

38
27
57
54
33
73

84
81.5
80.8
87.4
53
73.4

Le n g th of
fo llo w -u p
27 mo
26.5 mo
18 mo
4 yr
5 yr
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colostomy; (d) patients who have oc
clusion of one limb of an aortobifemoral or bi-iliac graft; and (e) pa
tients who have had unilateral aortofemoral or aortoiliac bypass operation
and in whom disease subsequently
develops in the opposite iliac artery.
Addendum
f

Between July 1, 1977 and July 15, 1978,
we performed femorofemoral grafting in
16 men and 7 women. There were no
operative deaths. Twenty-one of the 23
grafts remained patent in the early post
operative period, giving a 30-day patency
rate of 91.3%. In two patients the graft
became occluded after the first 30 days
and one of the grafts was successfully rerevised.
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Testicular Scanning: Its Efficacy in Diagnosing
Intrascrotal Lesions
William L. O rovan,

G ordon A. M cL orie ,

md , frcs [c]

characterized by reduced or absent
testicular perfusion, from acute epi
didymitis in which perfusion to the
affected side was markedly increased.
Subsequent papers2’7 have described
variations and refinements of the scan
ning technique and all have sug
gested that it has a high degree
of accuracy in diagnosing intrascrotal
lesions including acute testicular tor
sion, acute epididymitis, torsion of tes
ticular or epididymal appendages, tu
mours, spermatoceles and abscesses.
Accurate and rapid differentiation of
acute testicular torsion, a condition
necessitating prompt surgical interven
tion, from other acute, though nonsurgical, lesions of the scrotum such as
acute epididymitis is of great benefit
to the patient in avoiding unnecessary
exploratory scrotal surgery which is
often undertaken to exclude acute tes
ticular torsion in cases that are diag
nostically difficult.

Radionuclide scanning is a relatively
new diagnostic aid for evaluating
intrascrotal lesions. The authors present
a retrospective analysis of 34 patients
who underwent testicular scanning
from 1973 to 1978. While the technique
may be helpful, misleading results are
not uncommon and caution should be
exercised in interpreting the results.
In this series 22% of scans obtained
in cases of testicular torsion and acute
epididymitis failed to provide the cor
rect diagnosis. In view of the serious
consequence of testicular loss when
surgical exploration is delayed, testicular
scanning should not be relied upon
to the exclusion of other more
traditional methods.
La scintigraphie isotopique est un
instrument de diagnostic relativement
nouveau pour evaluer les lesions
intrascrotales. Les auteurs presentent
une analyse retrospective de 34 patients
qui subirent une scintigraphie des
testicules entre 1973 et 1978. Bien que
cette technique puisse etre utile, les
resultats qui pretent a erreur ne sont pas
rares et ils devraient etre in te rp re ts
avec circonspection. Dans cette serie,
22% des scintigraphies effectuees dans
les cas de torsion d'un testicule et
d'epididymites aigues n'ont pas reussi
a etablir le diagnostic exact. En raison
des consequences serieuses que peut
entrainer la perte d’un testicule, quand
I’exploration chirurgicale est retardee,
I’on ne devrait pas se fier aux resultats
de la scintigraphie des testicules a
I'exclusion d’autres methodes
diagnostiques plus traditioneiles.

Patients and Methods

A retrospective analysis was made
of all patients who had scrotal radio
nuclide examination to help in the
diagnosis of intrascrotal lesions at our
centre from 1973, when the first such
scan was obtained, to 1978. In that
5-year period this examination was per
formed 34 times. The results of scan
ning in these 34 patients are summar
ized in Table I. The diagnosis was con
firmed at operation in 22 patients
and by clinical follow-up in the re
maining 12 patients with acute epidi
dymitis. The patients ranged in age

Radioisotopic scanning for evaluating
perfusion of the testicles and scrotal
contents was first proposed by Nadel
and associates1 in 1973. They used a
rectilinear scanner and sodium-99m
pertechnetate and were able to dif
ferentiate acute testicular torsion,

Table 1—Diagnosis in 34 Patients Who Under
went Testicular Radionuclide Scanning of the
Scrotum

Final diagnosis

From the department of surgery,
division of urology, University Hospital,
London, Ont.
Reprint requests to: Dr. W.L. Orovan,
Department of surgery, division of
urology, St. Joseph’s Hospital, 268
Grosvenor St., London, Ont. N6A 4V2

VOLUME 22, NO. 5, SEPTEMBER 1979

md,

/

Confirmed
No. of at operation,
patients no.(and % )

Acute testicular
torsion
Torsion of appendix
testis
Tumour of testis
Acute epididymitis

8

8 (100)

5
6
15

5 (100)
6 (100)
3 (20)

Total

34

22 (65)

from 5 to 74 years; 10 were children
and 24 were adults. In all cases of
acute testicular torsion, torsion of an
appendix testis and acute epididymitis,
radionuclide scanning was performed
as part of the initial diagnostic studies.
Scanning of suspected testicular tu 
mours found on physical examination
was performed as part of the overall
preoperative assessment and to evaluate
the usefulness of the scanning tech
nique in mass lesions of the testicle.
A standard technique was used in
which the patient is positioned supine
under the gamma camera and the scro
tum isolated and supported from below
by a thin lead shield designed to ex
clude background soft tissue activity
of the thigh from the scanning field.
The penis is taped to the lower ab
domen. Technetium-99m (pertechne
tate) (10 mCi) is injected into an antecubital vein; perfusion studies are per
formed at 2-second intervals for 60
seconds and blood pool images ob
tained at longer intervals over the next
5 minutes. Frequently markers are
placed at the inferior pole of each hemiscrotum to aid in anatomic orienta
tion. Results were interpreted as de
scribed by Holder and associates7 in
which the normal pattern of perfusion
is characterized by a low-level sym
metrical activity in the perfusion phase
and an overall intensity similar to the
thigh on blood pool image or sum
mation. Acute torsion of the testicle
is characterized by decreased or ab
sent perfusion during the dynamic
phase of the study and a rounded
“cold” area replaces the testicle on the
static blood pool image. Acute epidi
dymitis appears as markedly increased
perfusion on the involved side with a
“hot” spot representing the epididy
mitis on the blood pool image. Tumour
is seen as a slightly altered, usually
slightly decreased, area of perfusion in
an otherwise normally perfused testicle.
Torsion of an appendix testis gives
a normal perfusion pattern.
A cute Testicular Torsion

In eight patients the final diagnosis
was acute torsion of the testicle. All
of these diagnoses were confirmed at
operation (Table I). The result of scan-
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ning was misleading in three of the
eight patients; in two of these three
operation was performed immediately
on the basis of clinical diagnosis, and
in both acute testicular torsion was
confirmed. In the other patient the
clinical presentation and laboratory
findings were equivocal and surgical
exploration was deferred on the basis
of testicular scanning which indicated
the presence of acute epididymitis. The
patient was subsequently operated
upon when symptoms failed to resolve
with conservative therapy; at opera
tion an infarcted, distorted testicle was
found which necessitated orchiectomy.
Torsion of Appendix Testis

Five cases of torsion of the appen
dix testis were diagnosed preoperatively; in all cases the diagnosis was con
firmed subsequently at operation. In
this group operation was performed
either because the diagnosis was in
doubt or because of persisting severe
pain. In four of six scans obtained
in this group, the results (Table II)
were at variance with the eventual
diagnosis.
Secondary inflammatory
changes, though not noted clinically,
may account in part for the increased
perfusion noted in three of the six
scans (Table II).
Tumour o f Testis

Six patients with tumour were stud
ied. These were all nonacute presenta
tions and testicular scanning was used

as an adjuvant investigative procedure.
In five patients a mass was delineated
within the testicle; in four of these
the mass was slightly hypoperfused
and in one it was seen as an area of
slightly increased perfusion. In the
sixth patient no mass could be defined
by scanning although subsequent ra
dical orchiectomy did reveal that a
2-cm seminomatous tumour was pres
ent.
Acute epididymitis

Fifteen patients with acute epidi
dymitis underwent radionuclide scan
ning; 13 had a pattern of increased
perfusion. Two patients showed nor
mally perfused testicles and hemiscrota
(Table II). Three of these 15 patients
were subsequently operated upon for
unresolved pain or abscesses and the
diagnosis of epididymitis was con
firmed in all. The remaining 12 were
followed clinically and in all the con
dition resolved with antibiotic therapy.
Nine patients have been followed up
from 1 to 14 months; in none has
there been any indication of atrophic
testicles suggestive of missed torsion.
Discussion

The use of testicular radionuclide
imaging to aid in the diagnosis of intrascrotal lesions has received wide
spread attention in the recent surgical
and radiologic literature. Several previ
ous reports have attested to its general
efficacy as a diagnostic aid. Riley and

Table II—Scan Result Compared with Trial Diagnosis in 34 Patients Who Underwent Testicular
Radionuclide Scanning
Scan result
Increased Decreased Normal
perfusion perfusion perfusion

Final diagnosis
Acute testicular torsion

3

5

0

Torsion of appendix testis*

3

1

2

Tumour of testis

1

4

1

13

0

2

Acute epididymitis

Expected
result

Per cent
incorrect

Decreased
perfusion
Normal
perfusion
Slightly
altered
Increased
perfusion

37
66
17
13

*1 patient underwent scanning on 2 occasions.

Table III--Scanning Results Confirmed at Operation

Final diagnosis
Acute testicular torsion
Torsion of appendix testis
Tumour of testis
Acute epididymitis

480

Scan
correct

Scan
incorrect

Total no.
of cases

Scan
errors, %

5
2
5
3

3
3
1
0

8
5
6
3

37
60
17
0

15

7

22

32
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associates5 have reported a 6% false
negative scan result in differentiating
acute torsion of the testicle from acute
epididymitis, while Williamson8 puts
the figure at almost 10%.
While we have found this technique
to be generally helpful, misleading re
sults are not uncommon. Our own
experience in this admittedly small se
ries shows that in the 23 combined
cases of acute testicular torsion and
acute epididymitis investigated by ra
dionuclide scanning, the scan failed
to suggest the correct diagnosis in 5
(22%). Of the 22 patients in whom
the diagnosis was confirmed at oper
ation, the scans were found to be
misleading in 7 (32% ) (Table III).
In view of our results we would
urge that caution be exercised in the
use of this diagnostic modality. We
would echo the conclusions of Datta
and Mishkin4 that scrotal imaging
should be viewed along with all other
clinical and laboratory data in the
diagnosis of acute intrascrotal lesions.
Caution in interpreting the results of
these scans is particularly important
in view of the serious result of testi
cular loss which may occur when
a diagnosis other than acute torsion is
made and surgical exploration is thus
deferred until testicular damage is ir
reversible and salvage impossible. We
also stress that no time should be lost
in waiting for testicular scanning to
be carried out if the clinical impres
sion is that the patient requires an im
mediate scrotal exploration for salvage
of his testicle, as in the case of testi
cular torsion.
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Sensory Feedback in a Myoelectric Upper Limb Prosthesis:
a Preliminary Report
R.H. B rittain ,

m sc, p eng ,*

and

D.A. G ibson ,

d'enthousiasme. Cela lui donne un
sentiment de competence et de
confiance qu'elle n'a pas sans lui.

Upper limb prostheses are often
rejected because they do not provide
the sensory feedback available from a
normal hand. A system for providing
sensory feedback has been developed
at the University of New Brunswick for
use with the three-state myoelectric
controls prepared in the Bioengineering
Institute there. Strain gauges mounted
on the forefinger of an electric hand
provide information which is processed
electronically to cause a tingling
sensation in the patient's stump,
proportional in its intensity to the pinch
force in the finger.
This system has been used by a
patient at the Ontario Crippled
Children's Centre in Toronto, since
June 1976. She uses it consistently
with great satisfaction and enthusiasm.
It gives her a sense of competence
and confidence she does not have
without it.

The upper limb is commonly thought
of as an organ for grasping and moving
things and its sensory function is for
gotten. The importance, however, of
sensory feedback from the hand be
comes obvious when this feedback is
impaired by neurologic disease or
eliminated by amputation.
Many patients with a good upper
limb prosthesis are quite capable of
operating it efficiently but prefer not
to wear it simply because the effort of
monitoring the terminal device visually
is too tedious and distracting. The pa
tient may develop a fair sense of where
the prosthetic hand is in space from the
stump sensation, but firmness of grasp
is difficult to appreciate, even visually.
Professionals concerned with prosthe
tics have long recognized the need to
provide sensory feedback, but we have
not found any record of successful
fittings. The investigator most active in
this field is Schmidl1,2 who has de
veloped experimental feedback systems
for strength of grip, position sense and
for switching off rapid movements on
contact.
A system for providing sensory feed
back was developed at the Bio-Engi
neering Institute of the University of
New Brunswick. It provided, in a myo
electric limb, for the delivery of a ting
ling sensation to an area on the stump.
The strength of this stimulus is propor
tional to the force of the grasp.

Les protheses des membres superieurs
sont souvent rejetees parce qu’elles
sont incapables de procurer la retroaction
sensitive offerte par une main normale.
Un systeme capable de procurer une
retroaction sensitive a ete mis au point
a I’Universite du Nouveau-Brunswick
pour utilisation avec les controles
myoelectrique a trois etats prepares a
leur Institut de Genie Biomedical. Des
jauges de tension placees sur I'index
d’une main electrique procure
I’information qui est transmise
electroniquement, causant une sensation
de fourmillement dans le moignon
du patient, proportionnelle en intensite
a la force de compression dans le doigt.
Ce systeme a ete utilise par une
patiente du Ontario Crippled Children's
Centre, a Toronto, depuis juin
1976. Elle I'emploie regulierement
avec beaucoup de satisfaction et

Myoelectric Control with
Sensory Feedback

The sensory feedback system de
veloped has been made compatible with
the University of New Brunswick threestate myoelectric control system. This
system allows an amputee to control
opening and closing of an electrically
driven terminal device by using the
myoelectric output from a residual
muscle in the stump. The myoelectric
signal is sensed by three electrodes
mounted in the stump socket and one
muscle is used to control both opening
and closing. Electrode paste is not re
quired with this system.

From the Ontario Crippled Children’s
Centre, Toronto, Ont.
*Bio-Engineering Institute, University
of New Brunswick, Fredericton, NB
•Ontario Crippled Children’s Centre,
Toronto, Ont.
Reprint request to: Dr. D.A. Gibson,
Ontario Crippled Children’s Centre,
350 Rumsey Road, Toronto, Ont.
M4G 1R8
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The sensory feedback system is de
signed to generate a stimulus signal in
the form of short pulses of current
which are delivered to the amputee
through an additional electrode placed
in the stump socket. The repetition rate
or frequency of the pulses is made pro
portional to the pinch force of the ter
minal device. The pinch force is sensed
by miniature strain gauges mounted on
the forefinger of the device under the
cosmetic glove. This pinch-force infor
mation is processed by the system’s
electronics and is used to control the
frequency of the stimulator. Applica
tion of current pulses through the
stimulating electrode to the skin pro
duces a tingling sensation which alters
with changes in the frequency of the
stimulus. The strength of sensation can
be adjusted to a comfortable level when
the system is fitted. This feedback sys
tem works on a time-sharing basis with
the myoelectric control unit and, by
recognizing structural deflections in the
hand skeleton, delivers a proportionate
current to the ground reference elec
trode in the socket.
The control and feedback electronics
together with the rechargeable battery
are placed in a single package small
enough to be enclosed in the forearm of
a below-elbow prosthesis. The battery
is sufficient for a normal day’s use.
The engineering challenges met in
the design of this system include minia
turization of the electronics package,
reduction of the battery power required
to operate it to a minimum and elimin
ation of interference between the feed
back electronics and the control sys
tem electronics. This last challenge was
the most difficult because of the great
difference between the extremely small
myoelectric signals and the stimulating
signals which were both present at the
electrodes placed in the stump socket.
Special switching and sampling tech
niques were required to prevent the
stimulating signals from being processed
by the sensitive myoelectric amplifier.
The following case report illustrates the
application of the sensory feedback
system.
Case Report

In 1967, a 9-year-old girl with a conge
nital amputation below the left elbow
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attended the amputee clinic at the Ontario
Crippled Children’s Centre in Toronto.
Her ulnar stump was 8.9 cm long. She
was fitted with a conventional prosthesis
and a Dorrance hand operated by a cable
harness.
In January 1973, she was supplied with
a new myoelectrically controlled prosthe
sis having a rigid polyester resin Munstertype socket and a three-state University of
New Brunswick control system. Within a
month, the patient became an excellent
user of the prosthesis in spite of some
initial problems.
In June 1974, a duplicate prosthesis was
fitted, but with a feedback system added
by the Bio-Engineering Institute at the
University of New Brunswick (Figs. 1 and
2). Initially, there was some interference
in the feedback system caused by the
inner glove pulling on the leads to the
strain gauges. Stretching of the index
finger of the inner glove seemed to over
come this. The leads also were rerouted
in the hand frame and fixed to it with
epoxy. Proper calibration of the feedback

system seemed a rather delicate procedure
but, eventually, the patient could tell pre
cisely how hard she was gripping.
By September 1974, the patient’s stump
was covered with a severe rash. She had
become allergic to the Beckman silverchloride electrodes. The electrolytic en
vironment created by the feedback current
and the ever-present saline electrode paste
tended to aggravate the situation. This
problem persisted in spite of various med
ical treatments and replacement of the
silver electrodes with gold-plated ones.
Various makes of electrocardiographic
pastes were tried unsuccessfully. It seemed
essential to let the skin irritation subside
before any further attempt at fitting was
made and, therefore, in June 1975, she
was supplied with a passive cosmetic pros
thesis with a socket made of silicone rub
ber. By February 1976, the skin of her
stump had healed well and she was fitted
with a new myoelectric prosthesis with a
three-state dry control system (without
feedback). The socket comfort and sus
pension, which was by a suction valve,
were excellent and the patient obtained
good control over this myoelectric hand.
In June 1976, a three-state dry control
system with feedback was added to this
satisfactory limb. Again, adjustments to
the sensitivity of the feedback system had
to be made over a period of about 2 days.
Since that time, the patient has used
this hand with great satisfaction.
Discussion

FIG. 1—Patient showing natural appear
ance of prosthesis. Proximal part of pros
thesis is normally covered by clothing.

Although the sensory feedback sys
tem provides the patient with informa
tion about the force of grasp only and
does not match a normal hand’s ability
to distinguish shapes, texture and tem
perature, it provided our patient with
a sense of competence and confidence
she never had without it. Her enthu
siasm for it more than justified the
trouble taken to overcome the problem
of skin sensitivity and her continued
use of this prosthesis demonstrates that
sensory feedback in an upper limb pros
thesis is both practical and valuable.
References
1.

i d l H: The INAIL-CECA pros
thesis. Ortho tics Prosthetics 27: 6, 1973
2. Idem: The importance of information
feedback in prosthesis for the upper
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FIG. 2—Laterally in socket of pros
thesis is pair of active electrodes; distal
one is of bipolar construction. Outer
ring of bipolar electrode transmits sensory
stimulus. Reference electrode situated
medially is not shown.
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In addition to a group of urology
papers, the next issue of this journal
will contain a symposium on portal
hypertension. The symposium com
prises four papers (including a guest
lecture on the emergency treatment
of variceal hemorrhage by M.J.
Orloff) and a panel discussion.
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Colorectal Neoplasm: a Rare Complication of
Ureterosigmoidostomy
Serge D ube,

md ,*

J ean-P aul P erreault , md, frcs[c],* A ndre D umont ,
and D enis B ernard, md, frcs[c]*

A 24-year-old woman had a rectal
neoplasm which occurred 20 years
after she had undergone ureterosigmoi
dostomy for exstrophy of the bladder.
Only 41 cases of benign or malignant
tumours of the large bowel developing
after ureterosigmoidostomy have
previously been reported in the literature
Adenocarcinoma of the colon is most
frequently found and can develop even
after urine has been diverted away
from the colon. The presenting
symptoms are either those of ureteral
obstruction or of colorectal neoplasm.
This rare complication remains
intriguing and the possible pathogenetic
mechanisms are discussed.
Les auteurs rapportent un cas de
neoplasie rectale survenu 20 ans apres
uretero-sigmoi'dostomie pour extrophie
vesicale. La revue de la litterature
fait etat de 41 cas de tumeurs benignes
ou malignes. La tumeur la plus frequente
dans ces cas est I’adeno-carcinome
du colon et elle peut se developper
meme apres I'interruption de I'ureterosigmoidostomie. Les manifestations
cliniques peuvent etre celles de
I’obstruction ureterale ou des tumeurs
du colon. Cette complication, tout
en etat rare, demeure problematique
et les principaux facteurs
pathogenetiques sont presentes.

erature to emphasize that a tumour
may appear even after urine no longer
flows into the colon. We also discuss
the possible pathogenesis of this phe
nomenon.
Case Report
A 24-year-old white woman was ad
mitted to hospital in February 1972,
complaining of intermittent rectal bleed
ing for the previous 2 years. She had
also noted changes in her bowel habits.
At the age of 4 years, she had undergone
bilateral ureterosigmoidostomy for ex
strophy of the bladder, which was sub
sequently resected. At 11 years of age,
because of deteriorating renal function
secondary to infection and reflux, her
ureterosigmoidostomy had been converted
to an ileal conduit. Both ureters were
transected at the ureterosigmoid junction
and the sigmoid colon was closed. For
the next 12 years she had no problems
except for the rectal bleeding mentioned
above.
Upon admission her hemoglobin value
was 10.4 mg/dl; results of all other
laboratory tests were normal. Sigmoido
scopy revealed a sessile, ulcerated lesion

md|

(diameter 3 cm) situated 12 cm from the
anal margin and a large polypoid lesion
with a broad pedicle (diameter 1 cm)
18 cm from the anal margin. Biopsy of
the distal lesion suggested that it was a
villous tumour. The patient underwent
anterior resection of the rectum. Her post
operative course was smooth.
Gross examination of the resected
specimen showed two polypoid growths,
measuring 1.5 and 3.5 cm, at the proximal
end; 6 cm distal to these lesions there
was a 3-cm ulcerated growth, which on
macroscopic sectioning was seen to invade
the muscularis of the rectum. Microscopic
examination of the 1.5-cm polypoid le
sion (Fig. 1) showed a non-neoplastic
polyp covered by hyperplastic colonic
mucosa; there was underlying edematous
inflammatory tissue with round cell in
filtration and numerous blood vessels
around a fragment of sectioned ureter.
The larger polypoid lesion (Fig. 2) was
covered by hyperplastic mucosa; there
were tubular adenomatous changes (ade
nomatous polyp), basophilic cytoplasm,
loss of mucous secretion, areas of pseu
dostratification of the nuclei and numer
ous mitoses consistent with intraepithelial
malignant proliferation. The pedicle was
not affected. The pedicle itself contained
some fragments of sectioned ureter. The
ulcerated lesion (Fig. 3), found 6 cm
distal to the ureteral stumps, appeared
to be a moderately differentiated adeno
carcinoma invading the superficial layers
of the muscularis propria of the rectum,
a true Dukes A lesion.26

Ureterosigmoidostomy as a procedure
of urinary diversion is associated with
several complications, namely hyper
chloremic acidosis, hydronephrosis and
renal damage from reflux and infec
tion. Tumour originating at the site
of ureterocolonic anastomosis is a rare,
well-recognized but not well-under
stood phenomenon. Benign and malig
nant colorectal tumours have been
reported previously.1'25 We report a case
of rectal tumour occurring after ure
terosigmoidostomy and review the litFrom the *department of surgery,
University of Montreal, the department
of urology and the gastrointestinal
surgery and pathology units,
St. Luc Hospital, Montreal, PQ
Reprint requests to: Dr. Denis Bernard,
Department of surgery, Hopital St. Luc,
1058 St. Denis, Montreal, PQ H2X 3J4
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FIG. 1— Detail of polypoid growth
measuring 1.5 cm in diameter. Inflam
matory polyp is covered by hyperplastic
colonic mucosa. Lamina propria and sub
mucosa show edema and chronic inflam
matory reaction. At base of lesion, seg
ment of sectioned ureter is present (ar
row). (hematoxylin and eosin, reduced by
27% from X7.15).
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FIG. 2— Larger polypoid growth. Hy
perplastic colonic mucosa (arrow 1) cov
ers this broad-based polypoid lesion.
Adenomatous changes are present with
focal cellular atypia consistent with su
perficial intramucosal malignant prolif
eration (arrow 2). Fragment of sectioned
ureter is present at base of polypoid
growth (arrow 3) (hematoxylin and eosin,
reduced by 43% from X3-8).
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(62%) were adenocarcinomas of the
colon, 5 were undifferentiated car
cinomas, 4 mucinous adenocarcinomas
and 3 were transitional cell carcino
mas. The 10 benign lesions were al
most all adenomatous polyps. The
high frequency of adenocarcinoma in
the colon of younger patients is sta
tistically significant.25 Urdaneta and as
sociates25 have calculated the frequency
to be 500 times greater than expected
in this age group. It is interesting that
in 62% of the reported cases the pa
tient was younger than 40 (Fig. 4)
(mean 38 years), whereas only 7.5%
of the colonic carcinomas in the gen
eral population occur before the age
of 40 years (mean 58 years).27 How
ever, the frequency of malignant tu
mours does not seem to be related to
the period of time after the ureterosig
moidostomy (Fig. 5).

This patient, now 31 years old, is alive
and well 7 years after operation. At her
regular follow-up examinations, the anas
tomotic area has been pliable and sigmoidoscopic examinations have shown
no evidence of tumour recurrence in the
remaining rectum or sigmoid colon. As
an interesting corollary, exactly 5 years
after this patient’s operation we operated
on her mother for a polypoid adenocar
cinoma of the sigmoid colon, with a
good result.
Review of the Literature

Hammer,1 in 1929, reported the first
case of a neoplasm developing at the
site of ureterosigmoidostomy 10 years
after implantation, in a patient with
exstrophy of the bladder. Forty more
cases have since been reported in the
literature.2"25 The sex distribution (Ta
ble I) shows that males are predomi
nantly affected. One of the reasons for
this distribution is the greater fre
quency of exstrophy of the bladder in
boys. Of the 42 patients 26 (62%)
required ureterosigmoidostomy diver
sion for this condition. Other clinical
conditions which have been treated by
surgical diversion are shown in Table
II. Of the 42 lesions 32 were malig
nant. Of the malignant tumours, 20

Discussion

Among the etiologic t factors in
volved in the formation of tumour at
the site of ureterosigmoidostomy, two
particularly have been implicated: the
presence of urine in the colon and
mechanical irritation of the ureteral
stoma.
Possible carcinogens and irritants in
the urine have been suggested as im
portant factors. Although S’cott and
Boyd28 in relatively long-term experi
ments were unable to demonstrate that
B-naphthylamine, well recognized as a
carcinogen, caused malignant degenera
tion in dogs with ureterosigmoidosto
my, we could not rule out the role

played by the urine as a carcinogenic
factor even though our patient had
undergone ileal conduit diversion 13
years earlier. The study of Sommo
and Traverso29 appears to provide some
evidence to confirm the importance of
urine in the histologic modification
of the colonic mucosa. They studied
histologic and histochemical changes
in the bowel mucosa of patients from
2 to 48 months after ureterosigmoi
dostomy. They first noted a period
of proliferation during which the
glandular epithelium showed marked
cellular hyperplasia and overproduc
tion of mucus. This was followed by
atrophic changes. Undifferentiated cel
lular elements, which produced little
mucus, formed solid cords replacing
the normal glandular cells.
Some patients may lack repair en
zymes or possess enzymes that con
sistently lead to miscoding and per
petuation of an error in DNA produc
tion and its transcription. As Weisburger30 stressed in discussing the role
of the diet in colonic neoplasm, urine
could also modulate the effects of car
cinogens on the gut by its influence
on the microflora. Activation of the
microflora provokes the formation of
split products that may be carci
nogenic.
When there are mechanical factors
causing chronic inflammation, there is
a need for continuous repair of the
mucosa which increases the risk of an
abnormal healing process.
Although urine is diverted from the
colon, once the cellular changes have
been initiated their progression can-

Table I—Sex Distribution of Benign and
Malignant Tumours of the Colon and Rectum
Occurring after Ureterosigmoidostomy

FIG. 3—Ulcerated lesion that was sit
uated 3 cm distal to ureteral stumps is
moderately differentiated adenocarcinoma
which invaded wall of rectum as far as
superficial portion of muscularis propria
(arrow) (hematoxylin and eosin, reduced
by 43% from X9.28).

Sex

Benign Malignant Total (and % )

Male
Female

8
2

21
11

29 (69)
13 (31)

10

32

42 (100)

FIG. 4— Age distribution of malignant
ureterocolonic tumours compared to that
of colonic cancers in general population
(n = number of patients).

Table II— Distribution according to Primary Urologic Condition and Differentiation
into Benign or Malignant Lesions
Primary conditions
Bladder exstrophy1’2’4- 6'9-1012- 15’17-18'20.21’24'25*
Transitional cell carcinoma3’10’11’19'25
Epispadias8
Nonbacterial cystitis10
Interstitial cystitis25
Squamous cell carcinoma of bladder25
Persistent urinary fistula7'20
Congenital incontinence22
Trauma to bladder15

Malignant

6
2
I
1
0
0
0
0
0

20
5
1
0
1
1
2
1
1

26 (62%)
7
2
1
1
1
2
1
1

10

32

42

% )

FIG. 5— Distribution of malignant tu
mours in relation to time elapsed after
uterosigmoidostomy.

‘ Includes present study.
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not be limited. In the present case,
we can witness the progressive res
ponse of the mucosa to the different
stresses. At the ureterosigmoidostomy
junction we found two hyperplastic
lesions, and in one there were both
adenom atous and carcinomatous pro
liferations. The third tumour, found 3
cm distal to the ureteral stumps, was
a well-differentiated adenocarcinoma.
There is another possible explana
tion. In some cases there may be pre
disposing factors; the mother of our
patient also had an adenocarcinoma
of the sigmoid colon. Thus the role
of the urine, in this case, seems to
have been an adjuvant in manifesting
a pre-existing propensity for tumour
formation.
A number of factors are most likely
implicated in the pathogenesis of this
condition and their interrelationships
lead to a great deal of speculation.

Conclusion

7.

8.
9.

10.
11.
12.

13.

Although ureterosigmoidostomy has
been replaced to a large extent by
other methods of urinary diversion,
those patients who have had the pro
cedure should be followed up very
carefully. In the presence of rectal
bleeding or deteriorating renal func
tion, patients should be examined by
intravenous pyelography, roentgenog
raphy after a barium enema and sig
moidoscopy. Moreover, if conversion
to an ileal conduit is indicated, resec
tion of the colonic segment into which
the ureters had been implanted should
be done to prevent tumour forming
at the site of the ureteral stomas. It
will be interesting to see if this com
plication develops more frequently
with the increasing use of a colonic
conduit. The colonic mucosa is per
haps m ore sensitive to malignant de
generation than the ileum but with the
colonic conduit, mechanical trauma
and stagnation of urine are less
marked. However, one must be aware
that these tumours exist and that
they should be sought when indicated.
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Critique of Item 606 (SESAP II)
In a young man a painless testicular mass which does not transilluminate
is a neoplasm until proved otherwise. A hydrocele or spermatocele,
and possibly a hernia, would transilluminate. Preliminary studies should
include a roentgenogram of the chest, an intravenous pyelogram, and
an assay for gonadotropins. The preferred response is orchiectomy
through an inguinal incision. Needle aspiration of fluid or needle
biopsy is contraindicated because a testicular tum or is usually well
contained by the tunica albuginea, but once it is entered, the tumor
spreads rapidly to the scrotum and to the lymph nodes in the groin.
For the same reason, the incision should not be made through the
scrotum. The mass as described is very unlikely to be an epididymitis,
and administration of antibiotics, and observation for two to four
feeks, are therefore not justified.
Reference

606/ 1. Whitmore W F Jr: Tumors of the penis, urethra, scrotum and
testis, in Campbell MF, Harrison JH (eds): Urology, ed 3. Philadelphia,
WB Saunders Co, 1970, vol 2, pp 1211-1223
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Intraoperative Transmural Myocardial Biopsy:
a Simple Technique
S.M.

T .A . Salerno , md , frcs [c ],*
WASAN, MD, M SC, FCAP, FRCP[C]t

A Tru-cut disposable biopsy needle was
used in 10 pigs, 3 cadavers and
63 humans to obtain transmural
ventricular myocardium for diagnostic
and research purposes. The technique
proved simple and safe. In every case
an adequate amount of full-thickness
myocardium was obtained which was
examined by light and electron
microscopy and used for enzyme studies
and glycogen measurement.
line aiguille a biopsie jetable
Tru-cut a ete utilisee chez 10 pores,
3 cadavres et 63 humains pour
obtenir un prelevement du myocarde
a travers la paroi du ventricule pour
fins de diagnostic et de recherche.
La technique s’est averee simple et
sure. Dans tous les cas, une
quantite suffisante du myocarde entier
a ete obtenue et ensuite a ete
examinee aux microscopes optique
et electronique et utilisee pour des
etudes enzymatiques et des mesures
du glycogene.

Although endomyocardial biopsy can
be performed by the percutaneous
route,1-3 transmural myocardial samples
are more difficult to obtain. Search
for a simple method led us to use a
disposable needle which gave uniform
ly successful results.
Material and Methods

Ten Poland-China pigs were anes
thetized. The heart was exposed and
separate biopsy specimens were ob
tained from left ventricular myocar
dium using a Tru-cut biopsy needle
(Travenol Laboratories, Inc., Deerfield,
IL) (Figs. 1 and 2). The full-thickness
specimens (0.1 X 1.7 cm) weighing 8
mg each (Fig. 3) were examined by
light and electron microscopy, and were
From the departments of *surgery
and t pathology, Queen’s University,
Kingston, Ont.
Supported by Ontario Heart Foundation
grant 2-4
Reprint requests to: Dr. T.A. Salerno,
Department of surgery, Queen’s
University, Kingston General Hospital,
Kingston, Ont. K7L 2V7

D.P.

and

L ince , md , frcs [c ],*
C harrette , md ,

E.J.P.

used for glycogen measurement and en
zyme studies.
The need for transmural myocardial
biopsy specimens for clinical investiga
tion and diagnostic purposes prompted
us to try the same needle in three
cadaver hearts. The technique was
equally successful. This was followed
by use of the needle in a series of 63
patients of whom 55 had elective coro
nary artery bypass surgery, 5 had valve
replacement, 2 underwent elective
closed mitral commissurotomy and 1
had emergency pericardiectomy. Two
separate biopsies were done at the
apex of the left ventricle, at the start
of cardiopulmonary bypass and again
following completion of the proximal
anastomoses just before unclamping
of the aorta. The puncture site pro
duced by the needle was closed with
a simple superficial figure-of-eight su
ture of 4-0 Prolene (Ethicon Sutures
Ltd., Peterborough, Ont.).
In the patients who underwent valve
replacement, the left ventricular biopsy
was done at the site where the vent is
usually inserted.
There were no complications asso
ciated with the biopsy procedure. An
adequate amount of tissue was ob
tained in every patient and was used

frcs [c ]*

for clinical research in 60 patients and
for diagnostic purposes in 3 patients.
Discussion

Endomyocardial biopsy specimens
can be easily obtained by the percu
taneous route. The sample, how
ever, may not be representative of
the ongoing processes in the other
layers of the heart. Other techniques
including the use of the Silverman
needle,4 the Menghini needle5 and the
Dobell biopsy gun (Dobell ARC: un
published data, 1971) have been used
to obtain a specimen that includes all
layers of myocardium. The method we
describe is easy and reproducible. No
complications have occurred. In every
case adequate full-thickness tissue
cores were obtained. Specimens of this
sort may be of great value in elucidat
ing the nature of ongoing processes in
the different layers of the heart. We
think we have solved a major problem
for the cardiac surgeon involved in
clinical research, namely, that of ob
taining a full-thickness biopsy of the
myocardium.
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FIG. 2—Biopsy needle being positioned
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FIG. 3—Core of myocardium obtained
with Tru-cut biopsy needle.
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continued from page 451
DIE UNTERSUCHUNG DER BAUCHSPEICHELDRUSE. I. Hamberger Medizinisches Symposium 12. und 13.
Dezember 1975. Edited by Heinrich
Bartelheimer, Meinhard Classen, Friedrich-Wilhelm Ossenberg.
172 pp.
IHust. Georg Thieme Verlag, Stuttgart,
1976. DM 50, paperbound. ISBN 3-135446-01-8.

This well-prepared monograph presents
the proceedings of a conference devoted
to the diagnostic aspects of pancreatic
disease. The majority of the papers are
written in German, but some are in
English. Various diagnostic tests and pro
cedures introduced recently are reviewed
competently by different experts reporting
their own experiences. Tests for enzymes
and fetal antigen, ultrasonography, biopsy,
angiography and cannulation of the pan
creatic duct through a fiberoptic endo
scope are some of the diagnostic aids de
scribed and discussed. With the use of
these new procedures pancreatic disease
can be diagnosed accurately.
This text is an excellent, concise state
of the art review which can be recom
mended to all interested in pancreatic
disease.
W. ZlNGG, MD, M SC, FRCSfc]

Division of surgical research,
The Hospital for Sick Children,
Toronto, Ont.

GENERAL SURGICAL OPERATIONS.
Edited by R.M. Kirk. 412 pp. IHust.
Churchill Livingstone, Edinburgh; Long
man Canada Limited, Don Mills, Ont.
1978. Price not stated. ISBN 0-44301597-X.

This book is essentially a technique text
but has a unique style. The format of
each chapter is identical. The author pro
vides all data under the headings of pre
operative care, operative techniques, oper
ative considerations, problems, safeguards
and access. Most major procedures are
covered in one to two pages, yet the in
formation is complete and readable. There
are only two or three references for each
section but all are important and provide
good direction for further reading.
The first 12 of the 27 chapters are de
voted to abdominal surgery and 9 of these
are by Kirk himself so that there is good
continuity. The chapter on anorectal dis
eases is written by Lord who is a wellrecognized expert in that field. While there
were many technical points with which I
would raise mild objections, only in Lord’s
chapter did I find two worth pointing out.
On page 148, there is considerable con
fusion as to whether the patient is actually
in the Sims or the lithotomy position.
The statement that “patients remain in
hospital for six to ten days after hemor
rhoidectomy” would certainly raise some
eyebrows. Also, Lord states that anal
488

dilatation should be undertaken with
“caution in the elderly”. This point is not
emphasized enough since the text indi
cates that anal dilatation is quite accepta
ble and the author does not define what
is meant by “with caution”. The frequen
cy of incontinence is unacceptably high
when rectal dilatation is performed in
patients over 55 years of age.
Chapters 13 to 27 cover every other
sphere of surgery and, with one exception,
each chapter has been written by a sepa
rate author. Included in this block are
three chapters specifically related to gen
eral surgery dealing with the breast, en
docrine system and the head and neck
respectively. I found the chapter on the
endocrine system quite brief (three pages).
Also, in view of the increasing incidence
of hyperparathyroidism, I thought that a
half page dealing with this topic and pro
viding no illustration was inadequate cov
erage. On the other hand, there are am
ple articles in the literature dealing with
this sphere of endocrine surgery.
Orthopedic surgery is rather heavily
weighted receiving in this text three chap
ters for a total of 75 pages. Peripheral
vascular surgery, on the other hand, is
dealt with in 16 pages; although this
chapter is brief it is quite well done.
Similarly, cardiothoracic surgery received
only 20 pages. Perhaps, the editor could
justifiably argue that he wished to provide
only the bare essentials in these two areas
since the book is oriented towards the
general surgeon who might possibly have
to deal with all situations. However, the
intricate procedures described in the three
orthopedic chapters indicate that editing
was poor in these areas. My impression
was that the chapters on peripheral vas
cular, cardiothoracic and orthopedic sur
gery were solicited and then simply in
serted into the text as received. This is,
of course, a common problem with mul
tiple-authored texts. To give Kirk the
benefit of the doubt, it is possible that
general surgeons perform more ortho
pedic surgery than peripheral vascular
or cardiothoracic surgery in Great Britain.
Also, the format of these chapters is iden
tical to that used in the other chapters
suggesting that some editing was carried
out.
In summary, this textbook of surgical
techniques is brief but very complete and
to the point. Every aspect of surgery
from ingrown toenails to foreign bodies
in the eye is covered in cookbook style.
This renders the text excellent for rapid
preoperative review of the subject ma
terial. I particularly like the appropriate
check lists provided with most of the
procedures. This text does not replace
the standard surgical technique books
such as those of Cooper or Maingot
but it apparently was not intended to
compete with them. For the intern,
the first- or second-year surgical resi
dent, “General Surgical Operations” is
an excellent and highly recommended
book. It might be useful to the surgeon
located in a small community who must
perform many types of surgery. Ad
vanced surgical residents or completely
trained surgeons would find this text
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beneficial only for teaching more junior
colleagues.
J oel

B. F r e e m a n ,

m d , c m , fr c s [c ]

Chief, department of surgery,
Ottawa General Hospital,
Ottawa, Ont.
4
GENITOURINARY
PROBLEMS
IN
WOMEN. Jack R. Robertson. 149 pp.
IHust. Charles C Thomas, Publisher,
Springfield, IL, 1978. $16.75. ISBN
0-398-03668-3.

This book consists of an introduction and
chapters on the history of gynecologic
urology, anatomy and physiology, meth
ods of evaluating urinary incontinence,
the Robertson method, the neglected
female urethra, vesicovaginal fistula, blad
der drainage, urinary tract infections, the
dysfunctional bladder and urethra, and
pelvic surgery with endoscopic control. It
is devoted chiefly to the evaluation and
treatment of urinary incontinence in
women, the female urethra and vesico
vaginal fistula. The author presents his
views on the etiology, pathogenesis and
treatment of these conditions, often in
great detail.
The most interesting features of the
book are the sections devoted to the in
vestigation and management of urinary
incontinence in the female. However, it
is difficult to recognize that stress incon
tinence is seen within the larger frame
work of functional and etiologic classifi
cations of urinary incontinence.
Most urologists believe that the classic
paper by Marshall, Marchetti and Krantz
(The correction of stress incontinence by
simple vesicourethral suspension. Surg
Gynecol Obstet 88: 509, 1949) remains
the standard by which other methods for
investigating and treating stress incon
tinence are judged. They put forward the
exceedingly simple etiologic concept
which formed the basis of treatment. As
different methods of investigation have
appeared since 1949, each has developed
with its own jargon. The result is that
many different terms are now used to ex
plain the basic concept of Marshall, Mar
chetti and Krantz, but these terms are
related to the different methods of inves
tigation and not to the underlying pathol
ogy, thus causing much unnecessary con
fusion. This book is one example of many.
There are numerous examples in this
book of its parochial approach. There is
no mention of Victor Bonney’s paper of
1923 in the history chapter, a surprising
omission. No mention is made of attempts
at surgical treatment of stress incon
tinence before that of Kelly in 1893. In
the foreword, it is stated, “urologists
have concentrated their efforts on the
male, and most of them know very little
about the female urethra and bladder”.
The lack of knowledge of urologic in
terest in these conditions in the past 30
years is again surprising. There seems to
be little recognition that many of these
problems are now managed by multi
disciplinary treatment teams. The methods
presented are undoubtedly successful in
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the hands of the author and are interest
ing in this context.
W .E . C o l l in s ,

md

,

f r c s [ c ],

PLASTIC AND RECONSTRUCTIVE
SURGERY OF THE FACE AND
NECK. Proceedings of the Second In
ternational Symposium. Volume 1:
Aesthetic Surgery. Edited by George A.
Sisson and M. Eugene Tardy, Jr. 236
pp. Illust. Grune & Stratton, Inc., New
York; Longman Canada Limited, Don
Mills, Ont., 1977. $45.65. ISBN 0-80890941-X.

facs

Ste. 207,
1105 Carling Ave.,
Ottawa, Ont.
A

MANUAL OF THORACIC SUR
GERY. Arndt von Hippel. 247 pp.
Illust. Charles C Thomas, Publisher,
Springfield, IL, 1978. $13.75, clothbound; $8.75, paperbound. ISBN 0-39803689-6, clothbound; ISBN 0-398-03690X, paperbound.

PLASTIC AND RECONSTRUCTIVE
SURGERY OF THE FACE AND
NECK. Proceedings of the Second In
ternational Symposium. Volume 2: Re
habilitative Surgery. Edited by George
A. Sisson and M. Eugene Tardy, Jr.
348 pp. Illust. Grune & Stratton, Inc.,
New York; Longman Canada Limited,
Don Mills, Ont., 1977. $59.40, ISBN
0-8089-0956-8.

This book is an expanded version of a
previous publication, “Chest Tubes and
Chest Bottles”, by the same author. The
format is the same, chapters being divided
into short sections for easy reading. The
book is written in a flowing narrative
style and points are illustrated using sim
ple diagrams and anecdotal “case re
ports”.
“Chest Tubes and Chest Bottles” has
been enlarged by adding new chapters on
the diaphragm, the lung, the blood pump
(my italics), and pleural effusions; previ
ous topics have been discussed more fully
with extra emphasis on diagnosis and
methods of treatment of thoracic surgical
disorders. No attempt has been made to
cover the technical aspects of surgery,
although detailed methodology for pleural
aspiration and insertion of chest tubes is
given. The technique of closed needle
biopsy of the pleura is not mentioned.
This expanded text attempts to deal
with thoracic physiology and surgery as
they relate to closed chest drainage. How
ever, to describe the diaphragm as a
muscle sandwich, the respiratory system
as the air pump, or the heart as the blood
pump seems rather simplistic. Physiologic
misconceptions in the text may be the
result of this oversimplification, detractisg from the book’s quality as do some
errors of omission.
The chapters on chest tubes and bottles,
almost unchanged from the previous pub
lication, are very good. Included are
indications for insertion of tubes, de
tailed technique for introduction and an
excellent diagram illustrating an easy way
to secure the tube—always, I think, one
of the most difficult parts of the proce
dure. There is also a useful section on
“trouble shooting” problems that may oc
cur while the chest tube is in place.
The book is aimed at “less experienced,
or more highly specialized thoracic sur
geons”. Although the author relates his
personal experience rather than giving
a didactic review of the literature, I think
most thoracic surgeons will find it over
simplified. It would, however, make ex
cellent reading for practitioners who only
occasionally deal with chest tubes and bot
tles, and for all nurses who care for
patients who have undergone thoracic
surgery.
D. S t u b b i n g , m b , b s
Ambrose cardiorespiratory unit,
Department of medicine,
McMaster University,
Hamilton, Ont.
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In 1975 the American Academy of Facial
Plastic and Reconstructive Surgery hosted
the second international symposium on
the subject for which this Academy was
named. Inevitably these two volumes are a
summary of the proceedings, containing
some papers in full and others greatly
shortened. The panel discussions have also
been included. The books are thus neither
detailed enough to explain the latest tech
niques nor broad enough to be used as
general reference works.
The illustrations are the greatest draw
back to these two books. Preoperative
and postoperative pictures have been taken
from different angles, different distances
and under different lighting, so that a
true comparison is impossible. Indeed the
majority of comparative pictures are use
less.
Half the first volume on aesthetic sur
gery is devoted to rhinoplasty. An experi
enced rhinoplastic surgeon may gain a
few tips but no basic techniques are dis
cussed. A very short section is devoted
to rhytidectomy and most postoperative
photographs were taken at such a short
interval after operation that they are of
no use. The segment on the orbit dis
cusses blepharoplasty and devotes a sub
stantial chapter to supraorbital ridge re
duction. Again it is difficult to tell the
difference between preoperative and
postoperative appearances. Otoplasty is
limited to three pages on one technique.
The second volume on rehabilitative
surgery covers many subjects from the
head and cancer to laryngeal prominence
reduction for trans-sexual patients. As in
the first volume the photographs are poor
and distorted. Often they show change
but no improvement for the patient. Many
chapters consist of case reports only. In
deed one chapter is a case report of one
patient and an old technique for recon
struction of the temporomandibular joint.
A new superior pharyngeal flap technique
(which is not new) is described based on
five patients! Many of the best and most
modern techniques such as in microtia
correction, traumatic ear reconstruction
or electrical burns of the mouth seem to
/
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whenshock
threatens the lung
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helps reduce pulmonary
damage and increase
survival rates
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• preserves lysosome and cell membranes, thereby preventing the release of destructive
lysosomal enzymes3
0 preserves platelets thereby reducing the risk of intravascular coagulation1
• preserves leukocyte integrity thereby helping to maintain the pulmonary architecture1
The recovery of patients in shock is often complicated by a pattern of deteriorating pul
monary function, commonly described as shock lung. This pulmonary insufficiency
progresses despite restoration of haemodynamic balance and apparent stabilization of
the acute episode.
Under conditions of prolonged shock, lack of oxygen at the cellular level causes
alterations in the oxygen-carbon dioxide exchange m echanism . These
changes in cell metabolism lead ultimately to interstitial oedema and peri
vascular haemorrhage.1 Polymorphonuclear leukocytes aggregate in
the pulmonary capillaries and obstruct the pulmonary vascular
bed. As these trapped cells break down, they release lysosomes, tiny subcellular particles containing proteolytic
enzymes.1These enzymes attack their host cell and
<
go on to damage or destroy other cells.2 The re
sulting tissue dam age may not readily repair
itself even if the shock patient survives.
When administered in conjunction with
!*
standard therapeutic measures, SoluM I
Medrol exerts a protective effect
on the lung and improves the
patient’s chance of survival.
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be omitted and possibly are unknown to
the authors.
In summary there is little value in
these two volumes apart from historical
interest for those who attended this sym
posium.
I an R. M u n r o ,

m b , b c h ir , f r c s [c ]

Division of plastic surgery,
The Hospital for Sick Children,
Toronto, Ont.
THE
SECOND
INTERNATIONAL
SYMPOSIUM ON M ALIGNANT HYPERTHEMIA. Proceedings of a Sym
posium H eld in Denver, Colorado, April
1-3, 1977. Edited by J. Antonio Aldrete
and Beverley A. Britt. 560 pp. Illust.
Grime & Stratton, Inc., New York,
1978. $25.50. ISBN 0-8089-1073-6.

Malignant hypermia has become recog
nized as one of the principal causes
of death in patients who are anesthetized
for surgical procedures. The syndrome is
rare with prevalence ranging from, 1 in
14 000 to 1 in 110 000 but is inherited
as an autosomal dominant characteristic.
Therefore, every surgeon and anesthetist
should be acquainted with the recent ad
vances in etiology, detection, prevention
and management of this condition.
The first international symposium was
held in Toronto in May 1971. Since then,
much new knowledge has accumulated on
the subject. We can be proud that some
of the most fruitful research in this field
has been performed in Canada.
This text is divided into sections on
muscle physiology and biochemistry, diag
nostic and predictive tests, clinical ob
servations, studies in pigs exhibiting the
porcine stress syndrome (a condition sim
ilar to malignant hyperthermia in hu
mans) and the current treatment of this
affliction.
The main site of the disease is in
skeletal muscle where the regulation of
calcium ion distribution is abnormal.
Muscle samples from susceptible individu
als show increased contraction in response
to a wide variety of stimuli including
anesthetic agents and various forms of
stress. The exposure of malignant hyper
thermic muscle to halothane, succinylcholine and some other anesthetic agents
in vivo leads to a sudden release of cal
cium ions into the myoplasm which pro
duces all of the clinical features of the
syndrome. Recent studies suggest that the
“membrane disorder” responsible for the
disease may be present elsewhere in the
human body including cardiac muscle.
All individuals susceptible to malignant
hyperthermia have an underlying muscle
disease and two predisposing myopathies
have been defined; the commoner myo
pathy affects young boys whose physical
abnormalities include short stature, cryp
torchidism, pectus carinatum, antimongoloid slant of the palpebral fissures,
ptosis, webbed neck, low set ears, kyphosis,
lordosis and weakness of the serrati mus
cles. Malignant hyperthermia is also
known to be associated with osteogenesis
imperfecta.
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Clinically, the syndrome develops dur
ing the administration of anesthesia
usually in response to such potent agents
as halothane or succinylcholine. However,
many different types of drugs have been
shown to precipitate the condition. Even
the use of regional anesthesia does not
always ensure protection. The usual symp
toms are tachypnea, tachycardia, hyper
tension, cardiac arrhythmias, hypotension
and a rapid increase in body tempera
ture of approximately 2°C/h; muscle
rigidity may or may not be present. Labo
ratory studies show severe metabolic and
respiratory acidosis, hyperkalemia, hyper
glycemia and hypercalcemia followed by
hypocalemia, myoglobinurea and
a
marked increase in the metabolic rate
and in oxygen consumption. The patient
may become comatose, convulse, experi
ence cardiac arrhythmias or sudden car
diac arrest. The condition may be further
complicated by disseminated intravascular
coagulation, renal failure or sepsis.
Proper management depends on the
detection of susceptible persons so that
steps can be taken to prevent the use
of agents which may trigger the syn
drome. Immediate appropriate therapy at
the first signs of the syndrome will often
abort an attack and thus reduce mortal
ity.
This text reviews and evaluates vari
ous tests that have been used to screen
individuals for the condition when a
family history of death during or fol
lowing anesthesia alerts the anesthetist or
surgeon to the possibility that other fam
ily members may be afflicted. Creatinine
phosphokinase values will generally be
higher in susceptible persons. However,
false-positive and false-negative results can
occur.
Once suspected, muscle biopsy will
generally confirm the diagnosis. A posi
tive result from the caffeine or halothane
contracture test indicates susceptibility to
the syndrome. After additional trial studies
have been completed measurement of
serum inorganic pyrophosphate concen
trations may be valuable.
Anesthesia can be administered to sus
ceptible patients providing that agents
known to trigger the condition are
avoided. Once the clinical signs have been
recognized during anesthesia, the use of
the responsible agents should be discon
tinued immediately and cooling proce
dures instituted. The lactic acidosis, elec
trolyte imbalance, disseminated intravas
cular coagulation and anuria should be
treated vigorously.
The main message delivered by this
excellent collection of papers is that by
the utilization of current knowledge this
rare syndrome can be detected and effec
tively treated or prevented with a con
sequent reduction in perioperative mortal
ity.
A new drug, dantrolene sodium, which
lowers the myoplasmic calcium concen
tration, promises to be a most effective
agent in treating malignant hyperthermia.
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The impressive papers, featuring graph
ic illustrations on the anatomy, biochem
istry and pathophysiology of skeletal
muscle deserve special commendation and
should be of interest to those concerned
with muscle related diseases.
This book is recommended to all physi
cians as a source of information on the
complex subject of malignant hyper
thermia. However, this book is not easy
to read. Assimilation of the information
requires time and concentration.
J ohn H. F eindel,

md, cm , frcp [c]

Head,
Department of anesthesia,
Halifax Infirmary,
Halifax, NS
SHAW’S TEXTBOOK OF OPERATIVE
GYNECOLOGY. 4th ed. Revised by
John Hawkins and Christopher N.
Hudson. 547 pp. Illust. Churchill Living
stone, Edinburgh; Longman Canada
Limited, Don Mills, Ont., 1977. $98.
ISBN 0-443-01394-2.

Henry Gage, writing in “The Science of
Political Economy” in 1898, said: “The
value of a thing is the amount of labour
ing or work that its possession will save
the possessor.” Using this criterion, Shaw’s
book is not a good purchase for the prac
tising gynecologist. However, it can be
recommended for medical libraries cater
ing to students and prospective specialists.
To dispense with its main liability:
the publisher’s brochure states that in
recent years there has been greater em
phasis on the medical and endocrinologic
aspects of modern gynecology, yet gyne
cologists still require the traditional skills
of surgery. I agree with that statement,
but neither this book nor any other I’ve
seen will ensure this heritage. Why do
authors and publishers of surgical texts
continue to fantasize on this point? No
one can ever learn surgical technique
from a book. The techniques the surgeon
uses are those taught during the residency
period.
The artist’s drawings in this book are
typical of those seen in surgical texts.
They are grossly inadequate. One would
need the genius of Michelangelo, the in
novative spirit of Leonardo da Vinci and
a touch of Picasso to illustrate the flow
ing dynamics of a surgical operation.
Authors of surgical texts should stop de
ceiving themselves that it can be done.
This book does have some merits. Stu
dents and residents will benefit from the
chapters on anatomy, preoperative prepa
ration and postoperative complications.
There are also sound discussions on the
basic gynecologic diseases. Moreover,
since this is an operative textbook, it
provides the nonspecialist reader with a
general idea of the surgical approach to
these problems.
There is an adequate section on laparo
scopy. I heartily concur with the author
that one eye in the pelvis is often better
than two fingers in the vagina. But I
disagree on one technical point. The au
thor advises surgeons to make an incision
at the inferior margin of the umbilicus.
This is a potentially hazardous location.
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The umbilicus is not the entrance to
the pelvis. The aorta lies directly beneath
it and several reports in the medical liter
ature discuss injuries to this vessel result
ing from laparoscopy. More injuries will
occur in future if surgeons continue to
use this site. Why not use the true en
trance to the pelvis? This is three fingers’
width below the umbilicus. And the short
transverse incision in this location can
hardly be seen a few weeks later.
I found a glaring example of British
conservatism in the chapter dealing with
hysterectomy for benign conditions, in
which the author suggests the preserva
tion of healthy ovaries for any woman
under 50 years of age. I cannot see much
sense in this approach in Canada. Most
ovaries have lost their usefulness several
years before this age. I can understand
why this advice is offered in England—
estrogen therapy for menopause is not as
well accepted in Britain as it is in North
America. There must be tens of thousands
of women needlessly suffering from senile
vaginitis in that country. But such advice
for Canadian readers is questionable.
To end on a positive note, practising
gynecologists have a good track record
in avoiding bladder, ureter and bowel in
juries, but should they experience trouble
in this area, the chapters in this text deal
ing with these problems give good advice.
Similarly the sections on diagnostic radio
logy and chemotherapy also help to re
fresh the memory.
Texts such as this obviously have some
merit, but whether the book is worth

$98 to the practising gynecologist is de
batable.
K.F. W alker,

md , frcs [c ]

6150 Valley Way,
Niagara Falls, Ont.
TRAUMA OF THE CHEST. The Coven
try Conference 1977. Edited by W.G.
Williams and R.E. Smith. 266 pp. Illust.
John Wright & Sons Ltd., Bristol; Year
Book Medical Publishers, Inc., Chicago,
1977. $22.10, paperbound. ISBN 0-72360484-3.

At a time when the frequency of chest
trauma associated with motor vehicle
accidents is diminishing, due to the use
of seat belts and lower speed limits, there
has been a resurgence of interest in the
topic, as evidenced by new books deal
ing exclusively with chest trauma.
The fourth Coventry Conference was
devoted to trauma of the chest, and this
book is the proceedings of that confer
ence.
The three previous conferences covered
surgery of the esophagus, of the lung and
of the heart. At the fourth conference au
thorities from Europe, Great Britain, and
United States and Canada discussed in
detail their experiences with various as
pects of chest trauma. The book is not in
tended to be a reference nor a review of
all facets of thoracic injuries, but com
prises papers and discussions of se
lected topics. The topics include flail
chest, injuries to the aorta and great ves
sels, rupture of the bronchus, post-trau
matic pulmonary insufficiency, penetrat-
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ing chest wounds and physical and chem
ical injuries to the lung.
Particularly interesting are the diver
gent views on the management of flail
chest, with renewed interest being shown
in open reduction and fixation as exem
plified in a well-documented paper by
Dr. F. Paris from Valencia, Spain. Trinkle’s remarks on the pathophysiology of
flail chest are cogent and reflect the
experimental and clinical work he has
carried out in San Antonio emphasizing
the underlying pulmonary pathology
rather than the unstable chest wall.
Also included is an extremely com
plete, somewhat tedious, review of trau
matic diaphragmatic hernias. This review
contains a well-researched bibliography.
The section on penetrating wounds of
the chest, discussed by Platt from Dallas
and Trinkle, reflects their extensive ex
perience with this type of injury in
Texas. While their methods of approach,
particularly in the management of cardiac
injuries, differslightly, their views are
valuable to anyone who may be required
to manage such injuries.
It is hoped that the excellent papers
on post-traumatic pulmonary insuffici
ency will finally lay to rest the slick,
but inappropriate, term “shock lung”. The
relative
roles of
excessive crystalloid
fluid replacement and sepsis in the de
velopment of this condition are thorough
ly detailed.
The print used and the layout of this
soft cover book do not make for particu
larly easy reading, but there is a wealth
of information to be gleaned from some
of the papers, and, as such, the book
should be of interest to anyone dealing
with chest trauma.
H J. S achs, m d , f r c s [c ]
Division of cardiothoracic surgery,
Ottawa Civic Hospital,
Ottawa, Ont.
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URINARY
SYSTEM
MALFORMA
TIONS IN CHILDREN. Proceedings of
the International Pediatric Urological
Seminar, Philadelphia, 1976. The Na
tional Foundation— March of Dimes.
Birth Defects: Original Articles Series,
Volume XIII, Number 5, 1977. Edited
by Daniel Bergsma and John W.
Duckett. 481 pp. IUust. Alan R. Liss,
Inc., New York, 1977. $50. ISBN
0-8451-1014-4.

This book is a compilation of papers and
comments, most of which were presented
at a seminar on malformations of the
urinary system in children. Many of the
book’s contributors are well known for
their work on congenital anomalies and
surgery of the urinary tract.
The book is divided into nine logical
sections, ranging from megaureters to
urethral valves, prune-belly syndrome,
neuropathic bladder, exstrophy, hypospa
dias, reflux and cryptorchidism. It offers
a clear, concise summary in many cases
of the authors’ views on these subjects.
At the end of each section is a discussion
by some of the eminent contributors to
the field.
The physical appearance of the text
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does not compare with the glossy, slick
texts recently published on pediatric
surgery or reconstructive surgery of the
urinary tract. However, on close reading,
the roentgenograms are well reproduced
and the charts and tables are accurate
and well presented. The index, although
accurate, is only six pages long and could
be expanded.
As with the publication of any pro
ceedings, the text bespeaks a familiarity
with the topics presented. A surgeon with
limited experience in urinary malforma
tions in children and their management
might be confused by some of the arti
cles. However, for any surgeon familiar
with these malformations, this publication
will be of immense interest and use. .It
should be present in the hospital library
of any institution where pediatric surgery
is performed.
J.F . SCHILLINGER, MD, FRCS[C]

Chief, division of urology,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.
THE YEAR BOOK OF ORTHOPEDICS
AND TRAUMATIC SURGERY. 1977.
Edited by Mark B. Coventry. 429 pp.
lllust. Year Book Medical Publishers,
Inc., Chicago, 1977. $25.25. ISBN
0-8151-1876-7.

This year book follows the routine format
of previous editions, updated to reflect
the current interests in orthopedic and
traumatic surgery. One is always im
pressed by the progressive improvement
in quality of the abstract selections in
succeeding years, a particularly difficult
assignment for the editor.
The major attractions of the year book
series are the reader’s enjoyment in the
rapid scanning of a choice selection of
abstracts from a multitude of journals
and the inherent satisfaction of having
a glimpse at the world-wide orthopedic
scene in “Reader’s Digest” form. Such
abstracts are easily perused, demand
minimal concentration and readily arouse
the curiosity of the practising physician,
the academician or the trainee. As an
ticipated, specific interest in a certain
title invariably prompts the reader to
search out the full article from the given
reference.
The editorial comments on each article
are especially worth while, the remarks
of Coventry, the editor, being particularly
relevant and appropriately critical.
The changing emphasis in orthopedic
surgery is again reflected in this edition.
More space is now devoted to orthopedic
research, the popular trend of the 1970s.
Less space is allocated to such subjects as
prosthetics.
For relaxed reading in the field of
orthopedic surgery, this book is good
value. For the academic pursuit of a de
tailed subject, it has very limited use.
J a m es J. W il e y ,

m d , f r c s [c ]

Orthopedic clinic,
Children’s Hospital of Eastern Ontario,
Ottawa, Ont.

THE CANADIAN JOURNAL OF SURGERY

